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ABSTRACT
This thesis is based on the tenet that careful preoperative patient selection is
important before attempting resection with 'curative' intent in patients with
pancreatic or periampullary carcinoma. Little consensus has existed as regards the
ideal investigative algorithm for evaluating resectability in such patients. The aims
of this thesis were to validate staging laparoscopy, laparoscopic ultrasonography
(LapUS), and laparoscopic peritoneal cytology (LPC) in the staging of patients
presenting with pancreatic or periampullary carcinoma. A series of studies was
perfomed over a period of 52 months between 1991 and 1995 to evaluate the
efficacy of these techniques.
A systematic method for LapUS examination of the liver, biliary tree and pancreas
was devised. In Study 1, the ability of LapUS to image defined anatomical
landmarks was evaluated during (i) laparoscopic cholecystectomy, and (ii) staging
laparoscopy for pancreatic malignancy. Satisfactory imaging of all anatomical
structures considered important was shown to be feasible using LapUS.
In Study 2, staging laparoscopy with LapUS was performed in forty patients with
pancreatic or periampullary carcinomas otherwise considered to be potentially
resectable on the basis of transabdominal ultrasonography (USS) and / or
computerised tomography (CT). Occult metastatic lesions were demonstrated by
laparoscopy in 14 patients (35%). Following LapUS, staging information in addition
to that obtained from laparoscopy alone was obtained in 20 patients (53%), and
changed the decision regarding tumour resectability in 10 patients (25%).
Laparoscopy with LapUS was more sensitive and accurate than laparoscopy alone in
identifying tumour unresesctability (88% and 89% versus 50% and 65%).
Study 3 comprised a prospective 'blind' comparison of USS, CT, laparoscopy with
LapUS and selective visceral angiography (SVA) in the TNM staging of fifty
patients with pancreatic or periampullary cancer. The unique role of staging
laparoscopy in the detection of intraabdominal metastatic disease was verified by its
significantly superior sensitivity and negative predictive value compared with USS
and CT. In the evaluation of T stage, laparoscopy with LapUS was significantly less
likely to overstage tumour compared with USS or CT. Reliable determination of N
stage was not achieved by any investigation. When all these factors were
considered, laparoscopy with LapUS was shown to be superior to other
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investigations in identifying tumour resectability, and significantly more reliable
than CT in determining tumour unresectability.
in Study 4, LPC was performed in 46 of the above patients, and was found to be
insensitive in identifying patients with unresectable disease (23%). In seven patients
with positive cytology (15%), LPC was highly specific and predictive (100%) for
metastatic spread. However, LPC contributed no additional staging information over
laparoscopy. The median cumulative survival at three and six months was 17% and
8% for patients with positive LPC compared with 87% and 71% respectively for
those with negative LPC.
These studies provide evidence that staging laparoscopy with LapUS is efficacious
in the preoperative assessment of patients with pancreatic or periampullary cancer.
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Chapter 1 Introduction
"Select better the patients we resect
Select better who does the resection
Resect better those we select"
after Harold Conn*
The majority of patients who present with malignant tumours of the pancreas and
liver have a poor prognosis, and it is the clinician's duty to try and achieve optimal
palliation of symptoms and quality of life. Nevertheless, significant advances in
surgical technique in recent years have meant that for some patients, resectional
surgery offers the hope of prolonged survival, and perhaps even of "cure" from an
otherwise fatal disease. Careful patient selection is, however, fundamental to the
success of any attempt at "curative" resection in patients with pancreatic or hepatic
malignancy. In this task, the surgeon is reliant upon a variety of investigations to
help him in his clinical judgement, a field of practice where substantial
improvements have also been achieved in the latter half of this century.
The clinical work which comprises this thesis was performed in the context of a
specialist hepatobiliary and pancreatic surgical practice in a university teaching
hospital. The advent of the novel technique of laparoscopic ultrasonography in 1991
stimulated renewed interest in its ability to improve the management of patients with
pancreatic and liver malignancies. The clinical studies which comprise this thesis
will, therefore, be placed in context by a historical review which seeks to outline the
natural histories of these diseases, to recount the attempts made by surgeons to
ameliorate their courses, and to address the strengths and deficiencies of existing
imaging modalities in the assessment of patients presenting with pancreatic and
hepatic malignancy.
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1.1 Pancreatic and periampullary cancer
Approximately 95% of pancreatic malignancies arise from the ductal system of the
9
exocrine pancreas and are classified histologically as adenocarcinomas . Ductal
adenocarcinoma of the exocrine pancreas is one of the most common causes of
cancer death in the Western world and its incidence appears to be increasing. There
were an estimated 27 000 new cases and 24 500 attributed deaths in the United
States in 1988 making it the fifth leading cause of death in this category. In recent
years, more than 6 500 new cases have been registered annually in the United
Kingdom where pancreatic cancer is also ranked as the fifth most common cause of
death from malignancy in men, and sixth in women4.
Effective screening techniques for the detection of presymptomatic disease remain
c 7elusive , and local extrapancreatic tumour invasion and distant metastases are
frequently established by the time of presentation resulting in an appalling overall
prognosis. Fewer than 20% of affected patients survive the first year, and only 3%
o
of patients survive five years after diagnosis' . Over 75% of pancreatic cancers are
situated in the head of the gland, with the remainder distributed in the pancreatic
2 9
body and tail ' . Most patients are diagnosed as having pancreatic cancer on the
basis of their symptoms, the typical presentation being characterised by abdominal
pain and / or obstructive jaundice. Weight loss and a profound systemic response
marked by cancer cachexia and a rapid decline in wellbeing is commonly observed.
Carcinomas of the proximal pancreas may be considered as part of a larger group of
"periampullary" malignancies, which include adenocarcinomas derived from the
epithelium of the distal common bile duct, duodenum and papilla of Vater (i.e.
malignant neoplasms arising at or within 1 centimetre of the papilla). Periampullary
carcinomas show a spectrum ofmalignant behaviour, and often present at a
relatively early stage due to biliary obstruction. They are consequently more often
amenable to attempts at curative extirpation than ductal adenocarcinomas of the
pancreas, and carry a more favourable prognosis. However, difficulty in
distinguishing between true periampullary and pancreatic carcinomas in the clinical
setting is well recognised, whether preoperatively, during laparotomy or even
following pathological examination of the resected specimen9'10. This dilemma
was highlighted by Jones and colleagues who reported a histological diagnosis of
periampullary carcinoma in 27% of 118 patients who had undergone resections for
presumed pancreatic cancer11. Although contemporary staging classifications seek
11
to differentiate precisely between these pathological entities, continuing debate and
clinical uncertainty justify the consideration of pancreatic and periampullary
carcinomas together for the purposes of the work performed in this thesis.
1.1.1 Surgery for pancreatic and periampullary cancer
History of surgery for pancreatic malignancy
The first successful local resection of a periampullary carcinoma in continuity with a
19
sleeve of duodenum has been attributed to Halsted in 1898 . In the same year,
Alessandro Codivilla in Imola, Italy, performed the first pancreaticoduodenectomy
to remove a tumour situated in the pancreatic head, the patient surviving 24 days
1 ^
postoperatively . However, it was Walter Kausch in Berlin in 1909 who performed
the first truly successful pancreaticoduodenectomy by an en-bloc resection of the
pancreatic head, distal bile duct and duodenum in two stages in a patient with a
periampullary cancer who subsequently survived nine months14. Hirschel first
reported the performance of a one-stage pancreaticoduodenectomy in 191415.
Thereafter, resection of the pancreatic head was refined by a number of surgeons, but
it was Allen O. Whipple and his associates in New York who popularised the
"Whipple operation". Having first performed a "radical" two-stage resection of the
pancreatic head and duodenum in a woman with an ampullary carcinoma in March
1934, Whipple and colleagues reported their experience in three patients16.
Brunschwig extended the indications for radical pancreaticoduodenectomy to
17
carcinoma of the pancreatic head two years later , and Whipple succesfully
performed the operation in one-stage in 193918, at about the same time as Trimble of
Johns Hopkins Hospital, Baltimore19.
Modifications and refinements of the one-stage operation followed, to include biliary
reconstruction by choledochojejunostomy19'20, pancreatic stump drainage by
20 21
pancreaticojejunostomy and distal gastrectomy to avoid a blind duodenal stump .
The evolution of the one-stage operation in this way established the operation which
is now recognisable as the modern Whipple operation. Numerous technical
variations have since described which are beyond the scope of this review. Thus, the
concept and feasibility of radical pancreaticoduodenectomy for the attempted cure of
pancreatic or periampullary carcinoma was established over fifty years ago, and this
has remained the most common indication for pancreatic resection (others include
22chronic pancreatitis, benign pancreatic neoplasms andtrauma) .
12
However, failure to effect long term survival in all but a minority of patients
undergoing pancreaticoduodenectomy for pancreatic cancer, together with a wider
recognition of the potential for high postoperative morbidity and mortality, led to
increasing skepticism regarding the justification for the Whipple operation for
pancreatic cancer. Following the development of alternative methods for the
palliation of malignant obstructive jaundice, such as surgical biliary bypass and
biliary endoprosthesis insertion, Whipple's original assertation that "the considerable
90
risk of 30% to 35% is justified if they can be made comfortable for a year or two'
was increasingly challenged. In 1975, Shapiro reported little benefit for patients
undergoing the Whipple operation following retrospective comparison with an
apparently comparable group of patients treated by palliative surgical bypass24, Crile
having published similar findings five years earlier25. Furthermore, a literature
review at that time revealed a post operative mortality rate of 21% and a mean
survival of 14 months following theWhipple operation24. Gudjonsson's 1987
review of the world literature comprised approximately 37 300 patients with a
9^r
diagnosis of pancreatic cancer, of whom 4100 (11%) had undergone resection .
The average operative mortality in the 145 series reported therein between 1949 and
1986 was 18%. Only 157 five year survivors were identified (of whom 12 had not
undergone resection), for an overall five year survival rate 0.4%. He concluded that
50 years of intensive effort at resections for "cure" of pancreatic cancer had yielded
dismal results with minimal impact on survival, and urged abandonement of of the
9 z:
notion of "resection for cure" or "curable lesion" . A philosophy of "therapeutic
97nihilism" thus became prevalent among many surgeons .
Nevertheless, new data also emerged showing that a more favourable outcome was
possible. In 1968, Howard had reported a series of forty one Whipple operations
90
performed without operative mortality . Then during the 1980's, substantial
reductions in post operative morbidity and mortality were increasingly reported from
specialist centres, with mortality rates falling below 5% for the Whipple operation11'
29-41 peters an(j carey compared the multi institutional results of 2 133 Whipple
operations (for all indications) performed during the 1970's, with those performed in
99
1 474 patients during the 1980's . They reported a reduction in post operative
mortality from 18% in the former group to 7% in the latter.
Furthermore, improved survival data following pancreaticoduodenectomy also
emerged. A multicentre Japanese study reported pancreatic resection in 753 out of
3 315 patients with pancreatic cancer (23%)42. Of the 106 patients with tumours
measuring less than 2 cm in diameter (14%), 99% underwent resection for an
13
operative mortality of 4% and a five year cumulative survival rate of 37%. Trede
and colleagues in Mannheim, Germany, reported an actuarial five year survival of
36% among 76 patients who underwent radical curative resection of pancreatic
cancer between 1985 and 1989, and an actual survival of 25% for patients with
pancreatic cancer who had completed five year follow up . Other reports between
1987 and 1993 documented actuarial five year survival rates of 13 - 24% following
resection of pancreatic adenocarcinoma7'39'40'43. However, Trede and
associates documented that five year survival does not necessarily equate with
"cure", as patients alive five years after surgery had later died from recurrent
Of) OC
tumour ' . Nevertheless, the nihilism prevailing at the start of the decade among
some commentators gave way to one of "cautious optimism" by the late 1980's6.
An alternative strategy to the Whipple operation proposed by some surgeons is total
pancreatectomy. Theoretical advantages ascribed to total pancreatic resection
included elimination of the potentially dangerous pancreatico-enteric anastamosis,
eradication of any residual multicentric or pancreatic resection-margin malignancy
and the opportunity for a more radical resection of the distal pancreas, spleen and
regional lymph nodes44,45. However, no evidence for increased safety or post
operative survival has emerged to support total pancreatectomy or radical "regional
pancreatectomy" compared with the Whipple operation29' 30'45"49. For these
reasons, most surgeons now avoid routine total pancreatectomy in patients with
carcinoma of the pancreatic head, although not all50.
12A hundred years after Halsted's seminal report , transduodenal local resection, or
ampullectomy, remains an alternative operation to pancreaticoduodenectomy for the
resection of small periampullary carcinomas. Proponents of transduodenal
ampullectomy cite its relative simplicity compared with the Whipple operation, its
lesser impact on long-term digestive function and a lower post operative morbidity
C1 CQ
and mortality . As described above, however, the morbidity and mortality
associated with pancreaticoduodenectomy is extremely low in the hands of
experienced surgeons in specialist centres, while transduodenal ampullectomy has
not been reported to be a universally safe operation10. Other surgeons prefer the
more radical pancreaticoduodenectomy for malignant periampullary lesions54' 55,
although there is little evidence for improved survival. In the absence of a
randomised controlled study, the issue of which of these operations should be
perfomed for periampullary malignancy remains controversial. Nevertheless, there
is good evidence that transduodenal ampullectomy, when performed by experienced
14
surgeons in selected patients with Ti- T2 periampullary adenocarcinomas, provides
favourable results10'56' 57.
Carcinomas of the pancreatic body or tail usually present at an advanced stage and
are widely considered to be rarely resectable for cure50. However, there have been
CO
anecdotal reports of long term survival following aggressive surgery , and recent
series reported from The Mayo Clinic, Mannheim and Johns Hopkins cite
resectability rates of 8-12%, median survivals of 7-13% and actuarial 5 year
survivals of 0-11%50"61. Improved survival therefore may be possible in selected
patients with carcinoma of the distal pancreas.
Indications for pancreatic resection and patient selection
The resectability of pancreatic cancer is a relative concept and no universal
consensus exists as to what constitutes a "resectable" lesion. Resectability rates for
pancreatic cancer vary widely, and are dependent both on the degree of patient
selection prior to referral to a specialist practice, and the philosophy of the surgeon.
Resectability rates varied between 5 - 25% in selected series during the 1949 - 1980
period47, while Gudjonsson estimated a mean overall resectability rate of
approximately 10% in his comprehensive review of surgical practice for pancreatic
9 f\
cancer between 1949 and 1986 . Increasing resectability rates in more recent years
have been attributed to earlier diagnosis and selected patterns of referral. In their
review of this subject, Watanapa and Williamson documented a statistically
significant rise in resectability from 10% (436 out of 4 157 patients) during the 1971
- 1980 period, to 15% (859 out of 5 650 patients) during the 1981 - 1990 period62.
The impact of specialist referral practice on resectability rates for pancreatic
carcinoma was illustrated by Trede at Klinikum Mannheim, who reported a four-fold
increase in resectability rates from 5.1% to 21.3% between 1973-1975 and 1979-
1982, while the resectability rate for patients with periampullary carcinoma remained
at a constant 73%30.
Stratification of the results ofmany studies has identified several factors which
appear to herald a poorer prognosis, although the evidence from different centres has
not always concurred. Neverthless, it is the pathological tumour stage which
ultimately determines resectability, and is influenced by factors which include
tumour size, local extrapancreatic invasion and lymph node metastases. Distant
metastases preclude any prospect of prolonged survival and represent a universally
recognised absolute contraindication to pancreatic resection.
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The concept of improved resectability for patients with "small" cancers was
highlighted by the results of a multi-centre Japanese study reporting 753 pancreatic
resections in 3 315 patients with pancreatic cancer (23% resectability rate)42.
Resectability in a sub group of 106 patients (14%) with "small" tumours measuring
2 cm in diameter or less was 99%, and their cumulative five year survival was 37%.
Nevertheless, only 44% of these patients had tumour confined to the pancreas,
indicating that small cancer is not necessarily "early" cancer. Geer and Brennan
reported significantly improved survival for patients with tumours < 2.5 cm in
diameter, and tumour size was confirmed by multivariate analysis as a significant
an
predictor of poor survival . Other workers have also confirmed the importance of
tumour size in this context33'43'63' Warshaw and Swanson referred to an
arbitrary cut-off size of 3 cm to distinguish between curable and non-curable
tumours65, while others have emphasised a tumour diameter of 4 cm as indicating
unresectability66'67.
Extension of pancreatic cancer outwith the pancreatic pseudocapsule, which may in
turn reflect tumour size, invariably results in invasion of adjacent structures
including the hollow viscera, the tissues of the hepatoduodenal ligament, the
retroperitoneal tissues and mesenteric root, and the major peripancreatic blood
vessels. In particular, the close relationship between the superior mesenteric vessels
and the pancreatic head is responsible for early vascular invasion in some patients
with pancreatic head malignancy, resulting in anatomical and technical limitations to
resection, positive resection margins and locoregional tumour recurrence after
pancreaticoduodenectomy7'30'40'68. In this way, unsuspected tumour invasion of
the superior mesenteric and portal vein is recognised as one of the most commonly
encountered criteria for tumour unresectability, and was recognised as early as
195169 The negative prognostic value of peripancreatic vascular invasion has since
an nr\ 71been documented by several groups '
However, not all surgeons have regarded vascular invasion as an absolute
contraindication to attempted curative resection of pancreatic or periampullary
79
cancer. Fortner advocated the concept of the "regional pancreatectomy" , an
aggressive operation combining pancreatectomy with en-bloc resection of the
peripancreatic soft tissues, regional lymphadenectomy and resection / reconstruction
of the major peripancreatic arteries and veins. Prohibitive post operative mortality
72
rates, especially following arterial reconstruction , reinforced vascular invasion as a
factor contraindicating pancreatic resection, and led to recommendations for the
abandonement of this technique11'48 Nevertheless, some surgeons remain prepared
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to perform tangential or segmental resection of the portal vein when localised
tumour invasion is discovered during pancreaticoduodenectomy, and have
demonstrated the feasibility of this manoeuvre with low morbidity30'35'73~76.
Whether limited portal vein invasion can be shown to be a function of tumour site
rather than aggressive tumour biology, and therefore benefiting from segmental
resection in selected patients, remains a controversial issue.
Regional lymph node metastases have been discovered in the resection specimens of
44-88% of patients undergoing curative pancreaticoduodenectomy, and numerous
studies have confirmed this as a poor prognostic factor7' 33'39'40'42'43'47'65-67-75>
77"79, although not universally29'47. This issue was also addressed by Fortner in his
72
advocacy of the regional pancreatectomy , and some surgeons have demonstrated
improved survival following pancreatic resection with extended lymphadenectomy
TO 70
'
. However, other studies have demonstrated no survival benefit for radical
on on
resections compared with standard pancreaticoduodenectomy ' . As with
vascular resection, it remains to be seen whether the results reported by (mainly
Japanese) surgeons who perform aggressive retroperitoneal dissections can be
extrapolated more widely within the surgical community without incurring the
substantial morbidity and mortality which diminishes the worth of the Whipple
operation as a curative or palliative procedure.
1.1.2 Rationale for preoperative assessment of resectability in
patients with pancreatic and periampullary cancer
The aim of preoperative investigation in patients with suspected pancreatic and
periampullary carcinoma is to identify patients with potentially resectable tumours
who would benefit from curative resection. Conversely, the detection of those with
factors indicative of a poor prognosis allows an alternative treatment strategy to be
employed. The rationale for such preoperative patient selection is dependent on
several assumptions:
That injudicious tumour resection should be avoided.
As already discussed, identifiable criteria which predict for early tumour recurrence
and reduced post-operative survival in patients with pancreatic and periampullary
cancer include distant metastases, regional lymph node metastases and
extrapancreatic invasion of the retropancreatic soft tissues, major peripancreatic
vessels and viscera. Despite the readiness of some surgeons to perform aggressive
radical resections, and notwithstanding the philosophy of some which supports
17
palliative resections in the knowledge of early tumour recurrence, the majority of the
surgical community prefer to avoid resectional surgery in the face of advanced
pancreatic malignancy. Thus, resectability rates for pancreatic carcinoma have
remained in the range of 10 - 20% despite increasing specialisation and
fO
regionalisation of services .
That diagnostic laparotomy is an unacceptable primary method for evaluating
patients with pancreatic and periampullary cancer.
Unnecessary laparotomy may be the source of significant physical and psychological
morbidity, and is not a cost effective method of evaluating patients with suspected
pancreatic or periampullary malignancy. The review of recent practice by Watanapa
and Williamson indicates that laparotomy alone was performed in no fewer than
28% of patients during 1979 - 1980, for an operative mortality of 36% and a mean
survival of 2.6 months . This clearly represented poor palliative treatment in this
group of patients. The corresponding statistics had improved during the following
decade (1981 - 1990) such that 22% of patients were recorded as having undergone
laparotomy alone, for an operative mortality of 18% and a mean survival of 3.1
fO
months . Similarly, de Rooij and colleagues reported the experience of the
Ol
Memorial Sloane-Kettering Cancer Center, New York during 1983 - 1989 .
Exploratory laparotomy as a single procedure was performed in 117 out of 297
patients with unresectable pancreatic cancer (39%), although a previous surgical
bypass had already been fashioned in nearly a third of such patients prior to referral.
oi
The median survival in this group was 193 days . In Gudjonsson's review, the
"laparotomy with or without biopsy" rate was 33% .
Much of this apparent deficiency in the management of patients presenting with
pancreatic and periampullary cancer can be attributed to limitations in the reliability
of the available preoperative investigative methods. In particular, failure to detect
small volume, disseminated intraabdominal carcinomatosis until the time of
OO 07
laparotomy has characterised the management of this disease .
That there are viable alternatives to surgical palliation.
Laparotomy has always been justified in a proportion of patients with unresectable
pancreatic and periampullary carcinoma because of the opportunity to perform
palliative biliary and / or gastric bypass surgery. Established or impending
malignant biliary obstruction could be relieved by biliary-enteric diversion, and
gastroenterostomy could be performed either as a therapeutic procedure or
prophylactically in an attempt to relieve malignant gastric outlet obstruction.
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Watanapa and Williamson estimated that 49% of 5 650 reported patients treated for
pancreatic ductal carcinoma during 1981 - 1990 underwent surgical bypass
operations, a significant increase from the 45% managed in this way during the
fif)
preceding decade . However, the mean operative mortality in this series was 17%
(range 4 - 33%), although improved results have again been reported recently from
specialist centres. In the Johns Hopkins Hospital, Baltimore, Lillemoe and
colleagues reported an operative mortality rate of 2.5% in 118 patients undergoing
surgical palliation of unresectable pancreatic and periampullary cancer, 75% of
OO
whom had undergone biliary bypass combined with gastroenterostomy .
However, alternative non-operative methods of palliating malignant biliary
obstruction had been developed. Soehendra and Reynders-Frederix first describe the
OQ
feasibility of biliary stent insertion during ERCP , and this was soon adopted as a
rapid and effective method for the relief of obstructive jaundice . Percutaneous
transhepatic biliary stent insertion had also been established in this role by the late
1970's91'92. Problems encountered with biliary stents included their tendency to
gobecome occluded causing recurrent jaundice and / or cholangitis , and requiring
readmission to hospital for stent replacement. Also, technical problems prevent stent
insertion in a proportion of patients, especially by the endoscopic technique when
duodenal diverticulae, angulation of the duct and / or proximal duct strictures are
encountered. A randomised trial comparing endoscopic and percutaneous methods
of stent insertion in patients with malignant obstructive jaundice considered unfit for
surgery demonstrated the endoscopic method to have a significantly superior success
in the relief of jaundice, and significantly better 30-day mortality94. A combined
percutaneous and endoscopic approach has been shown to be succesfull in
circumstances where endoscopic stenting is difficult95'96.
The role of such non-operative techniques compared with surgical methods of
palliation of obstructive jaundice has been addressed in several studies. Watanapa
and Williamson compared the collective results of patients with pancreatic cancer
who had undergone surgical bypass (1 807 patients), endoscopic stent insertion (689
fO
patients) and percutaneous stent insertion (490 patients) . They discovered similar
mean success rates (90 - 93%) and 30-day mortality rates (9 - 14%). However, the
mean hospital stay and early complication rate was greater following surgical bypass
f\D
(17 days and 31%) compared with endoscopic stenting (7 days and 21%) . Of
course, biases due to patient selection are unavoidable in this type of meta-analysis.
19
Bornmann and co-workers reported a randomised comparison of percutaneous
transhepatic stenting with bypass surgery in 53 patients with incurable pancreatic
cancer97. Similar morbidity and mortality was observed, with a significantly shorter
post procedural hospital stay in the stent group. An increased incidence of recurrent
Q7
jaundice requiring readmission in patients with stents offset this early advantage .
The first two prospective randomised studies comparing endoscopic biliary stenting
with surgical biliary bypass also demonstrated no significant differences regarding
QO QQ
relief of jaundice or long-term survival ' . However, these studies have been
criticised for their small numbers, limited follow-up, usage of small bore stents and /
or bias towards the stenting arm. Also, the operative mortality of 15 - 24%
associated with surgical bypass in these studies is at variance with the results
OO
currently achieved in specialist centres . Nevertheless, a recent survey of palliative
operations performed for pancreatic cancer in 1 180 patients in U.S. Department of
Veterans Affairs hospitals between 1987 and 1991 reported a 13% post operative
100
mortality following biliary bypass .
Smith and colleagues at the Middlesex Hospital, London, have since completed a
prospective study randomising 201 patients with low malignant biliary obstruction to
surgical biliary bypass or endoscopic stent insertion101. They reported that in
stented patients, there was a significantly lower prodeure-related mortality (3%
versus 14%), major complication rate (11% versus 29%) and median total hospital
stay (20 versus 26 days). However, recurrent jaundice and gastric outlet obstruction
were also problematical requiring readmissions in the stented group, and there was
no significant difference in overall survival between stented and operated patients
(median 21 weeks versus 26 weeks respectively)101. Once more, the results must be
considered in the context of a relatively high operative mortality (14%). Indeed,
many of the operations were performed at the referring hospital, and not necessarily
by a consultant surgeon. It is also pertinent to note that cholecystjejunostomy or
choledochoduodenostomy was the method of surgical biliary bypass most frequently
employed in these studies, although many surgeons would regard choledocho- /
102
hepatico-jejunostomy as a better operation .
A retrospective Dutch study of 148 patients with advanced pancreatic cancer treated
between 1980 and 1990 broadly confirmed the findings of these comparative
1 AO
trials . It also sought to clarify the respective roles of endoscopic stent insertion
and surgical biliary bypass by stratifying patients into those with long survival (> 6
months) and short survival (< 6 months). They demonstrated that in short-term
survivors, the higher late morbidity associated with delayed stent occlusions was
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offset by the higher early morbidity and prolonged hospital stay associated with
surgical palliation. Conversely, in long-term survivors, there was no difference in
initial hospital stay between the two groups, but the late morbidity was significantly
higher in the endoprosthesis group of patients. They therefore concluded that biliary
stent insertion is the optimal method for palliating patients expected to survive less
than 6 months, while surgical biliary bypass should be reserved for patients with
longer life expectancy. However, prospective implementation of such a policy
requires prognostic criteria. The same authors identified male gender, advanced age,
liver metastases and large tumour size as unfavourable prognostic factors .
Proponents of a surgical approach to management also cite the role of (i) therapeutic
1 AO
or prophylactic gastroenterostomy for malignant gastric outlet obstruction , and
(ii) the desire for a histological diagnosis which may be obtained reliably by
operative tumour biopsy and will exclude non-ductal pancreatic tumour which have
a better prognosis(e.g. neuroendocrine tumour, cystadenoma, cystadenocarcinoma,
sarcoma or lymphoma)104.
The addition of prophylactic gastroenterostomy to surgical biliary bypass does not
appear to increase operative mortality, and a late reoperation rate for gastric outlet
fo 1 on
obstruction of 12-17% has been reported following biliary bypass ' .
Conversely, the reported experience of the Memorial Sloane-Kettering Cancer
Center, New York, indicated that a prophylactic bypass added to a therapeutic
o 1
bypass increased morbidity without prolonging survival . Furthermore, Dutch
workers have investigated specifically the role of prophylactic gastroenterostomy at
the time of surgical biliary bypass105. Citing higher complication rates following
gastroenterostomy, and having demonstrated no significant difference in the interval
to the occurrence of a symptomatic obstruction following gastroenterostomy in
asymptomatic patients, they presented a strong case against routine prophylactic
gastroenterostomy. It should also be appreciated that the impact of late gastric outlet
obstruction on morbidity and survival was accounted for in the aforementioned
randomised studies comparing stent insertion with surgical bypass97,101'103.
Secondly, advances in a wide range of both non-invasive and invasive imaging
techniques have significantly improved the yield in obtaining a histological or
cytological diagnosis of pancreatic malignancy. Accepting that false negative results
are inevitable in a proportion of patients, most now recognise that diagnostic
laparotomy is rarely necessary106.
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The available evidence therefore suggests that endoscopic stent insertion is feasible
in the majority of patients with unresectable pancreatic cancer, and that in the short-
term, it is as least as effective and probably safer than surgical biliary bypass in
relieving jaundice. On these grounds at least, laparotomy can no longer be
considered mandatory in the management of patients with pancreatic cancer,
especially in the elderly or unfit patient without symptoms of gastric outlet
obstruction.
There may also be health economic reasons for judicious patient selection for
surgical intervention. More efficient utilisation of available hospital resources is
facilitated by reliable planning of major resectional surgery, and avoidance of
unnecessary operations.
1.2 Methods of preoperative assessment of patients with
pancreatic and periampullary cancer
The pancreas is a small and complex organ situated within the retroperitoneal tissues
of the abdomen and concealed by overlying vicera. Intimately related to major
splanchnic blood vessels, the head of the pancreas marks the point of intersection of
all areas of the body and has accordingly been described as the "topographical centre
ofman"9. Thus, the pancreas has always been recognised as a difficult organ to
image, and has been called the "hidden organ" 107. During the last two decades, the
development of a variety of sophisticated radiological techniques has allowed direct
visualisation of primary abnormalities of the pancreatic parenchyma, ductal system
and vasculature, as well as changes in surrounding tissues.
The type of information required of the imaging examination in patients with
suspected pancreatic malignancy may be divided broadly into two types; (i)
diagnostic information, where an abnormal pancreatic lesion is suspected and
confirmation of the diagnosis is required, and (ii) staging information, where the
anatomical extent of established tumour is determined. This reflects the priorities
encountered in the management of patients who present with malignant obstructive
jaundice or suspected pancreatic cancer. Pancreatic cancer implies a grave
prognosis, and it is important to first establish the diagnosis so that the patient may
be properly informed and advised. Secondly, if one accepts the rationale for
accurate tumour staging (see Section 1.1.2), it is desirable both to identify patients
with localised tumours who may benefit from resectional surgery, and to
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demonstrate those with more advanced disease in whom efforts should be directed at
palliative measures.
Appraisal of the results of published studies of imaging investigations is often
confounded by variations in study design, methods of data analysis and the
definition and validation of endpoints. Furthermore, differences in equipment and
technique, and variations in the level of local expertise may introduce biases. Most
published studies of radiological imaging in patients with pancreatic and
periampullary cancer are "pilot studies", or "studies of diagnostic accuracy" as
discussed in Section 2.1.2. In the latter study design, results are expressed as
"summary measures of diagnostic accuracy", and the use of standard definitions for
such parameters is important to avoid confusion of terminology. For the purposes of
this thesis, the following standard definitions were adopted in the diagnosis / staging
of pancreatic or periampullary cancer:
Sensitivity: "the proportion of patients with tumour / unresectable tumour who are
reported to be positive".
Specificity: "the proportion of patients with no tumour / resectable tumour who are
reported negative".
Positive predictive value: "the proportion of patients reported positive who have
tumour / unresectable tumour ".
Negative predictive value: "the proportion of patients reported negative with no
tumour / resectable tumour".
To facilitate comparisons of the results of published studies, the nomenclature used
in this review, and in Tables 1.1 - 1.8, has been adjusted to conform to the above
format.
1.2.1 Conventional radiography and contrast studies
Until the development of ultrasound scanning in the 1960's, radiological assessment
of pancreatic disease was restricted to various techniques of enhancement of plain
1ORabdominal radiographs . Such methods were limited in their ability to confirm a
diagnosis of pancreatic cancer, and relied upon the presence of a soft tissue mass in
the upper abdomen, or upon indirect signs such as a distended 'Courvoisier' gall
bladder, splenomegaly secondary to splenic vein thrombosis, malignant ascites or the
discovery of sclerotic bone metastases. The majority of investigations in this
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category are of historical interest, and now contribute little to the preoperative
assessment of patients with pancreatic disease.
Upper gastrointestinal contrast studies
Upper gastrointestinal contrast studies were used to demonstrate secondary
pathological effects of primary pancreatic malignancies in the surrounding
structures. In this way, a barium meal could be used to diagnose pancreatic cancer
by demonstration of deformity within the retrogastric space, malignant infiltration of
1 HQ
the posterior wall of the stomach (the "pad sign") , and disfigurement of the
medial outline of the duodenum with shrinkage and traction giving the "inverted 3
sign"110. Insufflation of the stomach with air was described as a further manoeuvre
i no
which could provide information missed by a barium meal . However, the
fallibility of such methods was illustrated by Hodes and colleagues who failed to
identify pancreaticoduodenal tumours in a half of patients studied in this way111.
Pneumoperitoneum and pneumostratigraphy
Insufflation of the peritoneal cavity with gas was performed in an attempt to outline
the body and tail of the pancreas by demonstrating radiographically the tissue - gas
interface of the retroperitoneal structures. In 'pneumostratigraphy', the simultaneous
insufflation of the stomach and retroperitoneum was combined with lateral and axial
108
tomograms . Thus, the pancreas was defined anteriorly by stomach gas, and
posteriorly by retroperitoneal gas. Local irregularities due to a pancreatic tumour
could be defined, and it was claimed that the technique was sufficiently sensitive to
108
detect retropancreatic lymphadenopathy . The presence of adhesions was an
obvious limiting factor in the performance of this technique.
Hypotonic duodenography
Air insufflation following the ingestion of oral barium was used to produce a double-
contrast duodenogram, while hypotonia of the duodenal loop was achieved through
the administration of a spasmolytic agent. This revealed fine detail of the duodenal
mucosa in the vicinity of the papilla and pancreatic head sufficient to demonstrate
1 AO
even small tumours .
During the last twenty years, these techniques have largely been superseded by upper
gastrointestinal endoscopy as the investigation of choice for suspected direct
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involvement of the upper gastrointestinal tract by tumours of the pancreas and
periampullary region.
1.2.2 Cholangiography and pancreatography
Percutaneous transhepatic cholangiography (PTC)
Percutaneous transhepatic cholangiography became a routine method for routine
119 11^
biliary opacification after Okuda developed the "Chiba" needle in 1974 ' . Its
accuracy in establishing the diagnosis of malignant biliary obstruction was
demonstrated by Freeny and Ball who described its use in 112 patients114.
Successful opacification of the biliary tree was achieved in 100 patients (89%), and
pancreatic cancer was diagnosed with a sensitivity of 100% and specificity of 96%.
However, its diagnostic role in patients with suspected pancreatic malignancy was
rapidly superseded by ERCP, and indications for its use became restricted to
instances where diagnostic or therapeutic ERCP was not possible.
Endoscopic retrograde cholangiopancreatography (ERCP)
Endoscopic retrograde cholangiopancreatography (ERCP) was first described by
McCune and colleagues in 1968115, enabling direct, non-surgical imaging of the
biliary and pancreatic ducts for the first time. Combined with the opportunity for
endoscopic observation and biopsy of locally invasive tumour, and later therapeutic
OQintervention to achievebiliary decompression , ERCP rapidly became established as
a primary modality in the management of patients with malignant biliary obstruction
in the 1980's. In Freeny and Ball's study114, ERCP was performed in 376 patients
with suspected pancreatic disease between 1975 and 1979, yielding a sensitivity of
94% and a specificity of 97% in the diagnosis of pancreatic cancer. Obstruction
("blunt, tapering, irregular or meniscus" stenoses) of the main pancreatic duct and /
or comon bile duct were the most commonly observed criteria for the diagnosis of
pancreatic cancer, and the "double duct" sign was present in 27% of patients with
114
pancreatic cancer .
Nevertheless, such abnormalities of the bile and pancreatic ducts were not exclusive
to pancreatic cancer, and the limitations of ERCP (in common with all available
investigations) in differentiating malignancy from chronic pancreatitis were
recognised116'117. Furthermore, the continued development of abdominal CT
scanning led some authors to challenge the role of ERCP within increasingly
complex diagnostic algorithms for suspected pancreatic cancer, in which ERCP
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contributed little in addition to less invasive investigations such as CT, particularly
1 lO
with regard to tumour staging . Silverstein and colleagues employed the
technique of decision analysis to model and analyse diagnostic strategies in the
diagnosis of suspected pancreatic cancer in terms of diagnostic accuracy, cost and
invasiveness11^. Assuming a sensitivity of 90% and a specificity of 95% from
previously published studies, it was estimated that ERCP would be indicated in just
8-11% of patients if transabdominal USS was used as the first investigative method,
but that abandonement of ERCP altogether would substantially increase the
subsequent requirement for diagnostic laparotomy. In a cost-benefit analysis of the
diagnostic algorithm for pancreatic cancer employed at University College Los
Angles, Alvarez and colleagues have reported that the results of ERCP rarely altered
the management of patients in whom a pancreatic mass had been demonstrated on
CT120. Like Freeny and Ball a decade before114, they recommended its restriction
to use when CT was "normal or atypical". However, these findings should be
considered in the context of a practice where the therapeutic role of ERCP made
little contribution, endoscopic palliation of malignant obstructive jaundice usually
being deferred in favour of surgical palliation.
1.2.3 Transabdominal ultrasonography (USS)
Real-time B-mode transabdominal USS was developed in the 1960's, and was the
first cross-sectional imaging technique that permitted direct imaging of the
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pancreas ' . The principles of B-mode USS imaging are discussed in Section
1.2.8. Its safety, repeatability and relative inexpense made USS a popular primary
method in the investigation of patients with suspected pancreatic cancer. In
particular, USS was shown to be a reliable method for demonstrating biliary
1 90
dilatation and establishing the diagnosis of obstructive jaundice . However,
disadvantages of USS include its operator dependency and its vulnerability to image
degradation caused by factors such as body wall tissues and bowel gas. This was
reflected in the widely varying results obtained using USS in the investigation of
obstructive jaundice. Whereas some workers reported being able to use USS to both
define the level of biliary obstruction and diagnose the underlying lesion in 94-95%
and 68-81% of cases respectively124'125, others were unable to reproduce these
good results126'127.
In the hands of enthusiasts, technical refinements and improvements in USS
scanning techniques yielded consistently better results in the investigation of patients
with obstructive jaundice during the 1980's. Laing and co-workers were able to
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define the level of biliary obstruction in 92% of patients, and establish the
10Q
underlying diagnosis in 72% . For Gibson and colleagues in the Hammersmith
Hospital, London, the corresponding figures were 95% and 80% respectively, which
12Q
in their experience compared favourably with CT . Lindsell reported a sensitivity
of 84% and specificity of 95% for USS in defining abnormalities of the pancreas and
bilary tract, and recommended USS as a prelude to ERCP in the management of
120
patients with suspected malignant biliary obstruction .
The reported performance of diagnostic USS in identifying focal pancreatic tumours
also varied widely. Gudjonsson reviewed the results of 23 studies reported between
1977 and 1986, in which USS was used in the diagnosis of pancreatic cancer .
There were marked variations in the design of these studies, in patient selection, in
the exclusion of technically inadequate examinations and in the requirement for
histological proof of the diagnosis, and comparison of results was therefore difficult.
The reported sensitivities for USS in diagnosing pancreatic cancer ranged from 23%
to 95%26.
The results of other studies evaluating the diagnostic sensitivity of USS in this role
and published since 1982 are summarised in Table 1.1. Again, a variety of
methodologies and a wide range of results are apparent. Single-centre, single-
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modality studies of USS performed by enthusiasts yielded sensitivities of 98%
i ^2and 83% . In particular, the retrospective study reported by Maringhini and
colleagues comprised a population of 1 020 patients with suspected pancreatic
i ^2
disease, of whom 80 (8%) were shown to have pancreatic cancer . Despite the
unusually low prevalence of pancreatic cancer for a study such as this, the utility of
USS in their hands was illustrated by a negative predictive value of 95% and
sensitivity of 83%. Conversely, poorer results were reported from prospective
studies where comparison with other newer modalities was performed (sensitivities
51% - 65%)126'133~138. Nevertheless, USS was shown to be more sensitive than CT
in the diagnosis of pancreatic cancer in two small comparative studies139'140.
Few studies have evaluated the role of transabdominal USS in the staging of
pancreatic cancer (Table 1.2). The only study which has supported a primary role
for transabdominal USS in the assessment of resectability of pancreatic cancer was
121
reported by Campbell and Wilson . They evaluated retrospectively 54 patients
presenting with pancreatic neoplasms in Toronto General Hospital during 11 months
in 1986. Malignant lymhadenopathy was correctly identified in 16 patients (30%),
but missed in five. Liver metastases were detected in 16 patients (30%), and
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overlooked in three. Vascular invasion was identified in 12 patients (22%), seven of
which were validated as such at operation, with four false negative examinations
identified. In terms of overall staging, no false positive examinations were reported
(i.e. 100% specificity), and 31 out of 38 patients (82%) were identified as having
unresectable tumours. However, not all these findings had been validated surgically.
A retrospective Dutch study compared the results of USS and CT in the staging of
1
pancreatic cancer in 24 patients over ten years . Despite repeating USS in some
patients, neither technique was able to satisfactorily predict tumour resectability.
Four prospective, comparative studies have also reported USS to have been
insensitive in detecting criteria which contraindicated curative resection (sensitivities
8-16%), and poorly predictive of tumour resectability (predictive values of negative
results 29-68%)136"138'140. One study reported USS to have consistently overstaged
the disease with respect to vascular invasion, citing the predictive value of a positive
1v 1^1 11^7
result as 11% . However, this has not been the experience of others ' ' '
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1.2.4 Computerised tomography (CT)
Computerised tomographic scanning was introduced into clinical practice in 1975,
and initial reports documented its ability to generate cross-sectional images of the
abdominal organs including the pancreas, and diagnose pancreatic cancer through
the demonstration of focal pancreatic masses or contour abnormalities141"145.
Refinements in CT technology subsequently improved the quality of pancreatic
imaging. The speed of data collation was increased such that the original "18-27
second scanners" were replaced in the early 1980's by those requiring only 5-10
second scanning times146'14^. Image resolution was improved by the use of thinner
(5-10 mm) 'slices', and dynamic intravenous bolus contrast -enhanced CT protocols
140
were developed . These techniques maximised the density differences of normal
and pathological tissues, achieving bright enhancement of the abdominal viscera
with brilliant opacification of abdominal vessels. Thus, radiologists were able not
only to diagnose pancreatic neoplasms, but also to evaluate their relation with
surrounding tissues. In their description of the technique in 100 patients with proven
pancreatic cancer, Ward and colleagues identified a pancreatic mass in 95%, a lucent
area within the mass in 75%, coeliac or SMA involvement in 60%, pancreatic duct
dilatation in 50%, biliary dilatation in 38% and hepatic metastases149.
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Table 1.1 - Summary of published studies (1982-1993) evaluating USS in the
diagnosis of primary peripancreatic malignancy
Author and year Study design Results
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n = 42 (187)
Sensitivity = 72%
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figure in parentheses indicates total number of all USS examinations performed,
including those with a diagnosis other than pancreatic cancer.
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Table 1.2 - Summary of published studies (1988-1993) evaluating USS in the
staging of peripancreatic malignancy
Author and Study design Type of Results
year of publication information
Campbell et al131 Retrospective Overall Sensitivity = 82%
1988 USS only resectability Specificity = 100%
n = 51
1de Roos et al Retrospective Overall Sensitivity = 18%
1990 vs. CT resectability Specificity = 100%
n = 24 PPV = 100%
NPV = 18%
Bakkevold et al137 Prospective Overall Sensitivity = 16%
1992 Multicentre resectability Specificity = 98%
vs. CT/SVA PPV = 95%
n= 160 NPV = 29%
Rosch et al 136 Prospective PV invasion Sensitivity = 9%
1992 vs. CT/EUS/SVA Specificity = 72%
n = 40 PPV = 11%
NPV = 68%
Node metastases Sensitivity = 12%
Specificity = 80%
Palazzo et al138 Prospective PV invasion Sensitivity =17%
1993 vs. CT/EUS Specificity = 100%
n = 38 PPV = 100%
NPV = 41%




Yasuda et al140 Prospective Vascular invasion Accuracy = 55%
1993 vs. CT/EUS
n = 29
Megibow illustrated the evolution of the technique of CT scanning for pancreatic
cancer in a study which compared CT findings in 104 patients studied during 1979 -
148
1982, with 107 examinations during 1984 - 1987 . Pancreatic masses were
identified more frequently in the second group both for lesions situated in the head
of the gland (94% vs. 76%), and for lesions situated in the body and tail (96% vs.
89%). Thus, the development during the 1980's of rapid CT scanning techniques
with 'dynamic incremental' table movements and high volume, high concentration
bolus pump infusion of intravenous contrast enabled the detection of subtle,
intraparenchymal lesions, pancreatic and bile duct dilatation as well as hepatic and
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nodal metastases. Oral contrast was also administered prior to scanning to opacify
adjacent bowel loops. However, limitations associated with CT scanning were
observed in patients with a history of allergy to contrast material, in uncooperative
patients where respiratory movements or body motion prevents adequate scanning
and in those with marked weight loss where the absence of retroperitoneal fat
hindered the definition of tissue planes107'147'150
Gudjonsson reviewed the results of 21 studies evaluating CT in the diagnosis of
r\s
pancreatic cancer which had been reported between 1977 and 1986 . As before
(see Section 1.2.3), methodological flaws and variations in CT technique and in the
study designs confound valid comparison. This collective experience showed the
proportion of positive CT examinations to vary from 63 to 100% . It was
noteworthy that, despite improvements in CT technique over a decade, the studies
performed later in the period did not necessarily show better results. Furthermore,
Gudjonsson concluded that despite USS and CT having heralded a new era in
diagnostic imaging, no changes in the duration of symptoms up to the time of
diagnosis or in survival were apparent .
The results of 13 other studies evaluating the "accuracy" of CT in the diagnosis of
pancreatic cancer and published since 1982 are summarised in Table 1.3. Diagnostic
sensitivities in the range 69-99% are not at variance with the earlier experience
reported by Gudjonsson . Reasons for the relatively poor performance of CT in a
recent study includes the use of unenhanced CT techniques, perhaps reflecting a lack
1of specialist interest in pancreatic imaging . Neverthless, the 70% sensitivity
reported by a prospective multi-centre Norwegian study may well be representative
1 '5-7
of wider practice outwith specialist centres . However, this does not apply to
several prospective comparative studies reporting diagnostic sensitivities of 69-85%,
which may reflect their higher proportion of patients with small pancreatic cancers
and periampullary tumours134'136'138' 14°. That CT imaging alone is ultimately
unable to differentiate reliably between pancreatic cancer and other focal lesions
such as chronic pancreatitis is illustrated by the occurrence false positive
examinations, giving specificities of 53-69%, and positive predictive values of 83-
92%150"152.
Although CT has become the principal imaging modality used in the assessment of
resectability in patients with pancreatic cancer during the last decade, the reported
experience with staging CT has not been uniformly reliable. The results of
abdominal CT in the staging of pancreatic and periampullary cancer in studies
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Table 1.3 - Summary of published studies (1982-1993) evaluating CT in the
diagnosis of pancreatic cancer
Author and year Study design * Results
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figures in parentheses indicates total number of CT examinations performed
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reported since 1984 are summarised in Table 1.4. Jafri and colleagues provided the
first evidence to support CT as a reliable non-operative method of assessing the
1 CQ
resectability of pancreatic cancer in a retrospective comparison with SVA . Both
techniques performed comparably, correctly identifying 20 out of 22 patients
withunresectable tumours with no reported false positive results. However, no
independent validation of such findings was available in eight of these patients, the
authors instead citing "unequivocal findings on preoperative radiography".
However, it is Freeny and co-workers in Seattle who were mainly responsible for the
popularisation of dynamic CT in the staging of pancreatic cancer with their papers of
1988150 and 1993154. In their initial study, 161 patients with pancreatic cancer were
studied prospectively over 6 years, with histological confirmation of the diagnosis in
72%150. Local tumour extension was reported in 68% of patients, contiguous organ
invasion in 42%, liver metastases in 36%, lymph node metastases in 28%, and / or
vascular invasion of the major peripancreatic arteries or veins in 84%. Validation of
these findings was performed at laparotomy in 51 patients (32%), nine of whom
were thought to have had potentially resectable tumours, and 25 of whom had also
been evaluated with SVA. There were no proven instances where CT or SVA
examinations had overstaged the tumour, although palliative pancreatic resections
were performed in four cases. Seven out of nine patients were amenable to
"curative" pancreatic resection (albeit with nodal micrometastases in five patients).
The findings of SVA and CT were approximately comparable, and the
abandonement of SVA in favour of CT was recommended by the authors.
The same group subsequently reported their updated experience over ten years154.
They performed CT in 213 patients with pancreatic cancer, and SVA in 60 patients,
correlating the findings with those obtained at surgery in 71 patients (33%). The
incidence of CT criteria indicating tumour unresectability were essentially the same
as the previous study. As before, there were no false positive results pertaining to
tumour resectability, and SVA again failed to contribute additional staging
information over CT. Of the 18 patients considered to have potentially resectable
tumours on CT in whom laparotomy was performed, six were found to be
unresectable (i.e. negative predictive value 33%). Also, only three out of 11 resected
tumours were histologically free of local or regional tumour spread.
While these studies seemingly provide reassurement that CT does not overstage
pancreatic cancer, thereby denying patients with potentially resectable tumour a
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Table 1.4 - Summary of published studies (1984-1993) evaluating CT in the
staging of peripancreatic cancer
Author and year Study Design Type of Results
Information
Jafri et al 153 Retrospective Overall staging Sensitivity = 91%
1984 vs. SVA Specificity = 100%
n = 27 PPV = 100%
NPV = 71%
Freeny et al 150 Retrospective Overall staging Sensitivity = 95%
1988 vs. SVA Specificity = 100%
n = 51 PPV = 100%
NPV = 78%
Ross et al 155 Retrospective Overall staging Sensitivity = 72%
1988 CT only Specificity = 75%
n = 66 PPV = 93%
NPV = 38%




de Roos et al135 Retrospective Overall staging Sensitivity = 50%
1990 vs. USS Specificity = 50%
n = 26 PPV = 85%
NPV = 15%
Warshaw et al 86 Prospective Overall staging Sensitivity = 56%
1990 vs. MRI / Lap / Specificity = 88%
SVA PPV = 92%
n = 55 NPV = 45%
Bakkevold et al137 Prospective Overall staging Sensitivity = 27%
1992 Multicentre Specificity = 98%
vs. USS / SVA PPV = 97%
n = 209 NPV = 35%
Gulliver et al156 Retrospective Overall staging Sensitivity = 91%
1992 CT only Specificity = 76%
n = 67 PPV = 89%
NPV = 80%
Rosch et al 136 Prospective PV Invasion Sensitivity = 36%
1992 vs. USS / EUS / Specificity = 85%
SVA PPV = 50%
n=60 NPV = 78%
Node metastases Sensitivity = 36%
Specificity = 80%
Freeny et al154 Prospective Overall staging Sensitivity = 90%
1993 vs. SVA Specificity = 100%
n = 71 PPV = 100%
NPV = 33%
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Table 1.4 (continued) - Summary of published studies (1984-1993) evaluating
CT in the staging of peripancreatic cancer




Bryde Andersen et al Retrospective Overall staging Sensitivity = 68%
1993 CT only Specificity = 67%
n = 52 PPV = 70%
NPV = 64%
Vascular invasion Sensitivity = 90%
n = 38 Specificity = 39%
PPV = 62%
NPV = 78%
Palazzo et al 138 Prospective PV invasion Sensitivity = 71%
1993 vs. USS/EUS Specificity = 86%
n = 38 PPV = 89%
NPV = 63%




curative resection, it should be noted that surgical validation of positive findings was
obtained in no more than one third of all patients. Also, the prevalence of resectable
pancreatic cancer in this study (6%) was so low, that the apparent CT detection of
tumour unresectability was skewed to provide a stated sensitivity of 97%15 .
Thesefindings may not be representative of specialist surgical practices where higher
rates of tumour resectability are encountered, and unsurprisingly, several other
studies have failed to reproduce similar data (Table 1.4).
Other published studies evaluating CT as a staging method in patients with
pancreatic and periampullary cancer all reported false positive findings and
identified a variable tendency to overstage tumour. In the context of overall tumour
staging, this was reflected by specificities of 50-98%, while the predictive value of a
CT result indicating tumour unresectability varied from 70-97%86' 135' 137' ^2' ^5'
156. More specifically, the specificity of CT in demonstrating vascular invasion has
been reported as 39-86%, and the positive predictive value 50-89%136'138'152.
Some authors therefore maintain that CT alone is not an adequate basis on which to
oz: i co
determine the operability of patients with pancreatic or periampullary cancer00' '
155
Despite a comonly held belief that CT is highly sensitive in identifying liver
metastases107'148, several workers have recorded the failure of CT to detect small
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metastatic lesions of the liver and peritoneal surfaces ' ' Moreover, in
their study of 88 consecutive patients with pancreatic or periampullary cancer,
Warshaw and co-workers reported CT to have missed such "occult" metastases in 25
out of 27 patients, and have recommended routine preoperative laparoscopy to
Ozr
address this deficiency . This issue is considered more fully in Section 1.2.7.
However, not all surgeons accept these findings as representative of their
practice159. In a study of 90 patients evaluated by CT and SVA at the Johns
Hopkins Hospital, Baltimore, there were only six instances where unsuspected
peritoneal metastases were reportedly discovered at laparotomy160.
In an attempt to improve the sensitivity of CT in the detection of peritoneal
metastases in the context of gynaecological malignancy, Halvorsen and colleagues
performed intraperitoneal contrast enhanced CT161. They reported an increased
sensitivity of 100% (16 / 16) compared with 64% (11/ 16) for unenhanced CT.
However, a comparative study of intraperitoneal contrast enhanced CT versus
standard CT in patients with a variety of abdominal malignancies by Nelson and co-
1
workers failed to show any advantage . Such techniques have never been
employed routinely in the evaluation of patients with pancreatic cancer, in whom
intra-peritoneal tumour dissemination is typically of minimal volume.
A significant recent advance in CT technology was the development of spiral (or
helical) CT163,164. This technique enables faster acquisition of truly volumetric CT
data, and was made possible because of technical refinements such as the slip-ring
gantry, improved detector efficiency and greater tube cooling efficiency164. A pilot
study of spiral CT of the pancreas has reported far superior vascular opacification
with reduced respiratory artifact compared with conventional CT, while the
capability for rapid imaging permits the acquisition of thin (< 5 mm) sections with
correspondingly increased resolution . Also, retrospective reconstruction of
overlapping slices has enabled three-dimensional images of the portal venous sytem
to be created165. The implications of these technological advances for the staging of
patients with pancreatic cancer remain to be defined, and studies investigating the
efficacy of spiral CT in the assessment of tumour resectability are awaited.
1.2.5 Magnetic Resonance Imaging (MRI)
The role ofMRI in the diagnosis and staging of patients with pancreatic and
periampullary carcinoma is unclear. Several comparative studies have reported no
discernible advantage for MRI over CT in identifying tumour unresectability due to
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extrapancreatic tumour spread ' ' . The results of an American multi-centre
148
study comparing CT and MRI in the staging of pancreatic cancer are awaited .
1.2.6 Selective visceral angiography (SVA)
The rationale for performing SVA in patients with suspected pancreatic malignancy
is threefold; (i) to establish the diagnosis of pancreatic cancer, (ii) to assess tumour
resectability and (iii) to define the arterial anatomy of peripancreatic region.
The feasibility of angiographic examination of the abdominal vasculature was first
1 ^8
reported by Farinas in 1941 . Seldinger subsequently refined the technique of
transfemoral visceral angiography with the introduction of flexible arterial catheters
which could be used to cannulate selectively the coeliac and superior mesenteric
arteries . However, the first reported angiographic diagnosis of pancreatic cancer
through identification of an abnormal tumour circulation was achieved by
translumbar aortography170. The ability of the interventional radiologist to
demonstrate abnormalities of the pancreas markedly improved with continued
171
refinements in the technique of SVA , and the procedure was established as an
important diagnostic tool during the 1960's and 1970's.
Tylen and Arnesjo documented the correct diagnosis of pancreatic cancer in 79 out
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of 116 patients (68%) , and Freeny and colleagues also reported SVA to have been
11%
"valuable for diagnosis" in 68% of cases . The diagnostic sensitivity of SVA was
reported to be 72% in a prospective study by Mackie and colleagues174, and more
175
recently 54% in the experience of Appleton and co-workers . The results of a
multi-centre survey of Norwegian hospital practice, where SVA was associated with
a 33% diagnostic sensitivity for pancreatic cancer, may be more representative of
1XI
non-specialist practice . Clearly, subsequent experience has not supported
Bookstein's original observation that a normal angiogram "nearly excluded"
17 f\
pancreatic cancer . No angiographic criteria have been identified which are
specific enough to differentiate between pancreatic cancer and chronic
pancreatitis116'177.
The advent in the 1970's of less invasive imaging techniques such as USS, CT and
ERCP gradually replaced SVA as a diagnostic modality in patients with suspected
pancreatic pathology, with recommendations that it should be reserved for
investigation of rare vascular neoplasms, for instances where the results of other
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investigations were equivocal and for the preoperative assessment of tumour
177
resectability .
The use of SVA in the preoperative staging and assessment of resectability of
pancreatic and periampullary cancer is controversial. Although it was originally
178
shown to be possible to demonstrate hepatic metastases using SVA , other studies
have discounted its utility in this role, reporting sensitivities of 33 - 46%, and
frequent false positive findings116'179' 18°. Rather, SVA has been used primarily to
assess local tumour invasion, Bookstein and colleagues having recognised in 1969
that vascular invasion could be diagnosed by the signs of major artery occlusion and
17f\
irregular encasement . Other workers also confirmed that angiographic evidence
172 181
of arterial invovement determined operability and survival ' .
It has since become clear that portal-superior mesenteric venous invasion is
inevitably present in patients with involvement of the coeliac and / or mesenteric
O/:
arteries due to cancer of the pancreatic head . Indeed, Buranasiri and Baum had
emphasised the importance of the portal venous phase of SVA in identifying portal
182vein invasion in their report of 1972 , and portal venous occlusion, stenosis,
encasement or displacement during the portal venous phase of SVA became
established as criteria indicating tumour unresectability. Other workers attempted to
improve portal vein contrast enhancement by direct cannulation of the superior
171 18^mesenteric vein in percutaneous transhepatic portography • , or by direct
184
puncture of the spleen in splenoportography . Reichardt and Ihse also
demonstrated that portal venography could identify local tumour invasion where
18^
none had been evident on arteriography . However, the invasiveness of these
techniques, together with continued refinements in portal phase venography during
SVA and the overall diminishing role of SVA with the advent of less invasive
modalities in the 1980's led to their abandonement as routine procedures.
The results of studies evaluating the ability of SVA to predict tumour resectability,
and validating the findings by surgical exploration, vary and are summarised in
Table 1.5. It is clear that SVA commonly understages pancreatic cancer, inasmuch
as its sensitivity in demonstrating tumour unresectability ranged from 41-91%, and
the predictive value of negative findings ranged from 44-83%86'136'137'153'160'175
1 OA
. Therefore, the absence of angiographic abnormalities neither excludes the
diagnosis of pancreatic cancer, nor the presence of malignant vascular invasion.
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Table 1.5 - Summary of published studies (1984-1993) of SVA in the evaluation
of pancreatic cancer
Author and year Study design Type of information Diagnostic accuracy
Jafri et al 153 Retrospective Overall staging Sensitivity = 91%
1984 vs. CT Specificity = 100%
n = 27 PPV = 100%
NPV = 71%
Appleton et al 175 Retrospective Overall staging Sensitivity = 58%
1989 SVA alone Specificity = 88%
n = 43 PPV = 88%
NPV = 58%
Warshaw et al 86 Prospective Overall staging Sensitivity = 66%
1990 vs. CT / MRI / Specificity = 94%
Lap PPV = 95%
nIIG NPV = 54%
Dooley et al 160 SVA alone Overall staging PPV = 79%
1990 n = 90 NPV = 77%
Bakkevold et al137 Prospective Overall staging Sensitivity = 44%
1992 Multicentre Specificity = 88%
vs. USS / CT PPV = 88%
n = 72 NPV = 44%
Rosch et al136 Prospective PV invasion Sensitivity = 45%
1992 vs. CT/EUS/ Specificity = 100%
SVA PPV = 100%
n = 40 NPV = 83%
Murughia et al 180 Prospective Overall staging Sensitivity = 41%
1993 SVA alone Specificity = 90%
n = 46 PPV = 85%
NPV = 52%
Of more concern is the incidence of false positive angiographic findings, where signs
of tumour unresectability on preoperative SVA were refuted during surgery. This
reality is reflected by reported specificities of 88-94%, while the predictive values of
positive results have been cited in the range 79-95%86'137'160'175' 180 However,
1^ 1
not all studies report tumour overstaging with SVA ' . Explanations for false
positive findings include "notching" in the vicinity of the portal - superior
mesenteric venous junction which has been labelled a "normal variant"160, spasm of
the SMA mimicking tumour encasement160, and coiling of the hepatic artery causing
indentation of the portal vein .
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Table 1.6 - Summary of published studies (1979-1993) of SVA in the evaluation
of the peripancreatic arterial anatomy in patients with pancreatic cancer
Author / year CHA or RHA from Total arterial

























Detractors from SVA cite its unreliability in tumour staging and the availability of
nc -i HA 177 180 1 8S
effective alternative modalities ' ' ' ' , comparative studies with dynamic
CT having shown the latter to be at least as reliable as SVA in predicting tumour
unresectability150'153. In other centres, CT and SVA are considered complimentary
modalities86' 16°. Nevertheless, proponents of routine preoperative SVA maintain
its empirical contribution to tumour staging, and cite its utility in providing
1 zrrv 110/; 188
beneficial information regarding the peripancreatic arterial anatomy • ' .
The rationale for obtaining a preoperative "anatomical roadmap" has been justified
by the reported high incidence of anomalies of the peripancreatic arterial anatomy.
In particular, the presence of an accessory or replaced common or right hepatic
artery arising from the aorta or SMA has been reported with an incidence of 14-27%
in angiographic series (Table 1.6)153'160'174'175'180,186'188. Such an aberrant
hepatic artery may run behind, through or in front of the pancreatic head, and is
frequently discovered passing posterolateral to the structures within the
hepatoduodenal ligament. It is at particular risk of injury during transection of the
189
retropancreatic fascia in the final stages of resection of the pancreatic head .
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Injury to such an artery may result in ischaemia of the biliary anastamosis causing
dehiscence or stenosis, and / or hepatic ischaemia189'19°. Alternatively, routine
SVA has been recommended to detect unsuspected coeliac axis compression or
stenosis, as division of the gastroduodenal artery during pancreatic resection in such
1 07
cases may provoke hepatic ischaemia .
Nevertheless, it may be possible to identify anomalous hepatic arterial anatomy
using other modalities such as dynamic CT154, or laparoscopic ultrasonography158,
while SVA can itself fail to identify important vascular anomalies159. Moreover, the
detection and safeguarding of arterial anomalies during surgery for pancreatic cancer
can be accomplished by experienced pancreatic surgeons without resort to SVA .
1.2.7 Laparoscopy
History
Kelling is widely regarded as being the first person to introduce the concept of
laparoscopy in 1901, having inspected the abdominal cavities of dogs using air
insufflation and a cystoscope191. Nevertheless, Ott, a Russian gynaecologist, is also
reported to have performed laparoscopy in 1901 in a patient with oesophageal
192
cancer . In his description of 'laparoskopie' in 1911, Jacobeus was one of the first
to find a clinical use for laparoscopy in human patients in diagnosing ascites, liver
19^
cirrhosis, metastatic liver tumours and tuberculous peritonitis . Meanwhile, at the
Johns Hopkins University Medical School, Baltimore, Bernheim reported the first
"organoscopy" in the United States, in a patient of Halsted's with pancreatic
cancer194. Prophetically, he speculated that the technique"...may reveal general
metastases or a secondary nodule in the liver, thus rendering further procedures
unnecessary and saving the patient a rather prolonged convalescence"194 The
concept of diagnostic laparoscopy having been established, its continued evolution
was facilitated by technical advances. Kalk was responsible for improved
instrumentation and the use of a second access port195. In 1933, Fervers, who used
laparoscopy to treat adhesions, described the use of carbon dioxide or oxygen
instead of room air for creation of a pneumoperitoneum196. Veress invented the
197
spring loaded insufflation needle in 1938 , which until recently remained the
instrument of choice for achieving a pneumoperitoneum. Using forward-viewing
optics, the utility of the laparoscope in the evaluation of liver disease, ascites, and
gastric, colorectal and gynaecologic malignancy was further established in the Johns
Hopkins Medical School198'199. Further development of the Hopkins rod-lens
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optical system and the fibreoptic bundle finally allowed enhanced light
200 201transmission ' , leading to the development of contemporary videolaparoscopy
systems providing high resolution laparoscopic images for multiple observers.
Despite these advances, diagnostic laparoscopy failed to find widespread popularity
amongst general surgeons, and it was gynaecological specialists who were
responsible for most of the major developments in laparoscopy before the late
202 2fH1980's ' . Nevertheless, a role for diagnostic laparoscopy in the setting of
emergency general surgery was recognised by Paterson-Brown and his colleagues at
St Mary's Hospital, London, who demonstrated its efficacy in clinical decision
making in the management of patients presenting with an "acute abdomen"204.
Since the late 1980's, laparoscopic techniques have attracted massive attention
within the general surgical community with the development of therapeutic
laparoscopic and "minimal access" procedures. An account of the developments of
laparoscopy in this context is outwith the scope of this thesis.
The techniques by which a pneumoperitoneum, and laparoscopic trocar and port
insertion, may be achieved are worthy of further consideration. Until the 1980's,
most laparoscopics worldwide were performed by gynecologists, using the spring-
1Q7loaded Veress needle to enter and insufflate the peritoneal cavity so permitting
'blind' insertion of a trocar / port assembly into the cushion of abdominal gas. The
safety of laparoscopy performed by this technique was documented by the
confidential enquiry of the Royal College of Obstetricians and Gynecologists into
20^
gynecological laparoscopy in 1978 which consisted 50 247 procedures . There
were 1818 complications (3.6%), including four deaths (gas embolism (n=l), bowel
perforation (n=l), cardiac arrest (n=2)) for a mortality rate of 8 per 100 000.
However, whereas the 'minor' complications of laparoscopy were usually related to
the insertion of the Veress needle, more serious complications such as intestinal
insufflation, gas embolism or blood vessel injury have been documented with this
20f\
technique . In an attempt to diminish the incidence of such occurrences, the
alternative technique of 'open laparoscopy' by direct cutdown to the peritoneal
cavity, as initially advocated by Kelling191, has been recommended by
207 208
gynecologists and surgeons alike . Furthermore, Byron and colleagues
performed a randomised trial comparing Veress needle and direct trocar insertion in
20Q
the context of gynecological laparoscopy . They reported a significant reduction
in the incidence of 'minor complications' (preperitoneal insufflation, failed entry or
more than three attempts to access the peritoneal cavity), and a significant saving in
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operating time for the direct insertion technique. For details of these techniques see
Section 2.3.1.
Laparoscopy in the assessment of pancreatic cancer
Modern laparoscopic optics and light sources provide a highly resolved and
magnified view of the peritoneal cavity. Laparoscopic examination is a sensitive
technique in the detection of intraperitoneal tumours, small quantities of malignant
ascites and tiny metastatic lesions involving the serosal surfaces of the peritoneal
cavity, omentum and liver. Between 1973 and 1989, this was illustrated by a series
of diverse reports which documented the utility of laparoscopy in the assessment of
patients with a variety of intra and extrabdominal primary tumours without resort to
laparotomy. Thus, the utility of diagnostic and staging laparoscopy was
910 911
demonstrated in patients with bronchogenic carcinoma , ovarian tumours ,
919 91S 91 ^ 917
gastroesophageal carcinoma , gall bladder carcinoma , breast carcinoma ,
91R 91Q 990
malignant melanoma and lymphoma ' in whom the laparoscopic findings
directly influenced patient management.
However, attempts to evaluate the pancreas using laparoscopy were hindered by its
retroperitoneal location. The diagnosis of pancreatic malignancy was usually
inferred from the observation or 'palpation' of a retrogastric mass, and secondary
signs such as the features of obstructive jaundice, ascites or metastases, and portal
hypertension or splenomegaly in the presence of portal vein invasion. Nevertheless,
some workers described the feasibility of direct laparoscopic inspection of the
pancreas by 'supragastric pancreoscopy', where the pancreas was visualised through
991the gastrohepatic omentum , 'supragastric bursoscopy' where the lesser sac was
999 994entered having incised the lesser omentum , and 'infragastric bursoscopy'
where the lesser sac was entered having incised the gastrocolic omentum or
OO 22S
mesocolon ' . These techniques could also be used to facilitate laparoscopic
229
biopsy of pancreatic masses under direct vision .
However, the success of supragastric pancreoscopy was dependant upon the quantity
of fat in the lesser omentum, Meyer-Berg and colleagues reporting a success rate of
99^
only 60% using this approach . Furthermore, obliteration of the lesser sac with
adhesions, inadequate access to the the pancreatic head, and little available
information regarding local tumour invasion of retroperitoneal structures were
probable reasons for the failure of this approach to attain widespread acceptance as a
viable method of evaluating pancreatic disease at a time when newer radiological
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imaging techniques were gaining in popularity. Similarly, attempts to improve the
diagnostic yield of laparoscopy in patients with suspected obstructive jaundice by
laparoscopic cholecystcholangiography, where contrast radiography was performed
following transhepatic needle puncture of the gall bladder, were rapidly superceded
by more refined techniques such as PTC and ERCP227'228.
Conversely, laparoscopy was reported to be highly efficacious in the detection of
metastatic disease in patients with pancreatic malignancy, as originally described in
Bernheim's seminal report of 1911194. Ishida and colleagues in Tokyo performed
laparoscopy in 71 patients with pancreatic cancer between 1976 and 1981, detecting
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intraabdominal metastatic disease in 43% of examinations . They identified liver
metastases in 11% and 50% of patients with tumours of the pancreatic head and
body respectively, and peritoneal dissemination in 24% and 64%. Meanwhile,
Cuschieri's group in Dundee had performed laparoscopy immediately prior to a
07 QC
proposed laparotomy in 73 patients with pancreatic cancer ' . Large omental
deposits (n=8), peritoneal seedlings (n=39) and / or hepatic metastases (n=55) were
identified laparoscopically. Furthermore, direct tumour invasion of adjacent organs
(colon, mesocolon, duodenum and / or stomach) was detected in 12 patients, and an
overall histological / cytological diagnosis of pancreatic malignancy was achieved in
61/65 patients (92%). However, it is not possible to assess the impact of
laparoscopy in relation to alternative imaging techniques in the Tokyo study, while
in Cuschieri's series, preoperative imaging tests had already indicated liver
metastases in 49 out of 55 patients, and the laparoscopic findings did not affect the
decision to operate in 51 out of 73 patients (70%). Nevertheless, preoperative
investigations had failed to detect peritoneal carcinomatosis in any of the
laparoscopically detected cases, although CT scanning had only been available in
six83'85.
Warshaw's team in Boston performed staging laparoscopy to assess tumour
resectability in 86 patients between 1982 and 198984'86'230. Laparoscopy detected
intraabdominal metastases in a total of 35 patients (41%). The sensitivity of
laparoscopy in detecting such lesions was 96% (22 / 23), whereas intravenous
contrast enhanced CT failed to detect these in all but two cases. Stepwise
discriminant analysis confirmed the unique role played by staging laparoscopy in
this context86.
Preliminary work in the University Department of Surgery, The Royal Infirmary,
1 CO
Edinburgh has reproduced these findings , demonstrating unsuspected hepatic
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metastases, peritoneal seedlings and / or malignant ascites in four out of twelve
patients following laparoscopy.
1.2.8 Laparoscopic Ultrasonography (LapUS)
The principles of high-resolution contact ultrasonography
In general terms, B-mode real-time ultrasound imaging involves the generation of
"live" cross-sectional grey-scale images of the tissues underlying the ultrasound
transducer. The transducer, which is mounted on a probe, is connected by cable to a
dedicated digital electronic system or scanner. The critical element of the transducer
is the piezoelectric crystal, which has unique physical and electrical properties. The
elements used most commonly in contemporary ultrasound transducers are
composed of lead circonite titanite crystals. Application of an electrical current to
the crystal causes it to vibrate and generate sound waves. Conversely, if mechanical
force (such as a sound wave) is applied to the crystal, an electrical potential is
generated. Thus, the crystals within a transducer serve as emitters and receivers of
ultrasound. The emitted ultrasonic pulses are partially reflected to varying degrees
from the structures being scanned. The returning echoes cause the transducer to
generate electrical signals which are transmitted to the scanner, amplified and
displayed on a high definition monitor as a pattern of pixels. The resultant two-
dimensional (B-mode) grey-scale image varies in brightness in proportion to the
intensity of the reflected ultrasound, which is determined by the properties of the
tissues being scanned.
The quality, detail and sharpness of the ultrasound image are dependent on both the
axial and lateral resolutions of the transducer, which represent the ability of the
scanner to discriminate two reflective points in line with, and perpendicular to, the
ultrasound beam respectively. Greater axial resolution is achieved by the use of
higher wavelength frequencies, while increased lateral resolution is dependent on a
narrower ultrasound beam width and focus.
Laparoscopic intraoperative ultrasonography utilises the principles of intraoperative
contact ultrasonography (IOUS) during laparoscopy. The fundamental advantage of
IOUS compared with conventional transabdominal USS derives from the placement
of the ultrasound transducer in direct apposition with the intraabdominal tissues.
This manoeuvre permits the use of relatively high frequency transducers (7.5 - 10
MHz) which achieve correspondingly high image resolution, while avoiding the
45
image degradation experienced when scanning from outside the body wall during
transabdominal USS. This "acoustic attenuation" is widely attributed to interposed
body wall tissues, overlying viscera and bowel gas. The increased tissue penetration
of these structures required of the ultrasound beam during transabdominal USS
dictates the use of a lower resolution transducer, with correspondingly poorer
resolution.
Other factors which are important in determining image quality include the purity of
sound produced by a crystal, and the sophistication of the electronic signal
processing systems software used in the scanner. A variety of artifacts and image
degradations which are instrument related and which may cause interpretative errors
have been defined . However, these factors may be recognised and discounted
with experience, and have been minimised with modern ultrasound systems.
Of greater significance is the global degradation in image quality arising from
corruption of the beam forming process, with aberrations of the acoustic wavefronts
due to non-uniform acoustic velocities which reduce spatial and contrast
2^9resolution . These instrument-independent artifacts and image degradations are
attributed to an ultrasound-tissue interaction, and it has been suggested that this is
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due to a simple anatomical "monolayer" such as subcutaneous fat . In their recent
study attempting to elucidate and quantify the factors which affect image quality
during transabdominal USS, Shmulewitz and colleagues scanned 140 predominantly
231
elderly patients . Satisfactory USS imaging of the intraabdominal organs was
attempted, including the liver, hepatoduodenal ligament and pancreas. While
visualisation of the major organs was possible in 98% of cases, an improvement in
image quality was said to be desirable in 78%. Obesity and immobility were found
to be associated with poor image quality, and poor "acoustic windows", where the
acoustic path to the organ of interest was obscured by ribs or gas containing
intestine.
In a separate experiment in an animal model, transabdominal USS was performed
sequentially following the dissection and removal of the anatomical layers of the
231abdominal wall . Image quality was reported to gradually improve from the
epidermis inwards, until optimal image quality was achieved with the transducer
placed against the liver surface. Thus, aberrations could not be attributed to any
single anatomical layer, but rather the aggregated effect of the various abdominal
wall structures. These studies offer an explanantion for the improved resolution and
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image quality which have stimulated the development of intraoperative and
laparoscopic contact ultrasonography.
Assessment of pancreatic disease by intraoperative ultrasonography
Intraoperative ultrasonography has been shown to aid the operative decision making
process during operations for both benign and malignant pancreatic disease,
localising and characterising impalpable abnormalities and providing information
which would otherwise require extensive dissection. In particular, IOUS may help
establish the diagnosis of pancreatic carcinoma, and define the local resectability of
the lesion with regards to its involvement of the adjacent peripancreatic blood
vessels. In this way, IOUS was reported to have been 'very or moderately helpful'
in 11 of 22 operations undertaken by Plainfosse and colleagues . Serio and co¬
workers found IOUS helpful in 21 out of 24 operations where pancreatic resection
for carcinoma had been attempted , the information obtained indicating tumour
resectability in 12 cases, and unresectability in nine. The largest experience with
IOUS during 177 pancreatic operations reported by Machi and colleagues confirms
the utility of IOUS in this role , where beneficial additional information was
derived from IOUS in 73% of cases. Compared with preoperative radiological
investigations (presumably CT), IOUS was reported to have been significantly more
specific and accurate in the determination of tumour unresectability due to portal
vein invasion . Nevertheless, many pancreatic surgeons have preferred to
undertake a trial dissection or mobilisation of the pancreas at open operation, and the
adoption of IOUS in this role has remained confined to a relatively small number of
enthusiasts.
History of laparoscopic ultrasonography
Laparoscopic ultrasonography is now possible using commercially available
ultracompact, sterilisable probes with similar imaging specifications as
contemporary high resolution IOUS systems, and which may be introduced through
standard 10/11 mm diameter laparoscopic ports. However, the concept of LapUS
907
was first reported in the 1950's Japanese literature , and later repeated by German
900
investigators in the early 1970's . These early studies in LapUS utilised prototype
A-mode scanners, which were the forerunners of modern B-mode instruments. A-
mode scanners generate uni-dimensional spikes which reflect the amplitude strength
of the returning echo on the vertical axis, and the distance from the transducer along
the horizontal axis. Although inherently more difficult to interpret than the cross-
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sectional images of B-mode imaging, Look and co-workers demonstrated the
feasibility of these A-mode LapUS devices in diagnosing cholelithiasis and gall
bladder cancer238.
A variety of prototype LapUS instruments were tested by Japanese workers during
the early 1980's, all of which employed B-mode transducers incorporated into the
shaft of the laparoscope itself and termed "echolaparoscopes". Their findings were
presented to the 1982 Congress of the Swedish Society for Medical Sciences. Ota
and colleagues at the University of Tokyo compared their 7.5 MHz mechanical
radial scanning echolaparoscope with a contemporary transabdominal scanner .
They reported "sharp and fine" images of the abdominal viscera, an improved lateral
resolution of 1.0-1.3 mm, the demonstration of small intrahepatic tumours below the
ribs which could not otherwise be imaged and "an approach to the pancreas could be
carried out with available informations". Furukawa and colleagues also used a 5-7.5
MHz 360° radial scanning echolaparoscope in 126 patients240. They were able to
image liver tumours, liver cysts, gallstones and tumours of the digestive tract
(including the panceas) using this device. Success with a similar instrument was
also reported by Aramaki and colleagues241.
In 1984, Okita and colleagues in Yamaguchi University School of Medicine, Ube,
Japan, reported their experience with prototype LapUS instruments which utilised a
3.5 - 5 MHz linear array transducer at the flattened end of a 13 mm diameter
94?
laparoscope which could be articulated through 180° in two planes . They
described the first case of successful LapUS imaging of a pancreatic carcinoma in a
patient in whom CT, SVA and laparoscopy alone had produced equivocal results.
With the exception of isolated workers in Europe who continued to investigate the
utility of LapUS in the assessment of the liver, LapUS failed to become established
as a method for investigation of pancreatic disease during the remainder of the
1980's. However, two developments were probably responsible for stimulating
renewed interest in the concept of LapUS in the early 1990's. In addition to its use
in pancreatic surgery, IOUS had increasingly been shown to be indispensable in liver
surgery, and had become a technique with which many hepatobiliary surgeons were
familiar. There were also several studies demonstrating that IOUS could be at least
as accurate as intraoperative cholangiography in detecting CBD calculi during
ooz 94^ 94f\
cholecystectomy ' Secondly, the dramatic changes in surgical practice
which occurred with the popularisation of laparoscopic surgery, and in particular
laparoscopic cholecystectomy, led to increasing interest in LapUS as a method of
48
examining the CBD as an alternative to intraoperative cholangiography. In 1991,
Rothlin and co-workers in Zurich reported their experience with a prototype 5.5
MHz 360° radial sector scanning LapUS probe originally designed for examination
of the lower urinary tract247. They were able to image the structures of the
hepatoduodenal ligament and the entire biliary tract during laparoscopic
cholecystectomy, also detecting CBD stones in the process.
Meanwhile, the team in the Royal Infirmary, Edinburgh, had adapted for use during
laparoscopy a sterilisable 16 mm diameter 7.5 MHz linear array ultrasound probe
designed for endorectal contact sonography (Aloka US660-7.5). A custom built
large port assembly was used to achieve access to the peritoneal cavity and this
improvised LapUS system was successfully used to evaluate patients with liver
tumours . Laparoscopic ultrasonography was also used to evaluate twelve patients
with pancreatic malignancy, all of whom were considered potential candidates for
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pancreatic resection on the basis of available ultrasound and CT scans . Now
using a commercially available 7.5 MHz linear array LapUS probe (Aloka UST
5522-7.5), images of the pancreatic cancer and its relationships with neighbouring
ducts and vessels were observed. Findings of intrahepatic metastases (n=4), regional
lymphadenopathy (n=4), retroperitoneal invasion (n=2) and / or portal vein invasion
or displacement (n=4) were documented in six patients in whom laparotomy was
avoided. Thus, LapUS alone defined criteria of unresectability in two patients, in
addition to four patients shown to have metastatic spread following laparoscopic
inspection. Five out of the six patients deemed to be resectable by LapUS
underwent pancreatic resection, one patient being shown to have malignant
158
lymphadenopathy at the time of laparotomy .
Dutch workers had contemporaneously evaluated LapUS, also improvising with a 16
mm diameter 7.5 MHz linear array transrectal probe before employing the purpose
designed Aloka UST 5522-7.5249'250. In Eindhoven, Jakimowicz successfully
employed LapUS in the assessment of a variety of intraabdominal malignancies, but
emphasised the role of the technique in the evaluation of the biliary tree during
OCA
laparoscopic cholecystectomy in a series of 145 patients . In Amsterdam, Cuesta
also reported the utility of LapUS in detecting intrahepatic metastases during staging
laparoscopy for a variety of neoplasms, although was not successful in satisfactorily
oci
imaging pancreatic tumours . In addition, several reports have documented the





Cytopathological examination of peritoneal washings obtained during laparotomy or
laparoscopy has been advocated for the identification of exfoliated pancreatic cancer
cells within the peritoneal cavity, two studies having reported that positive peritoneal
cytology may yield important diagnostic and staging information in patients with
pancreatic cancer ' . In the first study, Martin and Goellner performed
peritoneal cytology following laparotomy in 76 patients with a variety of intra¬
abdominal malignancies, twenty of whom had pancreatic cancers, 18 of which were
unresectable . Positive peritoneal cytology was observed in five patients (25%),
all of whom had advanced tumours precluding resection. Three of these patients had
overt metastatic disease involving the liver, peritoneum or omentum. However, the
other two patients were noteworthy inasmuch as negative peritoneal cytology had
been obtained at initial laparotomy when local invasion of the superior mesenteric
vein had prevented resection. Several days later, repeat peritoneal cytology at
reoperation for intraoperative radiotherapy was positive. The authors concluded that
positive peritoneal cytology was common in patients with pancreatic cancer,
reflecting the propensity of such tumours to disseminate within the abdominal cavity
at an early stage . They also hypothesised that pancreatic mobilisation and biopsy
may be implicated in the intraperitoneal dissemination of such tumours.
Although peritoneal cytology was recommended as a simple and inexpensive
technique in the evaluation of pancreatic cancer during laparotomy, its potential use
in the preoperative diagnosis and staging of patients with panceatic cancer was not
recognised until Warshaw reported its use during staging laparoscopy . Forty
patients with pancreatic cancer considered potentially resectable by CT underwent
cytological analysis of peritoneal washings obtained at staging laparoscopy (27
patients) or laparotomy (13 patients). Positive peritoneal cytology was obtained in
12 patients (30%): 33% during laparoscopy versus 23% at laparotomy. Positive
peritoneal cytology was associated with a significantly worse resectability rate (10%
versus 52%) and a significantly diminished six month survival. Furthermore, a
significant association between positive peritoneal cytology and previous
percutaneous needle biopsy was reported (75% versus 19%).
Warshaw257 thus concurred with Martin and Goellner256 that pancreatic cancer
sheds malignant cells into the peritoneal cavity early and commonly, that cytological
findings provided an additional index of resectability and established that
laparoscopic lavage was an effective means of cytological study. He also concluded
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that intraperitoneal spread of cancer cells may be promoted by tumour biopsy, and
that peritoneal cytology correlated with survival . No other work reproducing
these findings was in evidence at this time.
1.2.10 Endoscopic Ultrasonography (EUS)
Endoscopic ultrasonography (EUS) permits high resolution, real-time B-mode
scanning of the pancreas and neighbouring tissues from within the lumen of the
stomach and duodenum using an echoendoscope. The echoendoscope incorporates a
small, high-frequency ultrasound transducer at its distal end, and high resolution
images of the adjacent tissues are generated using similar principles of contact
ultrasonography as those exploited during IOUS and LapUS (as discussed in Section
1.2.8). The technique was originally developed in the early 1980's, and although
marked technical refinements have since occurred, pioneers of EUS demonstrated
the feasibility of the technique in diagnosing small pancreatic tumours, and in
OCQ O/CO
demonstrating evidence of local tumour invasion .
Studies evaluating EUS in the diagnosis of pancreatic and periampullary cancer have
reported excellent results, with EUS demonstrating superior sensitivities (85-100%)
compared with ERCP, USS, CT and / or SVA, as summarised in Table 1.7134'136'
1^8 140
'
. However, there is substantial overlap in the sonographic appearances of
malignant and benign lesions, and no reliable criteria have been defined which allow
accurate differentiation between focal pancreatic lesions due to neoplasia and those
due to chronic pancreatitis264.
In the staging of pancreatic and periampullary cancer, and in the hands of experts,
EUS has been shown reproducibly to be highly accurate in determining resectability
according to the T stage (see Table 1.8)134'136'138'140'263'265. Furthermore,
prospective comparison with USS, CT and / or SVA in this context has shown EUS
to be superior in determining malignant vascular invsion134'136'138'140.
However, EUS has been recognised as less accurate in the diagnosis of regional
malignant lymphadenopathy264'266. Having adopted an arbitrary node size of > 5
mm in diameter to represent malignant involvement, reported positive and negative
predictive values vary from 47-100% and from 55-71% respectively136'138'265.
Although significantly better than corresponding diagnostic accuracies yielded by
USS and CT (see Tables 2 and 4), the incidence of false positives due to reactive
hyperplasia, and false negatives due to nodal micrometastases has limited the clinical
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Table 1.7 - Summary of published studies (1988-1993) of EUS in the diagnosis
of peripancreatic malignancy


























n = 49 (64)
Sensitivity = 96%
Specificity = 73%






figure in parentheses indicates total number of EUS examinations
utility of EUS in lymph node staging264.
The procedure is also technically difficult, requiring ultrasound and endoscopic
expertise, and has been slow to gain widespread acceptance. Several other
limitations have emerged in the use of EUS. These include difficulties in intubating
the pylorus and duodenum with large calibre echoendoscopes, especially in patients
with locally invading tumours of the pancreatic head or periampullary region.
Imaging of the distal pancreas from within the stomach may also be impeded by
interposed bowel gas, and these factors have accounted for technical failure rates of
5-14%264. The optimal focal range of the transducer is usually 2-4 cm, which
restricts imaging of the majority of the right hemiliver, and of the peripancreatic
vasculature when tumours larger than 4 cm are encountered. For this reason, EUS is
insensitive in detecting distant metastases during tumour staging in patients with
pancreatic and periampullary cancer.
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Table 1.8 - Summary of published studies (1988-1993) of EUS in the staging of
peripancreatic malignancy
Author and year Study design Type of information Results
Yasuda et al134 Prospective PV invasion Sensitivity = 93%
1988 vs. USS/CT/SVA Specificity = 88%
n = 42 PPV = 100%
NPV = 89%
Tio et al 265 Prospective Ca head of
1990 EUS alone pancreas (n = 45)
n = 67
Overall T stage Accuracy = 92%






Overall T stage Accuracy = 87%




Rosch et al136 Prospective PV invasion Sensitivity = 91%
1992 vs. USS/CT/SVA n = 40 Specificity = 97%
n = 60 PPV = 91%
NPV = 97%
Node metastases Sensitivity = 72%
Specificity = 73%
Snady et al 263 Prospective Overall Sensitivity = 85%
1992 vs. CT/ERCP resectability Specificity = 80%
n = 42 n = 24 PPV = 89%
NPV = 73%
Palazzo et al 138 Prospective PV invasion Sensitivity = 100%
1993 vs. USS / CT Specificity = 65%
n = 49 PPV = 83%
NPV = 100%




Yasuda et al140 Prospective PV invasion Sensitivity = 88%
1993 vs. USS / CT Specificity = 78%
n = 29
Node metastases Accuracy = 66%
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Summary
A variety of radiological techniques have found popularity in the diagnosis and
staging of partients with pancreatic and periampullary cancer, particularly USS, CT
and SVA. Other modalities such as MRI, laparoscopy, LapUS and EUS have not
achieved widespread usage and continue to be evaluated. The available evidence
indicates that no single modality is alone accurate in evaluating such patients.
Although investigative algorithms have been devised to optimise their assessment,
there remain inadequacies in their preoperative evaluation, particularly in the
selection of patients with potentially resectable lesions. There is therefore a need to
improve current methods of evaluating patients with pancreatic and periampullary
cancer such that patients with resectable lesions are selected reliably, while those
with inoperable lesions may be spared unnecessary surgery.
Hypothesis
Laparoscopy, laparoscopic ultrasonography and laparoscopic peritoneal cytology
have the potential to influence clinical decision and therefore the management of
patients with pancreatic and periampullary cancer.
Aims
To assess the efficacy of laparoscopic ultrasonography in imaging the normal
hepatobiliary and pancreatic anatomy.
To assess the role of laparoscopy and laparoscopic ultrasonography in the
preoperative diagnosis and staging of patients with pancreatic and periampullary
carcinoma.
To further validate the accuracy of laparoscopy and laparoscopic ultrasonography in
the preoperative diagnosis and staging of patients with pancreatic and periampullary
malignancy by prospective comparison with alternative imaging techniques.
To assess the role of laparoscopic peritoneal cytology in the staging of patients with
pancreatic and periampullary carcinoma.
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Chapter 2 Patients and Methods
2.1 STUDY ENDPOINTS
2.1.1 Definition of resectability and staging conventions
As discussed in Section 1.1.1, definitions of tumour resectability vary widely, and
depend on the philosophy prevailing in individual institutions. Standardised
methods of documenting tumour stage are therefore essential to permit meaningful
comparison of clinical results in different groups of patients, and the staging of
cancer has thus been deemed as "hallowed by tradition" and its justification said to
be "unassailable"267. The TNM (Tumour, Node, Metastasis) staging system was
conceived by Denoix in 1943 , and adopted by the Union Internationale Contre Le
9fv7
Cancer (UICC) in 1950 . Its application in the staging of pancreatic cancer, and
its retrospective validation was performed independently in the 1970's by
9ZTQ
Rainsbury's and Pollard's groups ' . Further validation by prospective use in
the first randomised, multi-centre trials of chemotherapy for patients with pancreatic
cancer have confirmed the clinical validity of this concept63'271.
In 1987, the 1983 UICC TNM classification of pancreatic cancer and the 1981 AJCC
(American Joint Committee on Cancer) system were incorporated to form a revised
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staging classification (Table 2.1). This system facilitated a "telescopic
ramification" mechanism which permitted further classification by grouping into
stages I - IV (Table 2.1). Meanwhile, a different and more complex staging system
27^had been adopted by the Japanese Pancreatic Society . However, the 1987 UICC
staging classification has been accepted by all National TNM committees to enable





Pancreatic cancer staging from the 1992 UICC TNM classification
T category
To No evidence of primary tumour
Ti Tumour limited to the pancreas
Tia(<2cm) Tib (> 2 cm)
T2 Extends directly to duodenum, bile duct, peripancreatic tissues
T3 Extends directly to stomach, spleen, colon, adjacent large vessels
Tx Minimum requirements to assess the primary tumour cannot be met
N category
No No regional lymph node metastasis
N1 Regional lymph node metastasis
Nx Minimum requirements to assess the regional and juxta-regional
lymph nodes cannot be met
M category
Mo No distant metastases
M1 Distant metastases
Mx Minimum requirements to assess the presence of distant metastases
cannot be met .
Stage grouping
Stage I Tl-2, NO, MO
Stage II T3, NO, MO
Stage III Tl-3, Nl, MO
Stage IV Tl-3, NO-1, Ml
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As discussed in Section 1.1, strict differentiation between cancers of the pancreas
and those arising in the periampullary region can be difficult. Although the most
recent UICC staging classification strictly distinguishes between these entities267'
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, tumours which infiltrate both papilla and pancreatic head could be classified
pathologically as T4 periampullary cancers, or alternatively as T2 pancreatic
cancers. For the purposes of the studies performed in this thesis, all carcinomas of
the pancreas and periampullary region were considered together and classified
according to the UICC TNM classification of pancreatic cancer (Table 2.1). A
1 ^7similar approach has been adopted by others , and is justified for the purposes of
determining an endpoint of tumour resectability, as opposed to the outcome of
treatment.
The measured endpoints of "tumour resectability for cure" which were adopted in
272studies 2 - 4 are based upon the 1987 UICC staging classification (Table 2.1).
The convention adopted for the purposes of these studies defined tumour
resectability as:
T1 Tumour limited to pancreas / periampullary region
T2 Tumours invading the medial duodenal wall and / or distal bile duct only
No No regional lymph node metastases
Mo No distant metastases
(i.e. Stages I - II)
Criteria which were taken to represent tumour unresectability were defined as:
T2 Tumours invading retroperitoneal (retropancreatic) tissues
T3 Tumours invading stomach, spleen, colon, adjacent large vessels
N1 Regional lymph node metastases
M1 Distant metastases
(i.e. Stages II - IV)
2.1.2 Methods of analysis
The need to evaluate and compare the efficacy of the numerous new investigative
techniques which have been developed in clinical medicine over the past twenty
years has witnessed the development of a range of statistical designs and analyses.
In this thesis, several different study designs were employed, and these may be




Pilot studies typically evaluate the feasibilty of a new technique and address
qualitative issues such as the acceptibility of the method and the quality of the
images. Although such studies are descriptive and have negligible statistical
content, they are considered a necessary preliminary when a novel technology is first
evaluated. Study 1 was a pilot study, where laparoscopic ultrasonography was
evaluated with respect to its acceptability in imaging the hepatobiliary and pancreatic
anatomy, and where technical aspects of the procedure were assessed.
Diagnostic accuracy
Studies of diagnostic accuracy compare the diagnosis obtained using the study
technique with a final, or "gold standard" (or "evidence based") diagnosis. The term
"diagnostic accuracy" uses the concept of diagnosis in its broadest sense e.g. in
staging investigations where the issue is tumour resectability. This study design is
that which is most commonly reported in the literature, and Freedman has made the
analogy of diagnostic accuracy studies with phase II clinical trials (e.g. screening for
974the activity of a drug against a disease) .
The results in Studies 2-4 were analysed using measures of diagnostic accuracy,
and were expressed in the form of summary measures: sensitivity, specificity,
positive predictive value, negative predictive value and accuracy. The definitions of
these measures involve two assumptions: (i) that one particular disease is of interest,
and (ii) that the result is reported as either positive or negative for the disease in
question. The work in this thesis satisfies these assumptions inasmuch as all patients
evaluated in Studies 2-4 were selected on the basis that the diagnosis of pancreatic
or periampullary carcinoma was ultimately established. Secondly, the results of the
study investigations were expressed as "positive" or "negative" corresponding
respectively to "tumour present or absent", "tumour unresectable or resectable",
"metastases present or absent" etc. Thus, in the context of tumour staging, factors
contraindicating tumour resection were regarded as "positive", whereas findings
supporting the feasibilty of tumour resection for cure were regarded as "negative".
The method used for formulating summary measures of diagnostic accuracy
comprised the 2x2 contingency table (Table 2.2), where the reported results are
27^defined as true positive, true negative, false positive orfalse negative . In broad
terms, sensitivity is defined as "the proportion of diseased patients who are reported
to be positive", i.e. "the proportion of true positives that are correctly identified by
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the test". Specificity is defined as "the proportion of patients free of the disease who
are reported negative", i.e. "the proportion of true negatives that are correctly
identified by the test".
Predictive values reflect the probability that a test will give the correct diagnosis, and
provide direct information about how much reliance can be placed on the imaging
result. Thus, the positive predictive value (PPV) is "the proportion of patients
reported positive who have the disease" or "the proportion of patients with positive
test results (i.e. true positives plus false positives) who are correctly diagnosed (true
positive)". Conversely, the negative predictive value (NPV) is "the proportion of
patients reported negative (true negatives plus false negatives) who do not have the
disease (true negative)" or "the proportion of patients with negative test results who
are correctly diagnosed"276. In the context of Study 3, the PPV reflected the
predictive value of the statement "this patient's tumour is unresectable", while the
converse was true for the NPV.
Predictive values depend upon sensitivity and specificity, and critically, upon the
onA. ont\
prevalence of the abnormality in those patients being tested ' . The prevalence
can be interpreted as the probability, before the test is performed, that the patient has
the abnormality ("prior probability" of the disease). By incorporating it into the
formulae used to calculate positive and negative predictive values, these parameters
may be used to compare the utility of the investigation in environments with
onA n~if\
different disease prevalence (Table 2.2) ' . In this way, calculations of PPV and
NPV in Study 3 were adjusted for the prevalence of tumour unresectability derived
from previous experience in Study 2.
Statistical comparisons between summary measures of diagnostic accuracy in Study
3 were performed using the continuity-corrected chi square method, or Fisher's exact
test when expected frequencies were less than five. Statistical significance was
taken as P < 0.05.
59
Table 2.2
Format for calculating parameters of diagnostic accuracy by the 2x2
contingency table method
Result of staging investigation





TN = True Negative; TP = True Positive; FN = False Negative; TP = True Positive
TP TN
Sensitivity = Specificity =





PPV = positive predictive value; NPV = negative predictive value
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Clinical value
Clinical value studies aim to evaluate the contribution of an imaging technique to
real-life clinical management. The impact of the technique on both the diagnostic
and therapeutic process is studied by consideration of the clinician's assessment of
the patient before and after receiving the findings of the study investigation. This
study method was incorporated into Studies 2 and 3, where the efficacy of
laparoscopy and LapUS in detecting tumour dissemination was studied in patients
previously thought to be free of such disease. The resultant effect of laparoscopy
and LapUS in changing patient treatment was documented. Freedman has made the
analogy of clinical value studies with phase III clinical trials which attempt to
establish the place of a specific therapy in routine practice (e.g. randomised
274controlled trials in a clinical setting) .
Survival analysis
In Study 4, life table analysis was used to calculate actuarial survival from the time
277
of staging laparoscopy, and Kaplan-Meier plots were constructed .
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2.2 PATIENT SELECTION AND STUDY DESIGN
2.2.1 Study 1
Two groups of patients were studied.
(i) Patients undergoing elective laparoscopic cholecystectomy were studied to
quantify the frequency with which defined anatomical landmarks could be imaged
using LapUS. The LapUS examinations were performed as part of a prospective
study evaluating the role of LapUS and intraoperative cholangiography in the
detection of common bile duct stones during laparoscopic cholecystectomy. It was
anticipated that the hepatobiliary and pancreatic anatomy would be relatively
"normal" in this group of patients in whom there was no evidence ofmalignancy.
The indications for laparoscopic cholecystectomy included chronic gallstone disease,
previous episodes of acute gallstone related pancreatitis and gallbladder polyps.
Consent to perform LapUS was obtained as an integral part of the laparoscopic
cholecystectomy. It was explained that the procedure would be limited to ten
minutes, and that no additional ports would be required. The findings regarding the
diagnosis of common bile duct stones are beyond the scope of this thesis and will not
be presented.
(ii) Patients with suspected pancreatic or periampullary carcinoma undergoing
staging LapUS as a definitive procedure were also studied (see also Study 3). In this
context, the ability of LapUS to identify defined peripancreatic anatomical
landmarks was investigated, using a modification of the technique used in (i). In
addition, the ability of LapUS to identify the anomaly of an accessory or replaced
right or common hepatic artery was investigated. All patients provided written
consent prior to this procedure.
2.2.2 Study 2
All patients had presented with carcinoma of the pancreatic head or periampullary
region, having been referred by a surgeon or physician in another department, or by
their general practitioner, for further specialist treatment. All patients were
considered to be candidates for exploratory laparotomy and tumour resection with
curative intent on the basis of preceding USS and CT examinations (i.e no evidence
of local tumour invasion, regional lymphadenopathy or distant metastases). In this
scenario, all patients were studied with laparoscopy and LapUS to determine: (i)
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summary measures of diagnostic accuracy of laparoscopy alone compared with the
combined findings of laparoscopy and LapUS in predicting tumour resectability, and
(ii) the impact of laparoscopy in changing clinical decision making and avoiding
unneccessary laparotomy.
All patients provided written consent prior to the LapUS examination.
2.2.3 Study 3
Patients with carcinoma of the pancreatic head or periampullary region were
prospectively evaluated by an investigative algorithm consisting of USS, CT, LapUS
and SVA prior to laparotomy. A prospective blind comparison of the diagnostic
accuracies of these staging investigations in predicting tumour resectability was
performed.
All patients provided written consent prior to the LapUS examination.
2.2.4 Study 4
Patients with carcinoma of the pancreatic head or periampullary region studied in the
evaluation of laparoscopic peritoneal cytology (LPC) had all been recruited in Study
3, and were subject to the same methods of validation. Summary measures of
diagnostic accuracy of LPC in predicting tumour resectability, and the implications
of positive LPC on patient survival were evaluated. However, laparoscopic
peritoneal cytology was not performed in all patients in Study 3. The omissions are
attributable to breaches of protocol.
While all patients provided written consent for LapUS on these occasions, no
specific written consent for LPC was obtained as the instillation and retrieval of
peritoneal fluid was performed as an integral part of the routine LapUS examination.
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2.3 TECHNIQUE OF LAPAROSCOPY WITH
LAPAROSCOPIC ULTRASONOGRAPHY (LapUS)
2.3.1 Laparoscopy - General considerations
Laparoscopy was performed under general anaesthesia with endotracheal intubation,
mechanical ventilation and muscle relaxation in all cases. Having prepared and
draped a sterile field on the abdominal wall using povidone iodine solution,
laparoscopic access to the peritoneal cavity was achieved by one of two methods, (i)
The "closed technique", which was utilised during the earlier stages of Studies 1 and
2. A small skin incision was made in the immediate supra- or sub-umbilical region,
and a Veress needle inserted at an angle of 45° directed towards the pelvis.
Satisfactory insufflation of C02 gas through the Veress needle at a flow rate of 1 L /
min was ensured and a tense pneumoperitoneum with a pressure of 10-13 mmHg
confirmed by the presence of abdominal distension with a tympanitic percussion
note over all areas of the abdominal wall. Following removal of the Veress needle, a
10mm diameter disposable laparoscopic trocar and port assembly (Endopath,
Ethicon Ltd, Edinburgh, UK) was inserted through the umbilical incision and into
the abdominal cavity, again aiming towards the pelvis. Disposable ports were used
in preference to re-usable ports to minimise the risk of trauma to the vulnerable
laparoscopic ultrasound transducer from the spring-loaded metal trumpet valves
which were a feature of the non-disposable instruments, (ii) The "open technique",
which was utilised from February 1993 onwards (Figure 1). The umbilicus was
everted using toothed grasping forceps and a small vertical skin incision was made
from the apex of the umbilicus in a caudal direction. The 'umbilical tube' and its
junction with the linea alba identify the close approximation of the parietal
peritoneum with the umbilicus. A small stab incision at this site was enlarged by
blunt dissection with an artery forceps, permitting direct entry into the peritoneal
cavity. A disarmed disposable port (i.e. without the sharp trocar) or blunt Hasson
trocar (Endopath, Ethicon Ltd, Edinburgh, UK) was inserted under direct vision,
thereby avoiding risk of injury to the viscera. Rapid insufflation of C02 gas via the
inlet of the port was commenced at a flow rate of 4 L / min, and having established a
10-13 mmHg pneumoperitoneum, a second 10 mm disposable laparoscopic trocar
and port was inserted away from any adhesions or viscera under direct laparoscopic
vision (Figure 2).
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A variety of videolaparoscopic camera systems were employed (Olympus OTVSX,
KeyMed Ltd, Southend-on-Sea, UK; or Solos GS9635, Sigmacon Ltd, Heriots
Wood, UK). In each case, a 30° laparoscopic telescope (Solos, Sigmacon Ltd,
Heriots Wood, UK) was used to facilitate side-viewing of certain regions of the
abdomen such as the anterior abdominal wall, the diaphragmatic surface of the right
hemiliver, the undersurface of the left hepatic lobe and the pelvic viscera. The
videolaparoscopic examination was viewed using two high resolution Sony Trinitron
PVM-1443-MD monitors which were positioned either side of the head-end of the
operating table.
The examination was terminated with evacuation of the pneumoperitoneum and the
removal of all ports, taking care to arrest any port site bleeding. The midline fascial
defect in the linea alba was repaired with interrupted 1/0 Poly Dioxanone Sulphate
sutures (PDS, Ethicon, Edinburgh, UK), and skin edges closed with subcuticular 4/0
PDS sutures. Local anaesthetic infiltration of the wounds was performed using 10 -
20 ml of 0.5% Marcain (Bupivicaine Hydrochloride) (Astra Ltd, Kings Langley,
UK).
2.3.2 Laparoscopic ultrasonography - General considerations
Laparoscopic ultrasonography was performed using a variety of commercially
available equipment featuring similar specifications (Figures 3-5). A 7.5 MHz
multi-element linear-array LapUS probe, which consisted of a 9mm diameter rigid
wand incorporating a 3.8 - 4 mm transducer 'footprint' at its flattened end, was used
in every case (Aloka UST-5521-7.5 or Aloka, UST-5523L-7.5, KeyMed Ltd,
Southend-on-Sea, UK; or Tetrad 8A, Englewood, CO, USA). The LapUS probe was
connected by a sterile cable to a portable ultrasound machine (or "scanner") which
was positioned alongside the operating table (Aloka SSD-500 or Aloka SSD-680,
KeyMed Ltd, Southend-on-Sea, UK; or Tetrad 2200 imaging system, Englewood,
CO, USA, respectively). Sterilisation of the LapUS probe was achieved by
immersion for 20 minutes in 2.2% - 2.5% activated glutaraldehyde solution (Cidex,
Johnson & Johnson Ltd, Skipton, U.K.).
The LapUS scanning machines featured several variable image parameters (gain,
image direction, magnification, electronic measuring calipers, freeze frame) which
were adjusted by an unscrubbed assistant or theatre nurse under the direction of the
laparoscopic ultrasonographer (Aloka SSD-500 or Aloka SSD-680), or by the
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operator using a remote control handset placed within a sterile plastic sleeve (Tetrad
2200) (Figure 2).
Laparoscopic ultrasound images appeared in real-time on the small monitors which
were integral to the scanners. However, simultaneous viewing on the large operating
theatre monitors of both the laparoscopic view of the abdominal cavity and the
sonographic images was achieved by 'picture-in-picture' video mixing using a
Panasonic WJ-AVE5 audio-visual mixing desk (KeyMed Ltd, Southend-on-Sea,
UK).
The linear array LapUS transducers used generated real-time B-mode rectilinear
sonograms when placed in contact with the underlying abdominal tissues. The first
LapUS system used (Aloka UST-5521-7.5 / SSD-500) was tested using an industry
standard "phantom" to validate these specifications and to document its lateral and
axial image resolution. A full description of the test is shown in Appendix A. In all
cases, a standard image direction setting was used such that the distal end of the
LapUS transducer was represented on the right side of the sonogram, and the
proximal end on the left side.
Images were recorded using a Sony Umatic video cassette recorder, and hard copies
were obtained by video frame capture using an Aloka SSZ 700 colour echo copier
(KeyMed Ltd., Southend-on-Sea, UK) which utilised a dye transfer thermal
sublimation technique.
2.3.3 Diagnostic and staging laparoscopy
The insertion of two laparoscopic ports served two purposes; (i) the LapUS probe
and other laparoscopic instruments could be inserted via the second port and used to
manipulate the viscera, perform biopsies, aspirate ascitic fluid or peritoneal washings
and tamponade bleeding biopsy sites under direct vision; (ii) by alternating the
telescope and LapUS probe between two ports, LapUS scanning of the abdominal
viscera could be performed about two different planes under laparoscopic guidance
(Figure 2).
A systematic examination of the abdominal cavity was performed, examining the
serosal surfaces of the anterior abdominal wall, diaphragm, falciform ligament,
omentum, pelvic viscera, bowels and their mesenteries. Special attention was paid
to the capsular surface of the liver, gall bladder and hilar structures. A probe was
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used to displace loops of bowel, and to elevate the left hepatic lobe (Figure 6). The
latter manoeuvre was performed to permit inspection of its undersurface and expose
the lesser curvature of the stomach and gastrohepatic omentum. The contents of the
lesser sac, including the caudate lobe of the liver, the pancreatic body and major
branches of the coeliac trunk, could therefore be inspected in patients without
excessive intraabdominal fat (Figure 7). The presence of dilated venous collaterals,
which might indicate segmental portal hypertension secondary to portal or splenic
vein onbstruction, was noted and the disposition of the stomach was inspected for
signs of displacement by a retrogastric mass (Figure 8). The probe was used to
gently 'palpate' the pancreatic region for a mass (Figure 7A). The porta hepatis,
omentum, lesser curve and root of mesentery was inspected for lymph node
enlargement. No attempts were made to insufflate or enter the lesser sac, nor was
dissection or mobilisation of the pancreatic head or mesenteric root ever performed.
The site and appearance of any abnormalities detected during laparoscopy were
documented. Peritoneal tumour seedlings were suspected whenever small white
plaques or studs were seen on serosal surfaces (Figure 9). Any free intraperitoneal
fluid was aspirated for cytological assessment (see section 2.4).
Liver tumours were suspected whenever a solid focal lesion was visualised at the
surface of the organ (Figures 6 and 10). The number, size and site of suspected liver
lesions were documented according to the nomenclature of the segmental hepatic
anatomy originally described by Couinaud278'279. Liver tumours breaching the
hepatic capsule were recognised as pale in colour compared with the surrounding
hepatic parenchyma, whereas a discrete alteration in the contour of the liver was
regarded as suspicious of an underlying intrahepatic tumour deposit (Figure 6). In
the laparoscopic assessment of patients under consideration for resection of liver
tumours, particular attention was also paid to the general appearance of the liver,
documenting abnormalities such as the diffuse nodularity of cirrhosis, or the
yellowish opalescent appearance of diffuse fatty infiltration (steatosis).
Subtle abnormalities affecting the hepatic capsule, whether focal or diffuse, were
regarded with caution, especially in the context of established or recently relieved
biliary obstruction. It was recognised that serosal tumour seeds and malignant
subcapsular liver lesions can appear similar to benign abnormalities such as areas of
Fibrosis, fatty change, dilated superficial biliary radicles and biliary hamartomas
(biliary ectasia / von Meyenberg's complex). Laparoscopic biopsies of such
abnormalities were therefore always obtained to verify the diagnosis (Figure 33A).
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2.3.4 Technique of laparoscopic ultrasonography
Whenever the stomach and duodenum were seen to be distended, a nasogastric tube
was inserted by the anaesthetist and suction applied to evacuate luminal gas and
particulate matter which might degrade the LapUS images. The thin film of
moisture covering the abdominal organs usually provided excellent acoustic
coupling with the LapUS transducer. However, at the discretion of the laparoscopic
ultrasonographer, the instillation into the peritoneal cavity of up to 500 ml of normal
saline solution at room temperature was used to optimise transducer contact and
minimise the temptation to apply down pressure to maintain contact. This instilled
fluid also served as peritoneal washings for peritoneal cytological analysis (see
section 2.4).
A systematic LapUS examination of the liver, biliary tree and pancreas and
surrounding tissues was devised, based upon descriptions contained in standard
reference texts of transabdominal280 and intraoperative ultrasonography281. The
description of the LapUS examination contined herein has been arbitrarily divided
into sections which emphasise imaging of the liver, biliary tree and pancreas.
However, it should be appreciated that LapUS of these regions was in reality a
continuum between the three anatomical areas, the emphasis of each examination
being tailored to the individual circumstances of the patient.
In general, LapUS was performed using a rigid linear array probe which could be
moved between an umbilical port and a right flank port (Figure 2). Laparoscopic
ultrasonography via the umbilical port produced images orientated about a
predominantly sagittal plane. Conversely, scanning was performed about a
predominantly transverse plane when the probe was operated from a lateral port.
The LapUS probe could be advanced and withdrawn, swept laterally in arc and
rotated clockwise or anti-clockwise about its own axis with smooth movements. In
reality, scanning occured through a range of oblique and coronal "cuts", enabling the
laparoscopic ultrasonographer to appreciate three dimensional anatomical detail
from a sequence of two-dimensional real-time images. However, it is convenient to
describe the LapUS examination with separate reference to (i) the umbilical port /
sagittal scanning plane and (ii) the right lateral port / transverse scanning plane.
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2.3.5 Laparoscopic ultrasonography of the liver
Whenever a "reference" hepatic lesion was identified either by laparoscopic
inspection of the liver, or by preceding radiological investigations, characterisation
of its LapUS appearance was performed initially to facilitate recognition of any other
intrahepatic lesions, and for comparison with any other abnormalities. Thereafter, a
systematic anatomical survey of the liver was undertaken so that the precise pattern
of liver involvement could be documented, and no "blind areas" of parenchyma were
neglected. The anatomical survey relied on the recognition of intrahepatic vascular
landmarks given the paucity of surface markings on the liver capsule (Figure 11).
Sonographically, the normal liver parenchyma has a fine homogenous texture of
medium echogenicity. Portal tracts were characterised by their hyperechoic fascial
sheaths and diverging course away from the hilum. Laminar blood flow could be
observed within the prominent portal vein branches, but the intrahepatic arterial and
biliary radicles were normally not easily seen. The hepatic veins were always seen
converging in a posterosuperior direction towards the inferior vana cava, and were
characterised by the observation of central venous pulse fluctuations transmitted
from the inferior vena cava and right atrium of the heart.
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An appreciation of the hepatic segmental anatomy ' was fundamental to the
anatomical survey and the documentation of liver lesions. The eight hepatic
segments are divided into those constituting the right hemiliver (V-VIII), the left
hemiliver (II-IV) and caudate lobe (segment I). The right and left hemilivers are
divided by the plane of the principal fissure which passes between the gallbladder
fossa and the inferior vena cava. This plane has no external markings, but is defined
by the course of the middle hepatic vein which was identified at the outset of the
anatomical survey with the LapUS probe placed on the diaphragmatic surface of the
liver (Figure 11). Advancement of the LapUS probe in a posterior direction traced
the course of the middle hepatic vein to the confluence of the hepatic veins with the
inferior vena cava. Anteriorly, the structures of the hepatoduodenal ligament were
identified traversing the liver hilum. This plane represented an important anatomical
landmark from which a systematic survey of the right and left hemilivers was
performed (Figure 11).
The left hemiliver comprises hepatic segment IV (the quadrate lobe), and the left
hepatic lobe (segments II and III). These entities are separated by the insertion of
the falciform ligament and ligamentum teres. Scanning through hepatic segment IV
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identified the left hepatic pedicle giving branches to segments I-IV near the
ligamentum teres insertion. The boundary between segments II and III was
recognised by the course within the left lobe of the left hepatic vein, which
converges with the middle hepatic vein to form a common trunk before entering the
inferior vena cava. The fascia of the hepatic insertion of the lesser omentum
(gastrohepatic ligament) was identifiable as a well defined hyperechoic plane
demarcating the caudate lobe, the inferior vena cava and the paraaortic region from
hepatic segment II posteriorly.
The right hemiliver is divided by the transverse course of the right hepatic vein into
anterior (segments V and VIII) and posterior (segments VI and VII) sectors (Figure
11). This plane has no surface markings, and was best appreciated with the LapUS
probe inserted through the right flank port along the right paracolic gutter and right
lateral subphrenic space. Scanning in the predominantly coronal plane of the right
hepatic vein was achieved from this position. The anterior and posterior sectoral
divisions of the right portal pedicle were identified bifurcating perpendicular to the
plane of the right hepatic vein, and their respective segmental branches defined.
Focal hepatic abnormalities were characterised as isoechoic, hyperechoic or
hypoechoic compared with the background parenchyma (Figure 12). A variety of
benign lesions were also encountered, and characterised by their typical sonographic
appearances. These included simple hepatic cysts, areas of fatty infiltration,
fibronodular hyperplasia and haemangiomas. Simple cysts were anechoic, lacked a
defined wall and cause posterior acoustic enhancement. Focal fatty infiltration was
commonly observed adjacent to the ligamentum teres insertion and gall bladder
fossa in segments IV and V, and appeared as a circumscribed but irregular
hyperechoic area. Haemangiomas were identified as round, circumscribed
hyperechoic lesions which never caused posterior attenuation of the ultrasound beam
("shadowing"), although frequently were associated with posterior acoustic
enhancement. Any hyperechoic intrahepatic lesion causing posterior acoustic
attenuation was regarded as being highly suspicious of a metastasis of
gastrointestinal origin. Diffuse abnormalities of the liver parenchyma were also
interpreted with caution. A coarse and predominantly hyperechoic texture
throughout the liver was recognised as confirming steatosis or cirrhosis, especially
when suspected from the appearances of preoperative radiological investigations or
laparoscopic inspection. However, caution was excercised when there was the
possibility of diffuse malignant infiltration, and a tissue diagnosis was sought in
these circumstances.
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In patients with suspected focal hepatic malignancy, a careful and systematic search
for malignant focal lesions was performed, with reference to the sonographic
appearance of the reference lesion where possible. The presence of an anechoic halo
immediately surrounding the lesion was regarded as being pathognomonic for
OQO 9C4
metastases, hence the term "bullseye" or "target" lesions (Figure 12). The
number, size, site and spatial relationships of the tumour with important vascular
structures was documented so that where appropriate, anatomical liver resections
could be planned. The hilar and paraaortic regions were examined for malignant
regional lymphadenopathy, which was inferred from the finding of discrete lymph
nodes measuring more than 10 mm in diameter.
2.3.6 Laparoscopic ultrasonography of the biliary tree
Laparoscopic ultrasonography of the biliary tree was always preceded by
examination of the liver to identify intrahepatic duct dilatation or other incidental
intrahepatic pathology. Examination of the proximal biliary tree and gallbladder was
performed with the LapUS transducer positioned on the diaphragmatic surface of
hepatic segments IV and V, using the intervening liver as an acoustic window
(Figure 13). The gallbladder wall is normally thin (< 3 mm) and exhibits three
distinct echo-layers (Figure 14). It was examined for mural thickening, distension,
mucosal polyps or distortion by tumour infiltration. The number and size of any
contained gallstones, or the presence of echogenic debris or crystals and biliary
sludge was documented.
Examination of the extrahepatic biliary tree with the LapUS probe inserted through
the umbilical port provided laparoscopic sonograms in the longitudinal axis of the
hepatoduodenal ligament (Figure 13). The common bile duct, hepatic artery and
portal vein were identified as parallel tubular structures, which were separated
posteriorly from the inferior vena cava in the cephalad direction by the wedge
shaped caudate lobe of liver. These structures traversing the hepatoduodenal
ligament were distinguished by their (i) relative positions, (ii) vessel wall
characteristics and (iii) the nature of luminal blood flow. The course of the portal
vein, which is normally the largest structure within the hepatoduodenal ligament,
was defined by its posterior position, thin wall, lack of pulsatility and visible laminar
blood flow. The common hepatic artery was identified by its anteromedial position,
thicker wall and visible arterial pulsation. It could be traced inferomedially to its
origin from the coeliac axis at the superior pancreatic border, while superiorly its
usually traversed the portal vein and common hepatic duct to enter the liver hilum.
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The common duct was identified by its anterolateral position relative to the hepatic
artery and portal vein, its thicker fibrous wall, and the absence of any luminal flow.
Its confluence with the cystic duct was often apparent, and when dilated above
normal limits (i.e. > 8 mm in maximum diameter) a sediment of biliary sludge was
often apparent. Withdrawal of the LapUS probe from the umbilical port with slight
clockwise rotation of the transducer allowed the intra- / retro-pancreatic course of
the distal common bile duct to be traced through its divergent path away from the
portal vein and anterior to the inferior vena cava to the papilla of Vater. Common
duct stones were strongly suspected when a crescentic hyperechoic signal and / or a
dense posterior acoustic shadow were observed (Figure 14).
Examination of the extrahepatic biliary system in a predominantly transverse
direction with the LapUS probe operated from a right flank port was performed by
sweeping the transducer over the length of the hepatoduodenal ligament, gastric
antrum and proximal duodenum. Cross-sectional images of the portal vein
(posterior), hepatic artery (anteromedial) and common duct (anterolateral) were
obtained in this way (Figure 15).
2.3.7 Laparoscopic ultrasonography of the pancreas
Sonographically, the normal pancreatic parenchyma appears homogenous and of
similar or slightly increased echogenicity relative to that of the liver, and is
intimately related to several major blood vessels and ductal structures. An
anatomical survey of the pancreas and peripancreatic structures was performed with
reference to standard anatomical landmarks with the LapUS probe operated via
umbilical and right flank ports to achieve scanning in two planes.
Laparoscopic ultrasonography of the pancreas via the umbilical port
With the LapUS probe operated in a predominantly sagittal plane via the umbilical
port, and having examined the structures of the hepatoduodenal ligament (Section
2.3.6), the portal vein and common duct were followed inferiorly through their
mutually divergent courses (Figure 16). The course of the portal vein and superior
mesenteric vein posterior to the pancreatic neck was identified as the probe was
withdrawn inferiorly over the gastric antrum and first part of duodenum. The
pancreatic neck was recognised as a relatively thin structure measuring <15 mm in
the antero-posterior direction, and conveying the main pancreatic duct, which was
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identified in transverse section and measured < 3 mm in diameter when normal
(Figures 17 and 18).
From this key position of reference for the LapUS examination of the pancreas,
slight rotation or lateral displacement of the transducer to the right demonstrated the
head of the pancreas and the duodenum. The five echo-layers of the duodenal wall,
in which peristaltic movement was usually visible, demarcated the lateral extent of
the pancreatic head. The convergent courses of the pancreatic duct and common bile
duct anterior to the inferior vena cava were traced until their termination at the
papilla of Vater, which could be identified protruding into the duodenal lumen when
sufficient intraluminal fluid was present. The uncinate process was recognised as the
inferior extension of the pancreatic head which extended medially to "wrap behind"
the superior mesenteric vein over a variable distance (Figure 16).
Examination of the body and tail of the pancreas was achieved by rotation or lateral
displacement of the LapUS probe to the left from the reference position over the
pancreatic neck, using the course of the pancreatic duct as a guide. It was sometimes
helpful to position the LapUS transducer on the left hepatic lobe as a "standoff', thus
facilitating imaging of the para-aortic region (Figure 19). The superior mesenteric
artery was identified passing posterior to pancreatic neck and entering the mesenteric
root immediately to the left of the superior mesenteric vein. The origin of the
coeliac axis from the abdominal aorta was identified immediately above that of the
SMA, and its main branches identified by slight rotatory movements of the probe
(Figure 19). The presence of an anomalous (accessory or replaced) right hepatic
artery arising from the SMA or aorta was diagnosed by the demonstration of a
significant arterial branch arising at this level, and coursing superiorly into the
hepatoduodenal ligament while passing posterior to the pancreatic head, portal vein
and / or common duct (Figure 20).
Laparoscopic ultrasonography of the pancreas via the right lateral port
Examination in a predominantly transverse direction with the LapUS probe operated
from a right flank port required identification of the splenoportal mesenteric venous
junction, superior mesenteric artery, aorta and inferior vena cava which were the key
vascular landmarks delineating the posterior limits of the pancreas (Figure 21). The
walls of the stomach and duodenum beneath the transducer demarcated the anterior
limits of the gland. As the transducer was swept superiorly, the emergence of the
portal vein at the superior pancreatic border to enter the hepatoduodenal ligament
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was identified. At this level, the common hepatic artery was identified arching over
the portal vein, with the gastroduodenal and superior pancreaticoduodenal arteries
emerging to pass superficially between pancreatic head and duodenum. The full
length of the pancreatic duct, and the tortuous course of the splenic artery at the
superior pancreatic border could be appreciated from this position. Again, the
presence of an accessory right hepatic artery was identified passing posterior to the
pancreatic head, portal vein and / or common duct (Figure 20 B).
Laparoscopic ultrasonography for pancreatic and periampullary cancer
Carcinoma of the pancreatic head or periampullary region often caused secondary
changes which were apparent during the anatomical survey, such as dilatation of the
common bile duct (> 8 mm), cystic duct and gall bladder (Figure 22). When
previous decompression of a patient's obstructive jaundice by endoscopic or
percutaneous insertion of a biliary stent had caused collapse of the duct, its course
was identified by detection of the hyperechoic stent artefact. Dilatation of the
pancreatic duct (> 3 mm diameter) was typically accompanied by atrophy of the
surrounding pancreatic parenchyma in the pancreatic neck, body and tail.
Ductal carcinoma of the pancreas was diagnosed as a predominantly hypoechoic
mass with irregular margins, although often heterogeneous with patchy areas of
mixed echogenicity. However, it was also recognised that pancreatic carcinoma less
frequently appeared as a diffusely infiltrating and ill-defined tumour which was
isoechoic and could be difficult to diagnose (Figures 23 and 24).
Periampullary carcinoma was diagnosed by the appearance of a mass at the site of
the papilla of Vater, as indicated by the termination of the common bile duct and
pancreatic duct within the duodenal wall. Such lesions were recognised as poorly
defined isoechoic lesions prolapsing into the duodenal lumen as a sessile mass,
infiltrating the pancreatic head, and / or occluding the lumens of dilated pancreatic
and / or distal common bile duct (Figures 25 and 26).
Having characterised the primary pancreatic lesion, its local resectability was
assessed. Tumour invasion of the portal vein was the main consideration in
determining local resectability of pancreatic or periampullary cancer, with particular
attention to the right lateral aspect of the splenoportal venous junction. The
following criteria were adopted to indicate vascular invasion: (i) obliteration or
thrombosis of the vein, as evidenced by failure of the laparoscopic ultrasonographer
to demonstrate a patent vessel in the expected anatomical location, with or without
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venous collateralisation; (ii) a fixed stenosis of the vessel wall; (iii) loss of the
hyperechoic vessel / tumour interface with encroachment of hypoechoic tumour to
the vessel margin; (iv) vessel encasement as evidenced by tumour encirclement and
'rigidity'; (v) the presence of invading tumour within the vessel lumen (Figures 27 -
31). Care was taken to avoid creating artefactually the impression of portal vein
compression by excessive probe pressure.
Other evidence for local unresectability was sought by examining for tumour
extension into adjacent soft tissue planes, such as the mesenteric root,
hepatoduodenal ligament or retropancreatic fascia.
Regional lymph node enlargement (> 10 mm maximum node diameter) was
arbitrarily regarded as being suspicious of malignant involvement (Figure 32).
2.3.8 Laparoscopic biopsy
Standard straight-blade laparoscopic scissors and toothed forceps were used for
excisional biopsy of peritoneal or superficial liver lesions (Figures 9B and 33A).
Needle biopsies of deeper seated tumours within the liver or pancreas were
performed using a Tru-Cut needle (Baxter, Deerfield, IL, USA). This biopsy needle
is available in a range of sizes and incorporates a 20 mm specimen notch within a
sliding guillotine sheath. The tip of the biopsy needle was lightly abraded with a
scalpel blade to enhance its sonographic signal prior to LapUS guided biopsy.
Laparoscopic and LapUS guided needle biopsies were performed by a two puncture
"free hand" technique. The site of needle puncture on the abdominal wall was
chosen to facilitate access to the target area, anticipating the angle with which the
needle would be introduced into the sonographic field. The passage of the needle
was identified as a bright point source when the needle was perpendicular to the
sonographic 'cut', or as an hyperechoic linear 'artifact' when the needle was in the
same plane as the ultrasound beam. Slight rotatory or side-to-side movements of the
LapUS probe helped to maintain the three-dimensional orientation of the
ultrasonographer during the biopsy procedure.
Laparoscopic and LapUS guided fine needle aspiration cytology was performed for




The majority of LapUS examinations reported in this thesis were performed by a
Consultant Surgeon with several years experience with intraoperative and LapUS
(OJG), or by the author (TGJ) who was a surgical trainee at registrar level, and who
trained in the technique from October 1992. In study 1 (imaging of the normal
hepatobiliary and pancreatic anatomy), all LapUS examinations performed during
laparoscopic cholecystectomy were performed by the author. In addition, all staging
LapUS examinations in patients with pancreatic or periampullary cancer in Study 1
were performed by the author or OJG.
All LapUS examinations in Studies 3 and 4, and the majority of those in Study 2,
were performed by OJG or TGJ. Several LapUS examinations in Study 2 were
performed by surgical trainees at Senior Registrar level (JDG, MM and / or JW)
under the supervision of OJG. A standardised proforma (Appendix B) was
completed by TGJ or OJG upon completion of the LapUS examination.
2.4 LAPAROSCOPIC PERITONEAL CYTOLOGY
At the outset of laparoscopy, 300-500 ml of normal saline at room temperature was
instilled into the subhepatic space. Biopsy of suspicious serosal or liver lesions, or
of the pancreas, was always deferred until after the aspiration of lavage fluid to
minimise its contamination with tumour cells or blood. Following completion of
laparoscopic ultrasonography, an 80 ml sample of lavage fluid was aspirated using a
16 FG nasogastric tube (Vygon, 95440 Ecouen, France) inserted via a 5 mm
reducing sleeve and attached to a 30 ml catheter tipped-syringe (Figure 33B). The
specimen was transported to the Department of Pathology in 4 x 20 ml sterile
universal containers.
Peritoneal lavage specimens were centrifuged at 2 000 rpm for 10 minutes and the
supernatant discarded. The sediment was re-suspended in Glasgow's medium
containing 0.25% heparin, and cytospin preparations were made using 200 ml
aliquots of the suspension spun at 500 rpm for four minutes. The cytospin
preparations were fixed immediately in 95% methyl alcohol for 10 minutes. In
instances of heavy bloodstaining of the sample, additional cytospin samples were
prepared and lysed in 6% acetic acid in 95% methyl alcohol. Slides were stained
using the Papanicolau method, and when appropriate, additional stains for mucin and
/ or cell marker studies were performed.
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All cytological examinations were performed initially as part of the routine hospital
service by a number of cytopathologists. All specimens were also reviewed
independently by a Consultant Cytopathologist (EMcG). The results were
documented on a standardised proforma (Appendix B).
2.5 RADIOLOGICAL IMAGING TECHNIQUES
2.5.1 Transabdominal ultrasonography
In Studies 3 and 4, transabdominal USS was performed after a fast of at least six
hours using an Acuson 128 ultrasound machine (Mountain View, CA, USA) with
3.5 MHz or 4 MHz transducers. All scans were performed by one experienced
radiologist (PLA). Colour Doppler and Doppler spectral analysis were used to
assess the major peripancreatic blood vessels for tumour involvement. The presence
of significant turbulence or an increase in velocity > 100% at, or beyond, the region
of the tumour was taken as evidence of vascular invasion. The examinations were
performed 'blind', and a protocol form (Appendix C) was completed for each
examination by PLA. (Figure 34).
2.5.2 Dynamic CT
In Studies 3 and 4, CT scans of the abdomen were perfomed under the direction of
one Consultant Radiologist (ARW), or by a nominated deputy according to the
following protocol. Where CT scans had recently been obtained at a referring
hospital, the films were reviewed by ARW, and the examination only repeated if the
quality of the original scans were regarded as poor. The scans were interpreted
'blind', and a protocol form (Appendix D) was completed by ARW for each
examination.
Abdominal CT scanning was performed using a General Electric 9800 whole body
CT scanner (General Electric Medical Systems, Milwaukee, WI, USA). Contiguous
10mm slices were acquired through the entire liver and pancreas before the
administration of intravenous contrast. The examination was repeated following the
injection of a 100 ml bolus of iodinated contrasted medium (Iopamidol 370®). Ten
mm contiguous slices were obtained with scan acquisition performed in a craniad
direction to optimise contrast opacification of the superior mesenteric and portal
veins (Figures 35 and 36).
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Latterly, several CT scans were performed using the technique of 'spiral' CT
scanning with a Siemans Somatom Plus spiral-acquisition CT scanner. Scans were
performed before and during intravenous contrast enhancement with 100-120 ml of
Iopamidol 300®. For the precontrast scans, the liver and pancreas were scanned
during a single breath-hold using 10 mm nominal slice thickness and a 10 mm / sec
table speed. For the post-contrast scan, 5 mm slice thickness and 5 mm / sec table
speed or 10 mm slice thickness with 10 mm / sec table speed was used depending on
the volume of interest.
2.5.3 Selective visceral angiography
All angiographic examinations in Studies 2-4 were perfomed and interpreted 'blind'
by one Consultant Radiologist (DNR). A protocol form (Appendix E) was
completed for each examination by DNR.
A 7 Fg Cordis® superior mesenteric or Sidewinder® catheter was introduced
percutaneously into the right common femoral artery by the Seldinger technique, and
advanced into the abdominal aorta. The coeliac axis was initially selected, and 60-
70 ml of non-ionic contrast (Niopam 370E®, Merck Pharmaceuticals) was injected
at a rate of 6ml / sec and at a pump pressure of 600 psi. Following an initial delay of
one second, ten films were obtained at a speed of one film every two seconds. This
provided an anatomical display of the branches of the coeliac axis, and during the
venous phase, visualisation of the splenic and portal vein (Figure 37 and 38).
The catheter was then placed within the superior mesenteric artery, and 70 ml of
contrast are again injected at the same rate and pressure settings. A long film delay
of 9-10 secondss was employed, and ten radiographs obtained at a rate of one film
every two seconds. This sequence of films demonstrated any arterial anomalies
involving the superior mesenteric artery, such as an accessory or replaced right or
common hepatic artery (Figure 39). The longer delay ensured optimal visualisation
of the superior mesenteric and portal veins.
Where the meso-portal venous pathway lay across the plane of the vertebral column,
and imaging was consequently impaired, the examination was repeated with a 17°
right posterior oblique view with the catheter still in the superior mesenteric artery
and employing the same settings. Thus, the opacified veins were projected away
from the bony structures and clearer images obtained.
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2.6 VALIDATION OF RESULTS
Validation of the study endpoint of tumour unresectability was achieved in a number
of ways:
2.6.1 Laparoscopic findings
Tumour unresectability was regarded as having been validated when distant
intraabdominal metastases or malignant regional lymphadenopathy were discovered
during laparoscopy. Histological confirmation of the diagnosis was required in each
case. This was achieved by laparoscopic needle biopsy, fine needle aspiration
cytology and / or scissor-biopsy of the lesion.
2.6.2 Surgical assessment
Exploratory laparotomy was the ultimate arbiter of tumour resectability in the
majority of patients, and was always performed by a consultant surgeon who was
experienced in pancreatic surgery (DCC, OJG and / or SPB). The findings were
documented on a standardised proforma by TGJ (Appendix F). Laparotomy was
performed under general anaesthesia with endotracheal intubation, muscle
relaxation, mechanical ventilation and invasive monitoring (central venous pressure,
arterial pressure line and urethral catheterisation). A right subcostal incision was
performed, extended to the left where appropriate. A careful inspection of the
peritoneal cavity and viscera was performed, with palpation of the liver, mesenteries,
peripancreatic tissues and serosal surfaces for metastases, malignant
lymphadenopathy or extra pancreatic tumour invasion. Histological proof of such
findings was sought in each case by biopsy. Intraoperative ultrasonography of the
liver was performed using a 7.5 MHz 'T-probe' to search for intrahepatic metastases
(Aloka UST-576-T, KeyMed Ltd, Southend-on-Sea, UK; or Tetrad 6C, Englewood,
CO, USA).
Exploration of the pancreas itself was performed to assess local tumour resectability
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(i.e. T-stage) . The size and fixity of the tumour were assessed by superficial
palpation. Local tumour invasion of the tissues of the hepatoduodenal ligament,
mesenteric root, major arteries and stomach was regarded as evidence of
unresectability. The pancreatic head and duodenum were mobilised from the
inferior vena cava and aorta by the Kocher manoeuvre. Tumour infiltration of this
plane (Figure 40), including the paraaortic lymphoid tissue and origin of the superior
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mesenteric artery, was regarded as evidence of unresectability. Bi-digital palpation
of the pancreatic head and mesenteric root was performed to evaluate tumour
mobility and local tumour extension. Tumour invasion of the major peripancreatic
veins was assessed by dissection of the superior mesenteric vein at the inferior
pancreatic border between the third part of the duodenum and uncinate process, the
portal vein at the superior pancreatic border and its course through the
retropancreatic tunnel (Figure 41). Patients in whom limited tumour invasion of the
superior mesenteric and portal vein was suspected were regarded as unresectable,
and portal vein resection was not attempted.
Exposure of the anterior surface of the pancreas was achieved by entering the lesser
sac through division of the gastrocolic and gastrohepatic omenta. Direct invasion of
the posterior stomach wall was assessed by this manoeuvre. Evaluation of local
retroperitoneal invasion in patients with cancers of the pancreatic body and tail was
performed during mobilisation of the spleen and distal pancreas. Palliative
resections comprising gross transection of tumour in patients with locally invasive
disease were not performed.
In general, patients with cancers of the pancreatic head or periampullary region were
treated by a Whipple pancreaticoduodenectomy, patients with cancers of the
pancreatic body and tail underwent distal pancreatectomy, and total pancreatectomy
was reserved for a patient with carcinoma of the head and body.
Patients with periampullary tumours apparently localised to the papilla and
considered potentially resectable by local excision were evaluated superficially by
means of a longitudinal duodenotomy. Such tumours were regarded as resectable
when transduodenal local excision, or ampullectomy, could be achieved with
tumour-free resection margins.
2.6.3 Non-operative findings
Occasionally, patients were deemed to have locally unresectable pancreatic cancers
due to portal - superior mesenteric vein invasion on the basis of of the concurring
radiological findings of USS, CT, LapUS and / or SVA, together with the clinical
observation of a rapid death from carcinomatosis. In Studies 2-4, independent
validation of these findings during laparotomy was not obtained because an a priori
clinical decision had been made to palliate the patient non-operatively by means of
biliary stent insertion. The combined evidence of the various staging investigations
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and clinical findings were accepted as validation of tumour unresectability. Such
findings were documented on a standardised proforma by TGJ (Appendix F).
2.6.4 Histopathological findings
Validation of tumour resectability for cure in Studies 3 and 4 required the
demonstration of microscopically tumour free resection margins and regional lymph
nodes following routine histopathological examination of the resection specimens by
the staff of the University of Edinburgh Department of Pathology. Particular
attention was paid to the surgical transection lines of the stomach, common duct,
pancreas, duodenum and retropancreatic fascia. The findings were documented on a
standardised proforma by TGJ (Appendix F).
2.6.5 Documentation of data
The data recorded on standardised proformas for Studies 1-4 (Appendices B-F) were
collected and stored using a desktop computer database programme (Claris™
Filemaker Pro 2.1 Bv2 used with a Macintosh Centris 610 or Macintosh LC475), the
database format having been created by TGJ.
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Figure 1
Technique of "open" laparoscopy by direct cutdown. The umbilicus has
been everted and the umbilical tube and parietal peritoneum incised. This
provides direct access to the peritoneal cavity (as demonstrated by forceps)
facilitating insertion of the laparoscopic port under direct vision.
82
Figure 2
Technique of laparoscopy with LapUS. The telescope (with attached
camera and light source) has been inserted via the umbilical port (note
insufflation tubing attached to side port). The LapUS probe has been
inserted through the right flank port (note attached tubing for the instillation
of saline via the side port). The "remote control" handset has been placed
within a sterile plastic sleeve.
83
Figure 3
Aloka SSD-500 portable ultrasound scanning machine (back left) with Sony
thermal printer (back right). A 7.5 MHz linear array LapUS probe (Aloka
UST-5521-7.5), a 5 MHz intraoperative ultrasound "T probe" (Aloka UST-
576-7.5) (and a 5 MHz intraoperative ultrasound "I probe") are pictured in
the foreground (from back to front).
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Figure 4
Tetrad 2200 portable ultrasound scanning machine
(Tetrad Corp, CO, USA)
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Figure 5
Close-up view of the 4 cm "footprint" of the 7.5 MHz linear array
transducer at the end of the 9 mm diameter rigid shaft of the Aloka UST-




A. Inspection of the left hepatic lobe during staging
laparoscopy in a patient thought (on the basis of spiral CT
scanning) to have a potentially resectable periampullary
carcinoma revealed a subtle contour change near the inferior
edge.
B. Retraction of the liver edge with the LapUS probe revealed
small metastasis breaching the capsule of its undersurface.
Figure 7
A. "Palpation" of the pancreas using a rigid LapUS probe
during laparoscopy. The probe has been inserted through the
umbilical port, and LapUS images of the pancreatic body and
peripancreatic tissues are generated about the parasagittal plane.
B. Elevation of the left hepatic lobe to demonstrate the lesser
omentum, and the caudate lobe, common hepatic artery (lower
right) and accessory left hepatic artery (from the left gastric
artery) within the lesser sac. No nodes are identified.
Figure 8
A. Distended gastroepiploic veins and ascitic fluid in the region
of the porta hepatis providing indirect evidence of portal vein
invasion by carcinoma of the pancreatic head during staging
laparoscopy.
B. Anterior displacement of the stomach and gastrocolic
omentum by a carcinoma of the pancreatic body as viewed
during laparoscopy.
Figure 9
A. Previously unsuspected malignant peritoneal seedlings
discovered over the parietal peritoneum of the left inguinal
region during staging laparoscopy.
B. Malignant peritoneal seedlings covering the parietal




A. A small umbilicated liver metastasis arising superficially
within the right hepatic lobe and undetected until staging
laparoscopy in a patient with periampullary cancer.
B. Extensive tumour replacement of the left hepatic lobe
associated with ascites in a patient with pancreatic cancer.
Figure 11
Laparoscopic sonograms through the liver in a parasagittal plane slightly to
the left of the midline of the liver. The probe was inserted through the
umbilical port, and succesive cuts obtained as it was gradually withdrawn to
show the convergent courses of the middle (MHV) and left hepatic vein
(unlabelled) with the inferior vena cava (IVC). The hilar structures (left portal
vein (LPV), left hepatic artery (LHA) and left hepatic duct (LHD) surrounded
by the hyperechoic Glissonian sheath are shown in cross-section and separate
hepatic segments I and IV inferiorly.
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Figure 12
A. Isoechoic intrahepatic metastasis detected by LapUS with
the probe placed on the right hepatic lobe (insert). An anechoic
halo circumscribes the lesion, and electronic calipers indicate a
tumour diameter of five millimetres (small print / top right).
B. Laparoscopic sonogram of a hyperechoic metastasis (18 mm
in diameter) within the left hepatic lobe and also showing an




Laparoscopic sonogram in the longitudinal plane of the hepatoduodenal
ligament with the LapUS probe inserted through the umbilical port and the
transducer placed upon hepatic segment IV as an "acoustic window". The
divergent courses of the portal vein (PV) and inferior vena cava (IVC) enclose
the inferior tip of the caudate lobe in the cephalad direction (right of image).
The suprapancreatic common bile duct (CBD) lies anterolaterally, and its
diameter is estimated to be 4 mm by comparison with the 1 cm gaduated scale
(left margin of image). The cystic duct / common hepatic duct confluence is
also demonstrated. Laminar blood flow is just visible within the PV and IVC
(c.f the bile duct).
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Figure 14
Laparoscopic sonogram of the gall bladder obtained with the LapUS transducer
placed upon hepatic segment V as an "acoustic window" (insert). A single
large gallstone (GS) casts a posterior acoustic shadow, and the three echo-
layers of the thin gall bladder wall are demonstrated (M = mucosa
(hyperechoic); MM = muscularis (hypoechoic); S = serosa (hyperechoic)).
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Figure 15
Cross-sectional LapUS image of the structures of the hepatoduodenal ligament
obtained with the LapUS probe inserted via a right flank and orientated in a





Schematic diagram showing LapUS of the pancreas and peripancreatic anatomy
in a sagittal / oblique direction with the probe in the umbilical port, (i) in the
plane of the common bile duct, and (ii) in the plane of the portal vein. CBD =
common bile duct; IVC = inferior vena cava; PV = portal vein; HP = pancreatic
head; GDA = gastroduodenal artery; NP = pancreatic neck; PD = pancreatic
duct; UP = uncinate process; RHA = accessory right hepatic artery; SMV =




Laparoscopic sonograms obtained in a parasagittal plane through the normal
. pancreatic neck (NP) by withdrawal the LapUS probe through the umbilical
port. The course of the superior mesenteric vein (SMV) and portal vein (PV) is
shown posteriorly, with a cross-sectional view of the pancreatic duct as it
traverses the pancreatic neck. D3 = duodenum (third part); HA = common
hepatic artery; SMA = superior mesenteric artery.
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Figure 18
A pancreaticoduodenectomy specimen obtained from a patient with
periampullary carcinoma and photographed to demonstrate the cross-
sectional anatomy depicted in Figure 17. The neck is the thinnest part of the
pancreas as it arches over the portal vein (measuring < 1 cm in this
specimen), and the pancreatic parenchyma is transected in this plane during
pancreaticoduodenectomy. A metal probe identifies the cut end of the
dilated pancreatic duct. Stay sutures mark the inferior (left) and superior
(right) borders of the pancreas.
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Figure 19
LapUS imaging of the paraaortic region with the transducer positioned on the
left hepatic lobe (segment II). Withdrawal of the probe through the umbilical
port generates a sequence of images in the parasagittal plane. The pancreatic
body (BP) is imaged in cross-section, with the splenic vein closely applied
posteriorly (and in this example is compressed by probe pressure). The origins
of the superior mesenteric artery (SMA) and coeliac axis (CA) from the
abdominal aorta (AO) are demonstrated. In this case, no lymphadenopathy has
been identified in the paraaortic region, nor adjacent to the left gastric (LGA)
and splenic arteries (SA).
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Figure 20
A. Laparoscopic sonogram showing an accessory right hepatic artery
(aRHA) arising from the superior mesenteric artery (SMA) and
passing dorsal to the portal vein (PV) and common bile duct (CBD).
An enlarged lymph node (N) at the origin of the SMA is identified.
B. Transverse LapUS scan through the pancreatic head and neck
(via the right flank port (see insert)) showing an accessory right
hepatic artery (aRHA) passing posterior to the confluence of the
splenic and superior mesenteric vein. The pancreatic duct is shown
arching over the portal vein within the pancreatic neck.
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Figure 21
Schematic diagram showing LapUS of the pancreas and peripancreatic anatomy
in a transverse / oblique direction with the probe in the right lateral port, (i) across
the hepatoduodenal liagment at the superior pancreatic border, and (ii) across the
head, neck and body of pancreas. CBD = common bile duct; IVC = inferior vena
cava; PV = portal vein; HP = pancreatic head; CHA = common hepatic artery;
SAL = saline instilled into the subhepatic space; PD = pancreatic duct; SV =




A sequence of laparoscopic sonograms orientated in the long axis of the
common bile duct and obtained with the transducer positioned on the
hepatoduodenal ligament and withdrawn via the umbilical port. A well
circumscribed hypoechoic cancer of the pancreatic head is demonstrated (CA),
measuring three centimetres in diameter and obstructing the CBD and cystic
duct (CyD) (duct diameter approximately 2 cm). Probe down pressure has
compressed the inferior vena cava (IVC). The right renal artery (RRA) is
identified in cross-section posteriorly.
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Figure 23
Intraoperative sonogram through a thickened pancreatic neck obtained during
exploratory laparotomy. A diffusely infiltrating isoechoic carcinoma (CA)
arising from the pancreatic head, enveloping the portal vein (PV) and
associated with loss of the hyperechoic portal vein - parenchymal interface
(arrows) was demonstrated. These findings had not been recognised during
staging laparoscopy with LapUS.
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Figure 24
Intraoperative sonogram of the pancreatic body obtained during exploratory
laparotomy with the "T-probe" positioned on the gastric antrum. An isoechoic
cancer of the pancreatic body (CA) is shown invading the posterior wall of the
stomach (arrows). The five echo-layers of the stomach wall are shown, and
there is loss of the hyperechoic interface between tumour and gastric serosa
(S), with tumour infiltration of the hypoechoic muscle layer (M). These
findings had not been identified during staging laparoscopy with LapUS.
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Figure 25
A. LapUS scan showing the convergent terminal portions of the
pancreatic duct (PD) and common bile duct (CBD) are traced
through the pancreatic head alongside the inferior vena cava
(IVC) to the papilla. D2 = second part of duodenum.
B. LapUS scan showing infiltration of isoechoic periampullary
carcinoma into the lumens of the distal pancreatic duct (PD) and
common bile duct (CBD) within the pancreatic head.
Figure 26
A. LapUS scan obtained with
the transducer pressed against
the lateral wall of the
duodenum to show a sessile,
isoechoic periampullary
carcinoma (PAC) ulcerating
into the lumen of the second
part of the duodenum (D2).
Tumour is also identified
prolapsing into the lumen of the
pancreatic duct within the
pancreatic head.
B, Transverse LapUS scans showing pancreatic duct (PD) and common duct
(CBD) dilatation due to an isoechoic periampullary cancer invading the
pancreatic head (left of picture). The inferior vena cava (IVC), aorta (AO),




A. Hypoechoic cancer of the pancreatic head (CA) indenting
the superior mesenteric (SMV) and portal veins (PV) with loss
of the hyperechoic vessel - parenchymal interface (arrows). D1
= first part of duodenum; HA = common hepatic artery.
B. Magnified view of same LapUS examination as shown in
Fig 26A. Slight rotation of the LapUS probe demonstrates the
"cuffing" effect of the pancreatic head cancer causing an
"hourglass deformity" of the portal vein.
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Figure 28
Laparoscopic sonograms obtained in a parasagittal plane through the pancreatic
neck while withdrawing the probe through the umbilical port. A hypoechoic
cancer of the pancreatic head and uncinate process (CA) is shown invading the
lumen of the superior mesenteric vein at the level of the inferior pancreatic
border, immediately proximal to the formation of the portal vein (PV). A
dilated pancreatic duct (measuring approximately 6 mm in maximum diameter)




Laparoscopic sonograms obtained in the transverse direction at the level of the
confluence of the superior mesenteric (SMV) and splenic veins (SV) with the
probe inserted via the right flank port. An irregular, hypoechoic carcinoma of
the pancreatic head (CA) is demonstrated. There is no evidence of tumour
involvement of the peripancreatic blood vessels in this section.
SMA = superior mesenteric artery; AO = abdominal aorta; VC = vertebral
column; IVC = inferior vena cava.
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Figure 30
Laparoscopic sonograms during the same examination and at a slightly
superior level to that shown in Figure 29. Hypoechoic carcinoma (CA) extends
to invade the right lateral wall of the portal vein (PV) with loss of the normal
hyperechoic parenchyma - vessel interface and irregularity of the vein wall




High magnification laparoscopic sonogram examining detail of
the relationship between tumour (CA) and portal vein (PV) in a
patient thought to have potentially resectable cancer of the
pancreatic head. Loss of the parenchyma - vessel interface along
the right lateral wall of the vein (arrows) indicates the
unresectable nature of this tumour.
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Figure 32
Laparoscopic ultrasound appearances of malignant regional lymphadenopathy.
With the LapUS probe positioned on the left hepatic lobe as an "acoustic
standoff" (insert photograph), a well defined, hypoechoic lymph node
measuring 2 cm in maximum diameter is demonstrated alongside the left
gastric artery (LGA). Operative biopsy confirmed metastatic adenocarcinoma.
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Figure 33
A. Staging laparoscopy in a patient otherwise considered to
have potentially resectable pancreatic cancer revealed barely
perceptible whitish plaques scattered over the capsule near the
free edge of hepatic segment IV. Biopsy with straight-bladed
laparoscopic scissors documented metastatic adenocarcinoma.
B. Retrieval of peritoneal washings from the right sub-phrenic space during
staging laparoscopy using a catheter inserted through the right flank port.
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Figure 34
Transabdominal ultrasonography in a patient with suspected carcinoma of the
pancreatic head using a 4 MHz curvilinear array probe. This transverse image
through the pancreatic head has identified a hypoechoic tumour mass, which
has been measured with the electronic calipers to show a diameter of 39.6 mm
(see text bottom left of image). The hyperechoic artefact caused by a plastic
biliary endoprosthesis is identified traversing the tumour. The duodenal lumen
is demonstrated on the left side of the tumour, and the portal vein (right side of
tumour) appears to be free from invasion. Pancreaticoduodenectomy for
"cure" was later performed.
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Figure 35
Dynamic abdominal CT scan demonstrating a carcinoma of the pancreatic head
(arrow) causing gross biliary dilatation. The tumour was reported as well
circumscribed, localised to the pancreas and potentially resectable.
Exploratory laparotomy revealed malignant infiltration of the mesenteric root
in the region of the duodeno - jejunal flexure and of the retroduodenal soft
tissues. Palliative surgical biliary bypass was performed.
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Figure 36
False positive staging CT scan. A poorly - defined tumour of the pancreatic
head was identified (note the hyperattenuating appearance of the biliary
endoprosthesis traversing the tumour to enter the duodenal lumen). Malignant
invasion of the superior mesenteric vein in the region of its confluence with the
portal vein (arrow) was reported. Infiltration of the mesenteric root was also
identified. Pancreaticoduodenectomy for "cure" was later performed. An
accessory right hepatic artery arising from the superior mesenteric artery is




Portal venous phase of selective visceral angiography (catheter tip in the
splenic artery) in a patient with cancer of the pancreatic head. A subtle
indentation in the lateral wall of the portal vein (PV) indicating tumour
invasion is demonstrated (arrows). Local tumour invasion was confirmed
during laparotomy and trial dissection of the pancreas. A 7FG plastic biliary
endoprosthesis marks the site of bile duct obstruction by the tumour.
SV = splenic vein.
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Figure 38
False positive staging angiogram. Portal venous phase of selective visceral
angiography (catheter tip in the superior mesenteric artery) in a patient
considered to have potentially resectable cancer of the pancreatic head. An
indentation in the right lateral wall of the portal vein (PV) in the vicinity of the
portal - superior mesenteric venous confluence ("notching") was interpreted as
showing tumour invasion (arrows). The patient later underwent "curative"
pancreaticoduodenectomy. A 7FG plastic biliary endoprosthesis marks the site
of bile duct obstruction by a carcinoma of the pancreatic head which was later
resected for "cure". PV = portal vein.
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Figure 39
Selective superior mesenteric arteriogram demonstrating an accessory right
hepatic artery (aRHA) arising from the proximal superior mesenteric artery
(SMA). No evidence of mesenteric arterial invasion is identified. A 7FG
plastic biliary endoprosthesis marks the site of bile duct obstruction by a
carcinoma of the pancreatic head which was later resected for "cure".
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Figure 40
Exploratory laparotomy and trial dissection of pancreatic carcinoma.
Following mobilisation of the duodenum and pancreatic head from the
inferior vena cava (top left), exposure of the retropancreatic plane revealed
several small areas of fascial induration (note local charring following use
of diathermy). Biopsy confirmed local soft tissue invasion which had not
been detected by any preceding investigation.
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Figure 41
Exploratory laparotomy and trial dissection as a prelude to the performance
of pancreaticoduodenectomy for resectable carcinoma of the pancreatic
head. The superior mesenteric vein has been dissected free of the pancreatic
head and uncinate process with division of multiple small
pancreaticoduodenal veins (marked by blue Absolok® clips (Ethicon Ltd,
Edinburgh, U.K.). A tunnel has been established between the portal vein
and pancreatic neck in readiness for transection of the pancreas (marked by
black stay sutures at the inferior pancreatic border (top left of photograph)).
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Chapter 3 Study 1
Imaging of the hepatobiliary and pancreatic
anatomy using laparoscopic ultrasonography
3.1 INTRODUCTION
If LapUS is to be used to evaluate hepatobiliary and pancreatic diseases then its
efficacy in imaging normal anatomical structures should first be ascertained. As
there are no circumstances which permit the evaluation of LapUS in entirely normal
human subjects or healthy volunteers, an attempt was made to quantify the success
of LapUS in demonstrating anatomical landmarks as described in Section 2.3 in two
different groups of patients. The first comprised patients undergoing elective
laparoscopic cholecystectomy, in whom LapUS was being performed routinely to
detect common duct calculi, and in whom no major distortion of the biliary anatomy
was anticipated. The second group comprised patients undergoing elective staging
LapUS to investigate suspected pancreatic malignancy, accepting that anatomical
abnormalities wer expected in many of these patients.
3.2 PATIENTS AND METHODS
3.2.1 Laparoscopic ultrasonography during laparoscopic
cholecystectomy
Laparoscopic ultrasonography was performed by a defined laparoscopic
ultrasonographer (the author) during elective laparoscopic cholecystectomy in 80
consecutive patients (median age 56 years (range 21-82 years); male ; female ratio =
26 : 54) during a 14 month period (5/1/93 - 21/2/94). The indications for
laparoscopic cholecystectomy were: chronic cholecystitis / biliary colic syndrome (n
= 67); previous acute gall stone related pancreatitis (n = 10); empyema of the gall
bladder (n = 2); gall bladder polyps (n = 1).
Laparoscopic cholecystectomy was always performed by the "four port technique"
(a 10 mm port at the umbilicus, a 10 mm sub xiphoid port, a 5 mm port in the right
mid clavicular line and 5 mm port laterally in the right flank). Laparoscopic
ultrasonography was performed early in the course of laparoscopic cholecystectomy
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to minimise the degrading effects of gas within tissue planes or metal clips upon
image quality. A time limit of 10 minutes was imposed for the LapUS examination.
The technique of LapUS was performed as described in Sections 2.3.6 - 2.3.7 with
the exception that laparoscopic cholecystectomy did not require the insertion of a 10
mm right flank port. To have done so would not have been considered justifiable in
terms of potential morbidity and cost. The LapUS probe was therefore limited to use
via the umbilical port, and LapUS was performed in a predominantly sagittal plane
in all cases. The laparoscope was inserted through the sub-xiphoid port, which
allowed manoeuvre of the LapUS probe under direct vision.
The ability of the laparoscopic ultrasonographer to satisfactorily image the following
structures was documented prospectively using proforma sheets (see Appendix B):
Gall bladder (GB)
The whole gall bladder, including fundus, body and Hartmann's pouch.
Suprapancreatic common bile duct GCBD)
The entire length of the common duct from the confluence of the right and left
hepatic ducts to the level of the superior pancreatic border
Intrapancreatic common bile duct (3CBD!
The distal common duct as it passes behind or through the pancreatic head, and
anterior to the inferior vena cava, until its termination at the Papilla of Vater.
Portal vein (PYl
The entire length of the portal vein from its bifurcation into right and left branches in
the hilum, to its position posterior to the pancreatic neck inferiorly.
Common henatic artery proner CCHA)
The entire length of the common hepatic artery, proximally from the "takeoff' of the
gastroduodenal artery at the superior pancreatic border to its bifurcation into right
and left branches in the hilum.
Pancreatic duct (TP)
The pancreatic duct imaged in transverse section traversing the pancreatic neck
anterior to the portal vein, and passing obliquely across the pancreatic head to
terminate at the papilla of Vater.
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Papilla of Vater (Amp)
The confluence of the distal CBD and PD at a point within the medial duodenal wall
which was recognisable by visible peristalsis.
The frequency with which these structures were identified was expressed in the
context of four consecutive groups of LapUS examinations, each consisting of 20
procedures, performed between the following dates: Group A (5/1/93 - 15/3/93);
Group B (16/3/93 - 6/5/93); Group C (11/5/93 - 9/9/93); Group D (10/9/93 -
21/2/94).
3.2.2 Laparoscopic ultrasonography during staging laparoscopy for
pancreatic carcinoma
Laparoscopic ultrasonography was performed by one of two defined laparoscopic
ultrasonographers (the author and / or OJG) between March 1993 and April 1995.
All examinations were performed as part of elective staging LapUS in 50
consecutive patients with a diagnosis of pancreatic or periampullary carcinoma (31
male, median age 62 years (range 42-78 years)) (see Chapter 5 / Study 3). A biliary
stent had been inserted in the common bile duct of thirty patients, and a
cholecystojejunostomy had previously been performed in one patient at the referring
hospital.
The technique of LapUS was performed as described in Sections 2.3.5 - 2.3.7, with
the liver, biliary tree and pancreas examined in two planes using both umbilical and
right flank ports. The ability of the laparoscopic ultrasonographer to satisfactorily
image the following structures was documented prospectively using proforma sheets
(see Appendix B):
Common bile duct fCBDl
The entire length of the common duct from the confluence of the right and left
hepatic ducts to the papilla, or to the level of obstruction by tumour.
Portal / superior mesenteric venous trunk (PV / SMV)
The entire length of the venous trunk from its formation from tributaries in the
mesenteric root at the inferior pancreatic border, through its course immediately
posterior to the pancreatic neck, to the bifurcation of the PV into right and left
branches in the hilum.
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Splenic vein CSV)
The course of the splenic vein posterior to the pancreatic body and anterior to the
SMA to its confluence with the PV / SMV. Imaging of the SV at its origin in the
vicinity of the splenic hilum and pancreatic tail were not routinely made.
CQglidd axis (CA)
The origin of the CA from the abdominal aorta, its trifurcation into left gastric artery,
splenic artery and CHA, and the bifurcation of the CHA into GDA and CHA proper
at the superior pancreatic border.
Superior mesenteric artery (SMA)
The origin of the SMA from the abdominal aorta and its course posterior to the
pancreatic neck to enter the mesenteric root.
Pancreatic duct (PD1
The pancreatic duct imaged in transverse and longitudinal section traversing the
pancreatic body, neck and head.
Selective visceral angiography was performed in 32 patients as described in Section
2.5.5 (see also Chapter 5 - Study 3), and always after LapUS had been performed.
The ability of LapUS to identify an anomalous right or common hepatic artery was
correlated with the findings of SVA (Figure 39).
Anomalous right lor common) hepatic artery (nRHA)
The presence of an accessory or replaced right (or common) hepatic artery
originating from the SMA or aorta, and coursing in a cephalad direction posterior to
the PV / SMV (see Figure 20).
3.3 RESULTS
3.3.1 Laparoscopic ultrasonography during laparoscopic
cholecystectomy
Laparoscopic ultrasonography was successfully performed in every case. The
median time taken for LapUS was 9 minutes (range 3-10 minutes). The frequency
with which defined anatomical landmarks were identified using LapUS in Groups A-
D are shown in Table 3.1. The gallbladder and PV were easily identified in every
case. The suprapancreatic CBD and CHA were identified during every LapUS
examination only during later stages of the study. Most difficulty was initially
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experienced in demonstrating the distal CBD, pancreatic duct and papilla (60%, 45%
and 35% of examinations in Group A), although the frequency with which these
structures were identified improved to 85%, 85% and 75% of examinations,
respectively, in Group D.
Table 3.1 - Imaging of the pancreaticobiliary anatomy by LapUS: results of 80
examinations performed during laparoscopic cholecystectomy
Group A Group B Group C Group D
(n==20) (n=20) (n=20) (n=20)
(5/1/93 15/3/93) (16/3/93 - 6/5/93) (11/5/93 - 9/9/93) (10/9/93 - 21/2/94)
GB 20 (100) 20 (100) 20 (100) 20 (100)
SCBD 18 (90) 19 (95) 20 (100) 20 (100)
iCBD 12 (60) 17 (85) 18 (90) 17 (85)
PV 20 (100) 20 (100) 20 (100) 20 (100)
CHA 14 (70) 19 (95) 19 (95) 20 (100)
PD 9 (45) 15 (75) 17 (85) 17 (85)
Amp 7 (35) 16 (80) 17 (85) 15 (75)
3.3.2 Laparoscopic ultrasonography during staging laparoscopy for
pancreatic carcinoma
Access to the peritoneal cavity was achieved in all cases. However, access to the
region of the pancreas and porta hepatis was limited in three cases by adhesions
associated with previous open cholecystectomy or cholecystjejunostomy. The
frequency with which defined anatomical landmarks were identified using LapUS
are shown in Table 3.2. The demonstration of the PV / SMV trunk in each case
served to demonstrate the pancreatic neck, from which position the head of the
pancreas could be successfully imaged. Inability to define the confluence of the
splenic vein with the superior mesenteric vein in six cases was associated with the
presence of tumours directly invading this area. The 11 cases where there was
unsatisfactory imaging of the coeliac axis and / or superior mesenteric artery
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occurred in the chronological sequence: 1, 2, 3,4, 6, 8, 10, 11,21, 30 and 42. In the
latter case, adhesions had prevented satisfactory transducer contact with the area of
interest.
Table 3.2 - Imaging of the pancreaticobiliary anatomy by LapUS: results of 50










An anomalous right or common hepatic artery arising from the superior mesenteric
artery or aorta was demonstrated in eight of the 32 patients (25%) who underwent
SVA. This finding had been identified during LapUS in four out of eight cases
(50%). In addition, LapUS identified this variant in two of the remaining 18 patients
(11%) in whom SVA was not performed.
3.4 DISCUSSION
3.4.1 Laparoscopic ultrasonography during laparoscopic
cholecystectomy
This study demonstrates that successful LapUS imaging of the biliary and pancreatic
anatomy is feasible in the majority of patients. However, several problems were
identified. All ultrasound techniques are inherently operator dependent, and the
results of LapUS performed during laparoscopic cholecystectomy by a laparoscopic
ultrasonographer who was relatively inexperienced in the technique at the start of the
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study suggest a "learning curve" effect. While the gallbladder and portal vein were
easily identified as landmarks from the outset of the study, the improvement in the
frequency with which the other structures were identified is likely to reflect
increasing competence with experience. The CHA and suprapancreatic CBD could
be demonstrated consistently following the first 20 examinations, whereas the distal
CBD, PD and papilla prove to be more difficult to image. Nevertheless, these
structures have small dimensions in the absence of pathology, and their position in
the retroperitoneum behind the gastric antrum and duodenum increases the
likliehood of interference from luminal gas. Although no contemporaneous
comparison with another imaging technique such as transabdominal USS was
performed, the observation that following 40 examinations, the terminal CBD was
visible in 85-90% of examinations, and the papilla itself in 75-85%, could be
interpreted as evidence for the utility of LapUS in imaging this difficult anatomical
region.
Moreover, the terminal retro- / intrapancreatic portion of the CBD would be
expected to be collapsed in a proportion of patients without biliary obstruction. It is
also possible that even slight LapUS probe pressure over this area may have caused
obliteration of the duct and duodenal lumen. Several investigators have since
recognised the possible limitations of LapUS imaging of this region during
laparoscopic cholecystectomy, citing the potential to overlook impacted CBD stones
OQzr 9Q7
adjacent to the papilla ' . However, any consideration of the accuracy of
LapUS in detecting CBD stones, and hence its influence on clinical management,
was outwith the aims of the study.
These results appear to concur with those reported by Jakimowicz249'250, who had
previously acquired considerable personal experience with IOUS in the examination
of the biliary tract during open cholecystectomy245. In his pilot study, in which
LapUS was performed in 79 patients undergoing laporoscopic cholecystectomy,
successful examination of the biliary tract was performed in 96% of cases, with a 4%
failure rate because the bile duct could not be identified249. Using subjective
criteria, an "optimal or good" examination was achieved in 87% of cases. In his
subsequent study of 133 patients during laporoscopic cholecystectomy, in which
similar LapUS equipment to this study was used, failure to visualise the CBD again
OCQ
occurred in 4% of cases . The CBD was visualised up to the liver in 122 /133
cases (92%) and to the papilla in 121 /133 (91%).
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There are technical factors which also may have potentially influenced the success of
the examination. Although the LapUS system used in this study did not include the
facility for Doppler sampling, other workers have recommended its use as a
convenient means of distinguishing ducts from arterial and venous structures, and
OCA 255
thus increasing diagnostic yield ' Other workers have also suggested that
the linear array LapUS probe may be operated through the sub-xiphoid port during
254 2R7 2RQ
laparoscopic cholecystectomy ' ' This manoeuvre allows the LapUS
transducer to be placed perpendicularly alongside the free edge of the
hepatoduodenal ligament, thereby generating cross-sectional images of the
underlying structures, and permitting LapUS to be performed in two planes. Further
experience with the technique has since supported the adoption of this technique
during laparoscopic cholecystectomy.
Rothlin and co-workers also investigated the ability of LapUS to define the anatomy
200 201of the hepatoduodenal ligament using a different transducer configuration ' .
They employed a 360° radial scanning probe which was inserted through the
umbilical port and "dragged" alongside the hepatoduodenal ligament. In this way,
they reported their ability to create a detailed "map" of the anatomy of the
hepatoduodenal ligament, including the detection of biliary and arterial anomalies.
Normal examinations were obtained in 52 out of 75 patients (69%), and a diverse
range of anatomical variations were detected with a sensitivity of 82% (compared
2QOwith 100% for intraoperative cholangiography) . However, the potential role of
LapUS using this technique in patients with suspected hepatobiliary and pancreatic
malignancy is not clear given the limited tissue penetration associated with this type
of LapUS transducer (< 4 cm), and the lack of additional information regarding its
ability to detect other peripancreatic structures.
3.4.2 Laparoscopic ultrasonography during staging laparoscopy for
pancreatic carcinoma
This study shows that LapUS is able to demonstrate the important structures
comprising the pancreatic and peripancreatic anatomy in most patients with
pancreatic or periampullary malignancy. Again, the ability of LapUS to define the
pancreatic anatomy was not compared with that of alternative imaging techniques.
However, the relative success of LapUS in this task is illustrated by historical
comparison with the results of Kamin and colleagues who, using transabdominal
USS, failed to demonstrate the pancreas in 38% of examinations due to interference
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attributed to factors such as ascites and bowel gas . Similarly, Arger and co¬
workers had succeeded in visualising the pancreatic head and body in just 77% and
70% respectively, of 500 consecutive transabdominal USS examinations .
Adhesions following previous operations can limit the efficacy of LapUS, although
this was limited to a minority of patients in this study (6%). Anatomical distortion
caused by the presence of tumours in the pancreatic head or periampullary region
may make recognition of anatomical landmarks more difficult, and it must be
recognised that failure to demonstrate structures such as the splenoportal-mesenteric
venous junction during staging LapUS may be due to tumour obliteration rather than
technical failure (12% in this study). Conversely, malignant obstruction and
dilatation of the biliary and pancreatic ducts may facilitate the identification of these
structures, while the presence of a biliary stent allowed rapid identification of the
collapsed CBD. These factors help explain the higher frequency with which these
structures were demonstrated compared with the results obtained during the early
stages of the previous study.
Least success was experienced in imaging the coeliac trunk (78%) and SMA (80%)
from their aortic origins, an area which is probably the least accessible of all those
studied. Reasons for this again include the "learning curve" phenomenon as
unsuccessful examinations tended to occur earlier in the study, in addition to the
technical factors already enumerated. This aspect of the LapUS examination tended
to be performed last, and would have attracted the least emphasis in cases where
metastatic dusease had been demonstrated and biopsy required. In this way,
"breaches of protocol" may have contributed to the poorer results.
This study also confirms that the aRHA can be detected by LapUS, and it is pertinent
to emphasise that all LapUS examinations preceded SVA. Rothlin and colleagues
have also described this anatomical variant in six out of 100 LapUS examinations
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(6%) performed during laparoscopic cholecystectomy . They also reported the
detection of other "anomalies" consisting of hepatic or cystic arteries crossing
ventral to the CBD in 16% of LapUS examinations, although none of these findings
were confirmed by angiography. The anomaly of the aRHA may have important
implications for surgeons attempting pancreatic resection, and has been reported
with an incidence of 14 - 27% in angiographic series153'174'175'180'186'188 (see
Table 1.6 / Section 1.2.6). Its incidence as proven by SVA in this study was 20%,
LapUS having achieved the same diagnosis with a sensitivity of 50%, with no
misdiagnoses. However, the acquisition of this type of information is clearly
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operator dependent and subject to inter-observer variations. This may explain the
increased frequency with which the aRHA anomaly was detected by LapUS in the
present study (12%), compared with six out of 100 cases in Rothlin's series (6%).
Therefore, while LapUS may provide useful additional information of this type, the
surgeon should be aware that absence of this arterial anomaly during LapUS does
not exclude its presence.
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Chapter 4 Study 2
Laparoscopy and laparoscopic ultrasonography in the
staging of patients with potentially resectable carcinoma
of the pancreatic head and periampullary region
4.1 INTRODUCTION
A§ discussed in Section 1.2.7, initial reports suggested that laparoscopy could be
used to demonstrate intraabdominal metastases in a high proportion of surgical
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patients with pancreatic cancer ' ' . However, many of the patients in the
aforementioned studies had advanced tumours or pancreatic body cancers, and the
findings could be regarded to be of dubious clinical value as there had been little
prior patient selection using less invasive imaging techniques. Subsequent work by
Warshaw and colleagues suggested that truly unsuspected metastases had been
apparent during laparoscopy in up to 41% of patients considered to be candidates for
OA O/T
pancreatic resection on the basis of prior USS and / or CT ' .
However, the concept of preoperative staging laparoscopy failed to achieve
widespread popularity in the management of patients with pancreatic cancer. A
recently reported survey of national patterns of care for pancreatic cancer at 978
American institutions conducted by The Commission on Cancer of the American
College of Surgeons reported that laparoscopy had been performed in only 6% of
cases, a figure which had remained static between the 1983-1985 period and
1990 . The present study was therefore undertaken to evaluate the reproducibility
of earlier claims for the utility of laparoscopy, and to assess the clinical value of
staging laparoscopy in preventing unnecessary laparotomy in patients with
potentially resectable pancreatic or periampullary cancer.
Apart from a preliminary study of 12 patients performed at the Royal Infirmary,
1SR
Edinburgh , experience with LapUS in the evaluation of pancreatic and
2^0 242 2S0
periampullary cancer comprised a small selection of anecdotal reports ' as
discussed in Section 1.2.8. Having evaluated the ability of LapUS to demonstrate
the hepatobiliary and pancreatic anatomy in Study 1, the diagnostic accuracy of
laparoscopy aided by LapUS in the assessment of tumour resectability was
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investigated. To assess the contribution of LapUS to the laparoscopic examination,
these findings were compared with those obtained for laparoscopy alone.
4.2 PATIENTS AND METHODS
From January 1991 to September 1993, 40 consecutive patients diagnosed as having
pancreatic or periampullary carcinoma underwent staging laparoscopy (22 female,
18 male; median age 59 years (range 36-78 years)), of whom 38 also underwent
LapUS. Endoscopic insertion of a biliary stent had previously been performed in 21
patients (53 per cent). Failure to achieve laparoscopic access to the peritoneal cavity
occurred in one other patient with adhesions from a previous laparotomy, and this
patient was excluded from analysis.
All patients were considered, on the basis of USS and / or CT, to be candidates for
tumour resection with curative intent either by pancreatoduodenectomy or by
transduodenal local resection. A variety of scanning techniques and equipment had
been employed by the referring hospitals. Histopathological confirmation of
periampullary or pancreatic carcinoma was obtained in each case, either following
examination of the surgically resected specimen, by needle biopsy of the primary
tumour, by luminal biopsy of periampullary tumours during ERCP and / or by
biopsy of metastatic deposits during laparoscopy or laparotomy.
Decisions regarding tumour resectability were documented prospectively for staging
laparoscopy alone, and in conjunction with LapUS, at the time of the examination.
Predictions of tumour unresectability due to locoregional tumour invasion, malignant
regional lymphadenopathy and / or distant metastases were defined by the staging
convention outlined in Section 2.1.1. Laparoscopic and LapUS staging criteria were
interpreted as described in Sections 2.3.3 and 2.3.7. Validation of the end-point of
tumour resectability was achieved by laparoscopic, surgical or non-operative
methods as described in Section 2.6.1. Thus, surgical resectability was determined
by clinical means, and histopathological examination of resection margins for
microscopic tumour involvement was not used as an endpoint in this study.
Summary measures of diagnostic accuracy were calculated by 2 x 2 matrix analysis




Twenty two patients (55 per cent) progressed to laparotomy and operative
assessment of resectability of whom 12 patients were considered to be resectable for
"cure" (30 % overall resectability rate). Pancreatoduodenectomy was performed in
10 patients and one patient underwent transduodenal resection of a periampullary
adenocarcinoma. Another patient, in whom resectability of a periampullary
carcinoma was confirmed at laparotomy, became profoundly hypotensive during the
procuedure. It was considered appropriate to perform an expeditious biliary bypass
rather than attempt pancreatic resection on this occasion. Having refused further
surgery, this patient was alive with CT evidence of tumour progression two years
later. For the purposes of this study, he has been classified as having 'resectable'
disease. Palliative biliary and duodenal bypass procedures were performed in ten
patients in whom tumour unresectability was confirmed at laparotomy.
Criteria confirming tumour unresectability were confirmed by laparoscopic means in
14 patients (see below), and unresectability due to locally advanced tumour with
vascular invasion was validated non-operatively in four patients.
4.3.2 Laparoscopy (n=40)
Procedure-related complications were encountered in one patient (2.5 per cent
complication rate) in whom a port site haemorrhage had occurred with the discovery
of intraperitoneal blood at laparotomy six days later. A fall in the haemoglobin
concentration by 3.2 g/dl was measured in this patient and two units of blood were
transfused on day 2. However, the patient had remained haemodynamically stable
and asymptomatic, and no sequelae to this event were ientified.
In no patient was it possible to inspect the primary tumour directly during the
laparoscopic examination, although it was occasionally possible to 'palpate' a
retrogastric mass with the tip of a probe.
Previously unsuspected metastatic tumour spread to the liver (ten patients),
peritoneal surfaces (eight patients) and / or hilar lymph nodes (two patients) were
identified during laparoscopy in a total of 14 patients (35 per cent). Biopsy material
was obtained and metastatic carcinoma confirmed in each case. Exploratory
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laparotomy was withheld from these patients, who in terms of predicting
resectability, were regarded as having undergone 'true positive' laparoscopic staging
examinations.
Laparoscopy failed to detect malignant dissemination to distant sites within the
abdominal cavity in three patients (i.e. 'false negative' procedures). In one patient, a
cluster of tiny peritoneal tumour seedlings were concealed by adhesions in the right
subhepatic space having not been recognized by the laparoscopist. Failure to
diagnose liver metastases during laparoscopy ocurred in three patients. In one case,
laparoscopic biopsy of a suspicious subcapsular lesion yielded adiagnosis of biliary
ectasia, although biopsy at open operation confirmed metastatic carcinoma. A
10mm diameter metastasis within the caudate lobe of the liver was demonstrated by
LapUS in another patient. A small metastatic deposit on the free edge of the right
hepatic lobe was only discovered during exploratory laparotomy in a third patient.
A delay of two months had ensued between laparoscopy and laparotomy in this
deeply jaundiced patient. Ultimately, unsuspected small liver and peritoneal tumour
deposits were demonstrated following laparoscopy, LapUS and / or laparotomy in
17 of the 40 patients (43%).
Laparoscopy failed to identify locoregional tumour unresectability in 12 patients
(30%). Overall, there were 14 'false negative' laparoscopic examinations including
those where distant metastases were overlooked. The inability of laparoscopy to
identify factors confirming tumour unresectability in these patients was reflected by
a sensitivity of 46%, while the predictive value of a negative result was 50% (Tables
4.1 and 4.3).
Table 4.1










Tumour resectability was correctly inferred from the absence of signs of
dissemination within the abdominal cavity in all 12 patients considered resectable.
The absence of a tendency for laparoscopy to overstage these patients was reflected
by a specificity and PPV of 100% (Tables 4.1 and 4.3).
4.3.3 Laparoscopic ultrasonography (n=38)
Laparoscopic ultrasonography was deferred in two out of 40 patients undergoing
laparoscopy because widespread peritoneal carcinomatosis had been encountered,
and the insertion of a second 10mm laparoscopic port was considered unjustified
under the circumstances. Satisfactory LapUS images of the primary pancreatic and
periampullary tumours were recorded in 31 out of 3o patients (82 per cent).
Factors indicating tumour unresectability were correctly identified by LapUS in 23
out of 38 cases (61%). Liver metastases were identified in 10 patients, and / or
tumour invasion of the peripancreatic soft tissues and / or portal-superior mesenteric
vein in 24 patients. Regional lymphadenopathy was identified in 14 patients, and
biopsies were obtained to confirm malignant nodal infiltration in three cases. In
those patients with LapUS evidence of enlarged regional lymph nodes, but without
histological proof of metastatic involvement, tumour unresectability was always
validated by additional staging criteria and was never based upon an unconfirmed
diagnosis ofmalignant lymphadenopathy.
Failure to recognize tumour invasion of the portal-superior mesenteric vein in one
patient, and tumour infiltration of the suprapancreatic common bile duct and pylorus
in another, yielded two instances of 'false negative' results for LapUS. In another
patient, the diagnosis of retro-duodenal tumour infiltration from cancer of the
pancreatic head was refuted at laparotomy, and the patient underwent a Whipple
operation. This was the only 'false positive' LapUS examination in this series, which
diminished the 100% specificity of staging laparoscopy to 92%, while the predictive
value of positive LapUS findings were reduced to 96%. Conversely, the correct
identification of tumour unresectability in 23 out of 26 patients when the findings of
LapUS were considered improved the sensitivity of tumour staging to 88%, while
the reduced incidence of 'false negative' results improved the predictive value of a
negative examination from 46% to 79% (Tables 4.2 and 4.3).
In 20 patients (53%), information relevant to the assessment of tumour stage and not
apparent following laparoscopy was derived from the LapUS examination. This
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new staging information altered the laparoscopic decision concerning tumour
resectability in 10 patients (25%). Local invasion of the peripancreatic soft tissues
was defined in six of these 10 patients, invasion of the adjacent portal-superior
mesenteric vein in eight patients and / or the discovery of metastastatic liver disease
which had remained undetected during laparoscopy in one patient. Enlarged
regional lymph nodes were also demonstrated in six of these patients, although
biopsies were not obtained.
Table 4.2
Diagnostic accuracy of laparoscopy and LapUS in the staging of 38 patients







Diagnostic accuracy of laparoscopy compared with laparoscopy and LapUS in





Diagnosis - 31 /38 = 82%
Sensitivity 14/28 = 50% 23 / 26 = 88%
Specificity 12/ 12= 100% 11/12 = 92%
PPV 14/ 14= 100% 23 / 24 = 96%




4.3.4 Clinical value of staging laparoscopy with LapUS
The effect of laparoscopy and LapUS on patient treatment is illustrated in Figure 42.
Of the 40 patients with potentially resectable tumours who underwent laparoscopy,
unnecessary laparotomy was avoided in 14 (35%) due to the discovery and biopsy of
intraabdominal metastases. In a further four patients, local tumour invasion was
identified by LapUS, but not by laparoscopy, the findings corroborated by non-
operative means and surgery was avoided. Exploratory laparotomy was performed
in the remaining 22 patients, confirming tumour resectability in 12 patients (11 of
whom had been correctly identified as such by laparoscopy and LapUS), and tumour
unresectability in 10 patients (8 of which had been predicted as such by LapUS).
Figure 42
The impact of staging laparoscopy and LapUS on selection for surgery in 40


















This study has confirmed that small intraabdominal metastases are present in a
substantial proportion of patients considered, on the basis of conventional
radiological techniques, to have potentially resectable pancreatic and periampullary
cancers. Such findings were ultimately proven in 42% of such patients in this study.
While this incidence may appear suprisingly high, it is not at variance with the
experience reported by Warshaw and colleagues in their reports of 1986 (43%)
oz
and 1990 (31%) . However, the same group have since reported a diminished
incidence of unsuspected intraabdominal metastases of 24%, with a further reduction
to 18% when patients with carcinoma of the pancreatic head only were
9QCconsidered . They speculate that improvements in radiological imaging
techniques, earlier patient presentation and / or a change towards a more favourable
tumour biology are possible explanations for this apparent change.
The patient population comprising this study should be considered in the context of
a tertiary referral practice where a degree of prior patient selection will have been
inevitable. The relatively high resectability rate of 30% may be considered
indicative of this "centripetal bias". This contrasts with resectability rates ranging
from 4% in Gudjonsson's series and 2.6% in Bramhall and co-workers'
epidemiological study of practice in the West Midlands , through mean resection
fO
rates of 10-15% in Watanapa and Williamsons' collective review , to a figure of
21% recently reported by the collaborative experience of the French Association of
OQ7
Surgery . Nevertheless, prior screening with USS and / or CT scanning in patients
in the present study had failed to identify metastatic lesions, although variations in
equipment and personnel may have accounted for suboptimal examinations, and
methodological flaws could not be excluded using this non-standardized approach.
However, this situation did reflect clinical practice at the time of the study, and
represented the basis for decision-making prior to the adoption of laparoscopic
staging which supports the validity of these findings.
Laparoscopy was highly effective in identifying such unsuspected lesions (83%
sensitivity) and afforded the opportunity for their biopsy, thus providing a tissue
diagnosis without resort to unnecessary laparotomy. Warshaw and colleagues
previously used laparoscopy to detect intraabdominal metastases with reported
sensitivities of 82%84, 96%86 and more recently 93%2^5. Independent and
contemporaneous evaluation of staging laparoscopy in this role by other workers has
since been reported. Between 1993 and 1994, Bemelman and colleagues at the
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University of Amsterdam performed staging laparoscopy with LapUS in 73 patients
with carcinoma of the pancreatic head or periampullary region and considered to
9QQhave stage 1 disease on the basis of ERCP and Doppler USS . The incidence of
unsuspected metastases was 24%, and these were identified laparoscopically in 16
out of 21 patients (76%). Conlon and co-workers at the Memorial Sloane Kettering
Cancer Center, New York, also performed preoperative laparoscopy in 115 patients
with "radiologically resectable" pancreatic cancer between 1992 and 1994, defining
liver metastases in 17%, peritoneal carcinomatosis in 14% and / or visible malignant
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lymphadenopathy in 7% . These reports have corroborated the conclusions of the
present study that in patients with pancreatic or periampullary cancer, "occult"
intraabdominal metastases are encountered commonly despite imaging with
contemporary radiological techniques, and that staging laparoscopy is a sensitive
method for their detection.
Staging laparoscopy was also shown to be fallible in a proportion of patients, both in
detecting metastatic lesions, and in predicting overall tumour resectability where
locoregional tumour spread was overlooked. Adhesions, intrahepatic metastases,
delay to laparotomy and unrepresentative biopsy were implicated in the three false
negative laparoscopes performed in patients with overt liver metastases. These
limitations, albeit in a minority of patients, have also been recognised by other
29S 29R 299workers ' yo>^yy. The impact of LapUS in identifying previously imperceptible
intrahepatic metastases in the present study was minimal, and occurred in one
patient (3%). However, Bemelman and co-workers have since reported a different
29©
experience for which there is no obvious explanation . In their study, laparoscopy
identified liver metastases in seven out of 16 proven instances (44%), six cases were
diagnosed exclusively by LapUS (38%) and there were three false negative
procedures.
Ultimately, the actual false negative rate for distant intraabdominal metastases is
likely to be even higher due to the presence of "occult" micrometastases. Evidence
for this has been presented by Willet and colleagues, who reported distant
metastases to the liver, peritoneum and pleura as the dominant pattern of recurrence
among 12 "high risk" patients with periampullary carcinomas who had undergone
exploratory laparotomy, pancreaticoduodenectomy and post-operative
zro
radiotherapy . Also, by measuring the doubling times of cell lines derived from
liver metastases in patients with resected pancreatic cancers, Japanese workers have
extrapolated the size of "occult" liver metastases at the time of
^00
pancreatoduodenectomy to have been as small as 10 |im . Patterns of recurrence
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and long term follow-up were not assessed in the present study, and it therefore
seems inevitable that the true incidence of "occult" extrapancreatic metastases would
have been underestimated. Neverthless, this study has shown that staging
laparoscopy was efficacious and of real clinical value when its impact was evaluated
in clinically measurable terms at the time of surgical decision-making.
Laparoscopy was found to be an ineffective method of assessing locoregional
tumour invasion in this study. On no occasion was vascular invasion inferred from
secondary signs such as mesenteric venous congestion, and tumour infiltration of the
mesenteric root was never identified. Although no attempts at peripancreatic
dissection or instrumentation of the lesser sac were undertaken, routine observation
of the gastrohepatic omentum and lesser sac yielded no useful staging information.
This is at variance with the recent experience of Conlon and colleagues299. They
described "extended laparoscopy" by a four port technique, where adhesiolysis was
performed, periportal lymph nodes biopsied, the mesocolon retracted, the
gastrohepatic omentum incised and the major peripancreatic blood vessels and
lymph nodes examined. A complete examination was achieved in 94% of patients,
with vascular invasion diagnosed in 16 patients (15%) and coeliac or portal
lymphadenopathy proven in eight patients (7%). Vascular invasion was overlooked
in one case, giving an overall predictive value for a positive result of 100%, whereas
9QQ
the negative predictive value was 91% .
Explanations for these contrasting results may include differences in patient
populations. The latter study cites a 58% resectability rate, the prevalence of
vascular invasion as the sole source of unresectability was only 9% and the
incidence of cancer of the pancreatic body and tail was 25%299. The reproducibility
of locoregional tumour staging by extended laparoscopy remains to be ascertained.
The present study has also demonstrated that LapUS successfully exploits the
principles of IOUS in the assessment of patients with pancreatic cancer. The
immediate benefit of LapUS over laparoscopic inspection was illustrated by its
ability to image a focal pancreatic mass lesion in 82% of patients, whereas the
primary diagnosis could not be established by laparoscopy in any cases. Summary
measures of diagnostic accuracy for staging laparoscopy and LapUS have
approximated those reported by Machi and colleagues for IOUS in assessing portal
vein invasion . The improved staging sensitivity (88%) conferred by LapUS
reflects its ability to evaluate retroperitoneal tumour spread, and the resultant
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diminished incidence of 'false negative' findings was reflected by a negative
predictive value of 79%.
Nevertheless, local tumour staging by LapUS was fallible, and yielded two false
negative assessments where direct invasion of portal vein and suprapancreatic
common bile duct were not identified. Ofmore concern, however, was the instance
where the tumour was overstaged by LapUS, retroduodenal tumour invasion having
been identified in error. In this case, which was the fourth performed in this series,
it seems likely that dense acoustic shadowing posterior to a carcinoma of the
pancreatic head had been misinterpreted as tumour extension. It is, therefore,
tempting to ascribe this interpretative error to a "learning curve" phenomenon.
Nevertheless, this study may be considered as having validated the diagnostic
accuracy of laparoscopy combined with LapUS in the staging of pancreatic and
periampullary cancer. Furthermore, contemporaneous work with staging
laparoscopy and LapUS performed between 1993 and 1994 by Bemelman and
9QO
colleagues in Amsterdam has reproduced the findings . Their study was similar
inasmuch as the majority of patients had undergone insertion of a biliary
endoprosthesis and an identical 7.5 MHz linear array LapUS probe was employed.
They performed surgical exploration and trial pancreatic dissection in 49 out of 73
evaluated patients with pancreatic or periampullary cancer, for an overall
resectability of 41%. In addition, segmental resection of the portal vein was
performed in three patients, allowing histological validation.
There was one false positive LapUS prediction of portal vein invasion in a patient
with retroperitoneal radiation fibrosis, histological examination of the resected portal
vein indicating no direct tumour invasion. The specificity and PPV of LapUS in
predicting vascular invasion were therefore reported to be 96% and 93%
OQO
respectively . Failure to detect intraabdominal metastases in five patients,
together with the discovery of positive resection margins in seven patients accounted
for an overall sensitivity and negative predictive value of 67% and 65% respectively.
These latter parameters were slightly inferior to those obtained in our study, which
partially reflects the authors' use of stringent histopathological criteria in validating
tumour resectability. However, similar findings to our own were reported in that
staging laparoscopy with LapUS had changed therapeutic strategy in 25% of
patients, avoided unnecessary laparotomy in 19% and upstaged the tumour in
9Q&
41% . By contrast, other workers have reported difficulty in evaluating the
peripancreatic region using LapUS in patients with pancreatic malignancy, although
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the same group claimed success in detecting "occult" intrahepatic metastases .
While it is not possible to ascertain the reasons for the latter group's limited success
with LapUS in this context, the inherent operator dependency of the technique does
not make such findings wholly unexpected.
The provision of a tissue diagnosis of metastatic disease permitted clinical
management decisions to be based upon the laparoscopic findings. If one accepts
the rationale for avoiding unnecessary laparotomy in such patients as outlined in
Section 1.1.2, the impact of laparoscopy alone in averting an inevitable unnecessary
laparotomy in 35% of patients may have had a beneficial effect on the quality of
palliative care provided to the patient, as well as health economic implications. This
must remain speculative as these issues were not explicitly investigated in this study.
9Q*7 on/:
Nevertheless, surveys from France and the West Midlands region of the U.K.
have indicated that the incidence in the 1980's of laparotomy alone in patients with
pancreatic cancer was 12% and 14.5% respectively. Clearly these are areas where
the clinical management of patients with pancreatic or periampullary cancer might
be improved.
The present study has provided further evidence that incorporation of staging
laparoscopy into the preoperative investigative algorithm may be beneficial to the
management of such patients. Furthermore, the adoption of LapUS may further
facilitate the selection of patients with pancreatic or periampullary cancer for
appropriate surgery. However, further prospective validation of the technique in
comparison with alternative imaging investigations is indicated before the adoption
of LapUS into clinical practice can be recomended. The next study investigates this
matter.
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Chapter 5 Study 3
A prospective comparison of USS, CT , SVA and
laparoscopy with LapUS in the staging of patients with
carcinoma of the pancreas and periampullary region
5.1 INTRODUCTION
The previous chapter (Study 2) demonstrated the clinical value of staging
laparoscopy in the management of patients with pancreatic and periampullary
carcinoma. Also, the high diagnostic accuracy of LapUS both in establishing the
primary diagnosis and determining tumour resectability was documented. However,
LapUS was evaluated in a series of patients already identified as potentially
resectable on the basis of USS and / or CT, with the endpoint of locoregional tumour
resectability determined largely by the decision of the operating surgeon. To date,
no direct comparison between LapUS and other imaging modalities in the diagnosis
and staging of pancreatic and periampullary cancer has been performed. An attempt
to address these deficiencies was undertaken in a second cohort of patients.
A more rigorous method of validation was adopted in a prospective study which
compared LapUS with alternative imaging techniques (USS, CT and SVA). Special
reference was made to the various components of the TNM classification presented
111in Table 2.1 / Section 2.1.1 , as well as to overall tumour staging, in an attempt to
define the strengths and weaknesses of the individual modalities. Also, a more
stringent histopathological evaluation of resection margins was included in the
determination of tumour resectability.
5.2 PATIENTS AND METHODS
5.2.1 Patient details
Fifty consecutive patients presenting with carcinoma of the pancreas or
periampullary region were studied (31 male, median age 62 years (range 42-78
years)). Staging laparoscopy with LapUS (LapUS) was performed in all patients
between March 1993 and April 1995. A histological diagnosis of pancreatic or
periampullary carcinoma was obtained in 44 patients by percutaneous (four patients)
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or operative (n=10) needle biopsy of the pancreas, laparoscopic (n=15) or operative
(one patient) biopsy of metastatic lesions in the liver, serosal surfaces or regional
lymph nodes, histopathological examination of the pancreatic resection specimen
(n=14) and / or endoluminal biopsy of periampullary lesions (n=10). No biopsy
diagnosis was obtained in the other six patients, although a pancreatic mass lesion
was documented by imaging investigations, and death from carcinomatosis was
observed in each case (crude mean survival 34 weeks (range 12-67 weeks)). The
primary tumour was situated in the pancreatic head (33 patients), pancreatic body
(five patients), pancreatic head and body (one patient) and periampullary region (11
patients). A biliary stent had been inserted in thirty patients by the endoscopic (22
patients) or percutaneous route (eight patients), and a cholecystjejunostomy had
previously been performed in one patient at the referring hospital.
5.2.2 Staging investigations
Patients were managed according to the investigative algorithm depicted in Figure
43. Staging investigations were performed and interpreted by defined personnel as
described previously for USS (Section 2.5.1), CT (Section 2.5.2), LapUS (Section
2.3) and SVA (Section 2.5.5). The various investigations were interpreted 'blind'
without reference to the results of preceding staging investigations. Results were
recorded prospectively on standardised proformas (Appendix) and compared for
each stage.
Breaches of protocol occurred inasmuch as some patients failed to undergo all four
investigative modalities. Eleven patients did not undergo USS according to
protocol, either because of unavailability of the defined ultrasonographer during the
patients' hospital admission, or because of logistic difficulties in the timing of the
various interventions. CT scans which had been performed at the original hospital
within two months prior to referral, and which were regarded as being of satisfactory
quality, were not repeated in 12 cases (27%). However, five other patients did not
undergo repeat CT, despite the original scans having been deemed to be of
insufficient quality for inclusion in this study. Thirty three out of fifty patients
underwent SVA. The demonstration of biopsy proven metastases during
laparoscopy in 15 patients accounted for a decision to avoid operative intervention in
these patients, and SVA was accordingly regarded as unjustified as it would have
contributed nothing further to these patients' management. Breaches in protocol




Investigative algorithm employed in the diagnosis and staging of 50 patients
with pancreatic and periampullary cancer
Metastases
n = 15




5.3.3 Evaluation and validation of resectabilty by TNM stage
The results were expressed in terms of the TNM classification presented in Table 2.1
979/ Section 2.1.1 , and in terms of overall tumour resectability in the context of
pancreatic resection with the intention of cure.
Evaluation of T stage
As documented in Section 2.1.1, patients were considered as having pancreatic or
periampullary cancers which were resectable with curative intent when there was no
evidence of extrapancreatic tumour invasion (Ti), or when local tumour invasion
was limited to the distal common bile duct or medial duodenal wall (T2). However,
local tumour invasion of the peripancreatic fat, or tissues of the hepatoduodenal
ligament, were regarded as indicating unresectable tumour (also T2). Similarly,
tumour invasion or encasement ofmajor peripancreatic blood vessels, stomach,
spleen or colon indicated tumour unresectability (T3). Local tumour resectability by
T stage was validated by surgical staging in 29 out of 50 patients as described in
Section 2.6.1, and by non-operative means in six patients when all four staging
modalities and the patients' clinical course were indicative of advanced cancer.
Histopathological examination of pancreatic resection specimens was performed
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with particular attention to microscopic involvement of the resection margins with
tumour. For the purposes of this study, patients found to have positive resection
margins were regarded as having been 'unresectable' in the context of 'cure'.
Fifteen patients in whom metastases had been discovered, and who were neither
assessed by laparotomy or SVA, were not evaluable by T stage (Tx).
Evaluation ofN and M stages
For the purposes of this study, patients with distant metastases (Mi) or malignant
regional lymphadenopathy (Ni) documented by laparoscopic or operative biopsy,
and including those patients found to have lymph node metastases following
histological examination of the pancreatic resection specimen, were regarded as
having 'unresectable' tumours (see Section 2.1.1). Further investigation by SVA or
surgery was avoided in patients with biopsy proven distant metastases or malignant
lymphadenopathy. The absence of distant metastases (Mo) or regional lymph node
spread (No) was accepted only after full operative staging, including sampling of
suspicious lesions by frozen section histology where appropriate. Lymph node
status was unevaluable in 23 patients in whom operative staging was not performed,
while the M stage of three patients could not be validated for similar reasons (i.e.
'Nx' and 'Mx').
Overall staging
All fifty patients were classified overall as 'resectable' or 'unresectable', taking
account of the findings for each of the T, N and M stages. Overall unresectability
was therefore denoted by the demonstration of defined criteria contraindicating
tumour resection for any aspect of the TNM staging system, recognising that other
TNM criteria may have been classified as being 'resectable' in the same patient.
5.3.4 Analysis of results
Summary measures of diagnostic accuracy were calculated and compared as
described in Section 2.1.2 (Table 2.2). The predictive values of positive results in
determining tumour unresectability, and of negative findings in predicting tumour
resectability were calculated in the knowledge of the prevalence of tumour
unresectability within the population of evaluable patients by reference to Study 2.




Exploratory laparotomy was performed in 29 patients, 14 of whom underwent
tumour resection (Whipple operation in nine patients; transduodenal local resection
for periampullary carcinoma in three patients; total pancreatectomy in one patient;
distal pancreatectomy in one patient). Palliative bypass surgery was performed in 14
patients (duodenal and biliary bypass in eight patients; duodenal bypass alone in
five patients; biliary bypass alone in one patient), and laparotomy with tumour
biopsy was performed in one patient found to have invasion of the posterior wall of
the stomach from a pancreatic body carcinoma. However, three patients who
underwent tumour resection had either peripancreatic lymph node metastases (two
patients), or invasion of the peripancreatic soft tissues with tumour involvement of
the posterior resection margin (one patient), and for the purposes of this study these
tumours were considered to have been 'unresectable' for cure. Conversely, three
patients in whom transduodenal local resections were not possible due to pancreatic
tumour infiltration were, nevertheless, judged as having tumours which were
potentially resectable by pancreaticoduodenectomy. However, it was elected to
forego pancreatic resection in these frail patients of high cardiovascular risk status,
and palliative bypass operations were performed instead. Therefore, for the purposes
of this study, the prevalence of patients with 'unresectable' tumours was 72% (36
out of 50 patients).
Post operative morbidity following LapUS was encountered in one patient with
carcinoma of the pancreatic body who previously had undergone percutaneous
needle biopsy. Peritoneal carcinomatosis was revealed at laparoscopy and the
patient developed an umbilical port site metastasis six weeks later. The general
health of another two patients deteriorated rapidly after LapUS had revealed
histologically proven disseminated pancreatic cancer, with death occurring at six
days and two weeks later.
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5.3.2 Diagnosis of primary tumour
A focal mass lesion within the pancreas or periampullary region was revealed by
USS in 32 out of 39 patients (82%) and by CT in 42 out of 45 patients (93%).
Definition of a primary tumour mass was possible in 48 out of 50 patients (96%)
using LapUS. The tumour typically appeared as a discrete, irregular, hypoechoic
mass in cases of pancreatic cancer, or as an isoechoic or hypoechoic lesion
prolapsing into the lumen of the second part of the duodenum, or infiltrating the
pancreatic head in patients with periampullary carcinoma. There were two 'false
negative' LapUS examinations where focal tumour could not be demonstrated. Both
patients had diffuse isoechoic carcinomas of the pancreatic head, and in one the
examination was limited by adhesions associated with a cholecystojejunostomy
performed at the referring hospital.
The presence of the primary tumour was inferred from displacement of the
pancreaticoduodenal arteries, or by the displacement or invasion of the portal or
superior mesenteric veins in 21 out of 32 patients (66%) studied by SVA (P = 0.005
versus CT; P = 0.0008 versus LapUS). An anomalous right or common hepatic
artery arising from the superior mesenteric artery or aorta was demonstrated in eight
of the 32 patients (22%) as discussed in Section 3.3.2. Severe obliterative vascular
disease with occlusion of the coeliac and superior mesenteric arteries was shown in
one patient.
5.3.3 Evaluation of T stage
Validation of T stage status was achieved in 35 patients, by surgical staging in 29
patients and by non-operative criteria in six patients. Sixteen patients were staged
Ti, three patients were staged T2 (invasion of retropancreatic fat in one patient,
invasion of mesenteric root in one patient and invasion of hepatoduodenal ligament
in one patient) and 16 patients were staged T3 (vascular invasion in 15 patients, and
invasion of the posterior wall of the stomach in one patient). Tumour unresectability
according to T stage was, therefore, documented in 19 out of 35 evaluable patients
(prevalence 54%). The validated results of the various staging investigations in
predicting tumour resectability by T stage are shown as 2 x 2 contingency matrices
in Tables 5.1.1 - 5.1.4. The derived summary measures of diagnostic accuracy for T
staging are summarised in Table 5.2.
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There were six instances where LapUS failed to identify tumour unresectability due
to T2-T3 local tumour invasion (Table 5.1.3). Invasion of the portal-superior
mesenteric vein was not predicted in three patients, one of whom had a diffusely
infiltrating isoechoic carcinoma of the pancreatic head, the extent of which was
difficult to define, and another had a five centimetre diameter tumour in which dense
posterior acoustic shadowing largely obscured the vein-tumour interface. In the
third case, marked distortion of the portal-superior mesenteric vein by a three
centimetre diameter carcinoma of the uncinate process was identified, although no
direct venous invasion was identified and diagnosis of a potentially resectable
"pushing" tumour was predicted. However, during surgical exploration the tumour
was deemed to have extended too far posterior to the superior mesenteric vein to
enable resection without necessitating gross tumour transection.
Infiltration of the posterior wall of the stomach was undetected in one patient with an
eight centimetre diameter pancreatic body cancer, in which the tumour was
discovered to have extended into the lesser sac to infiltrate the serosa during
laparotomy. Retrospective review of the LapUS images in this patient revealed loss
of the normal hyperechoic interface between the stomach serosa and the pancreas
which had not been recognised during the procedure (see Figure 24). Infiltration of
the retroperitoneal soft tissues alongside the inferior vena cava was discovered
during Kocher's manoeuvre in one case (Figure 40). Retropancreatic fat invasion
was discovered by histopathological examination of the distal pancreatectomy
specimen of one patient. The sensitivities (60 - 71%) and negative predictive values
(58 - 73%) of all investigations in identifying tumour unresectability due to direct
extrapancreatic invasion did not differ significantly (Table 5.2).
There were 16 instances where overestimation of T stage by one or more
investigations was demonstrated. These 'false positive' findings were attributable to
USS in four patients (invasion of the portal vein (n=2), common bile duct (n=2) and /
or peripancreatic fat (n=l)), CT in eight patients (invasion of peripancreatic fat
(n=6), portal vein invasion (n=3) and / or colonic invasion (n=l)) (see Figure 36),
and SVA in four patients (slight narrowing of the superior mesenteric-portal vein
junction leading to the diagnosis of "encasement") (see Figure 38). All these
patients were subsequently shown to have resectable tumour by surgical validation
and histopathological examination of the resected specimen. There were no
instances of overstaging of T stage by LapUS (Table 5.1.3), and accordingly its
specificity and positive predictive value were significantly superior to that of both
USS and CT (Table 5.2).
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Table 5.1.1
Diagnostic accuracy of USS in the T staging of 26 evaluable patients with







Diagnostic accuracy of CT in the T staging of 32 evaluable patients with









Diagnostic accuracy of laparoscopy and LapUS in the T staging of 35 evaluable
patients with pancreatic or periampullary carcinoma
LapUS








Diagnostic accuracy of SVA in the T staging of 31 evaluable patients with




Angiography failed to detect local tumour unresectability due to proven portal vein
invasion or encasement in two out of six cases. The other false negative
examinations were due to invasion of the peripancreatic soft tissues (hepatoduodenal
ligament, mesenteric root and / or retropancreatic / retroduodenal fascia).
TABLE 5.2
Diagnostic accuracy of staging investigations in predicting tumour
unresectability according to T stage in 35 patients with pancreatic or
periampullary carcinoma
Sensitivity Specificity PPV NPV
USS 0.60 0.64* 0.66 0.58
CT 0.71 0.47* 0.61* 0.58
LapUS 0.68 1.00 1.00 0.73
SVA 0.67 0.69 0.72 0.64
*
P < 0.05; *P< 0.005 (USS /CT versus LapUS)
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5.3.4 Evaluation of N stage
Nodal status was evaluable in 27 patients, seven of whom had proven regional
lymph node metastases at laparoscopy (three patients), laparotomy (two patients) or
on histopathological examination of the pancreatic resection specimen in two
patients (prevalence of N1 stage 26%). The sites of the involved nodes were para
aortic (three patients), hilar (two patients), retroduodenal (two patients), mesenteric
root (two patients) and / or peripancreatic tissues (two patients). The validated
results of the various staging investigations in predicting tumour resectability by N
stage are shown as 2 x 2 contingency matrices in Tables 5.3.1 - 5.3.4. The derived
summary measures of diagnostic accuracy for N staging are summarised in Table
5.4.
Failure to detect lymph node metastases was associated with all four investigations
(sensitivity range 20-83%), while 'false positive' results were also obtained with USS
(two patients), CT (five patients) and LapUS (four patients), where histopathology
revealed lymph node enlargement >10 mm to be due to reactive hyperplasia.
Table 5.3.1
Diagnostic accuracy of USS in the N staging of 19 evaluable patients with
pancreatic or periampullary carcinoma








Diagnostic accuracy of CT in the N staging of 23 evaluable patients with









Diagnostic accuracy of LapUS in the N staging of 27 evaluable patients with









Diagnostic accuracy of SVA in the N staging of 21 evaluable patients with










Diagnostic accuracy of staging investigations in predicting tumour
unresectability according to N stage in 27 patients with pancreatic or
periampullary carcinoma
Sensitivity Specificity PPV NPV
USS 0.67 0.85 0.61 0.88
CT 0.83 0.71* 0.50 0.92
LapUS 0.71 0.80 0.56 0.89
SVA 0.20 1.00 1.00 0.78
*
P < 0.05 (SVA versus CT)
5.3.5 Evaluation ofM stage
M stage was evaluable in 43 patients, of whom 16 were shown to have liver and / or
peritoneal metastases following biopsy at laparoscopy (15 patients) or laparotomy
(one patient) (prevalence ofMi stage 37%). Metastatic lesions were visible during
laparoscopy in 15 patients. A small malignant lesion on the edge of hepatic segment
IV which, inexplicably, had not been detected during laparoscopy was discovered at
laparotomy in one patient. Laparoscopic ultrasonography was the only modality to
have detected small intraparenchymal liver metastases in seven out of 15 patients,
although laparoscopically visible surface lesions were also present in all these cases.
In 10 patients, both USS and CT failed to detect intraabdominal metastatic lesions
which were frequently very small (range l-15mm diameter). There was one 'false
positive' CT examination in which a patient with intrahepatic duct dilatation was
interpreted as having liver metastases. The validated results of the various staging
investigations in predicting tumour resectability by M stage are shown as 2 x 2
contingency matrices in Tables 5.5.1 - 5.5.4. The derived summary measures of
diagnostic accuracy for M staging are summarised in Table 5.6.
The sensitivity and predictive value of a negative result were significantly superior
for laparoscopic staging of metastatic disease compared with either USS or CT
(Table 5.6). Of the four patients with metastases who underwent SVA, none were
identified, and there were no false positive results.
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Table 5.5.1
Diagnostic accuracy of USS in the M staging of 32 evaluable patients with









Diagnostic accuracy of CT in the M staging of 39 evaluable patients with
pancreatic or periampullary carcinoma
CI







Diagnostic accuracy of LapUS in the M staging of 43 evaluable patients with
pancreatic or periampullary carcinoma
LapUS








Diagnostic accuracy of SVA in the M staging of 27 evaluable patients with
pancreatic or periampullary carcinoma
SVA







Diagnostic accuracy of staging investigations in predicting tumour
unresectability according to M stage in 43 patients with pancreatic or
periampullary carcinoma
Sensitivity Specificity PPV NPV
USS 0.29§ 1.00 1.00 0.7 it
CT 0.33* 0.96 0.83 0.59*
LapUS 0.94 1.00 1.00 0.96
SVA 0.00§ 1.00 - -
*
P < 0.05; t p < 0.01; tp< 0.005; § P < 0.001 (USS / CT / SVA versus LapUS)
5.3.6 Evaluation of overall tumour resectability
Fourteen patients were considered to have resectable tumours (i.e. 72% prevalence
of unresectability). Laparoscopy with LapUS was the most reliable modality in
determining overall tumour unresectability (Table 5.8), with overall positive and
negative predictive values of 97% and 68%. Laparoscopic ultrasonography correctly
upstaged disease following a 'negative' laparoscopy in patients with unresectable
tumours due to nodal metastases or local invasion in 14 patients (28%). One patient
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was staged overall as 'false positive' by LapUS on account of enlarged hilar lymph
nodes (12 mm maximum diameter) which were incorrectly interpreted as metastatic.
There were six instances where LapUS failed to identify factors precluding curative
resection when all factors were taken into consideration. Invasion of the portal vein
had not been predicted in three patients (see Section 5.3.3). Infiltration of the
posterior wall of the stomach was undetected in one patient, retropancreatic fat
invasion was discovered in the distal pancreatectomy specimen of one patient and
malignant peripancreatic lymphadenopathy (14 mm maximum node diameter) was
demonstrated in the pancreaticoduodenectomy specimen of the remaining patient.
The validated results of the various staging investigations in predicting overall
tumour resectability are shown as 2 x 2 contingency matrices in Tables 5.7.1 - 5.7.4.
The derived summary measures of diagnostic accuracy for overall staging are
summarised in Table 5.8.
Table 5.7.1
Diagnostic accuracy of USS in the overall staging of 39 evaluable patients with
pancreatic or periampullary carcinoma








Diagnostic accuracy of CT in the overall staging of 45 evaluable patients with
pancreatic or periampullary carcinoma
CI







Diagnostic accuracy of LapUS in the overall staging of 50 evaluable patients









Diagnostic accuracy of SVA in the overall staging of 32 evaluable patients with
pancreatic or periampullary carcinoma
SVA








Diagnostic accuracy of staging investigations in predicting overall tumour
unresectability in 50 patients with pancreatic or periampullary carcinoma
Sensitivity Specificity PPV NPV
uss 0.67 0.56 0.80 0.40
CT 0.66 0.54* 0.79* 0.38
LapUS 0.83 0.93 0.97 0.68
SVA 0.62 0.64 0.82 0.40
*
P < 0.05; i P < 0.005 (CT versus LapUS)
5.4 Discussion
Staging laparoscopy with LapUS under general anaesthesia was shown to be a safe
and effective means of assessing patients with pancreatic and periampullary
carcinoma under consideration for definitive surgical intervention. The post
operative deaths of two patients at six days and two weeks was considered to reflect
their poor general health and advanced malignancy rather than any specific
complication of the laparoscopic procedure. Although their rapid decline might be
construed as reflecting injudicious selection for such an invasive procedure, the
diagnosis was uncertain in each case, and both had expressed a wish for further
investigation to clarify the prognosis. The two instances of malignant port site
seeding are a cause for concern. The implications of this complication are
^01 ^n?
considered more fully in Section of 6.4 of Study 4 ' .
5.4.1 Detection of the primary lesion
In this study, the high sensitivity of LapUS in revealing focal pancreatic or
periampullary tumour masses in 96% of cases reflects the utility of high resolution
contact sonography. This finding is similar to that reported from studies of EUS (see
Section 1.2.10) in which reported diagnostic sensitivities of 98-100% were obtained
in patients with established diagnoses of pancreatic or periampullary cancer134'136'
140. However, such study designs inevitably overestimate the efficacy of such
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diagnostic tests, as was illustrated by two other studies of EUS in which patients
with non-neoplastic lesions (e.g. chronic pancreatitis) comprised 30% and 23% of
1 OQ O/CQ
the study populations respectively ' . Diagnostic sensitivities of 85% and 96%,
and specificities of 80% and 73% were reported, highlighting the problem in
differentiating malignant and benign focal pancreatic lesions in the wider patient
population, and reflecting the need for reliable tissue sampling techniques. Thus,
while it was not possible to investigate these wider issues in the present study, the
observation that LapUS was able to image the underlying abnormality in nearly all
cases underscores its utility in high-resolution imaging of the pancreas and
periampullary region.
The improvement in the diagnostic sensitivity of LapUS from 82% in Study 2 to
96% in the present study presumably reflects increasing experience with the
technique (i.e. "the learning curve"), as well as improvements in LapUS equipment.
Nevertheless, the failure in two cases to identify pancreatic cancers, which in
retrospect appeared echographically diffuse and isoechoic, has identified a
diagnostic pitfall. Interestingly, periampullary cancers were readily identified
despite their isoechoity and relatively small dimensions, due to dilatation of the
pancreatic and bile ducts which could be traced to their abrupt termination at the site
of obstruction.
It was also noteworthy that USS, CT and SVA were less performant than LapUS in
establishing a diagnosis. The 82% sensitivity of USS, and the 93% sensitivity of CT
should be considered in the context of previous studies which cite corresponding
figures in the range 51-98% (Table 1.1), and 69-99% (Table 1.3) respectively. The
66% diagnostic sensitivity of SVA obtained in the present study compared
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favourably with the experience of others (range 33-72% ' ) as discussed in
Section 1.2.6. Nevertheless, the deficiencies of SVA as a diagnostic tool have again
been emphasised, and these observations have reinforced the generalisation that
normal visceral angiograms and portal phase venograms are not able to exclude
pancreatic or periampullary tumours.
5.4.2 Detection of intraabdominal metastases
This study verified the findings of Study 2 that staging laparoscopy is highly
sensitive (94%) in detecting 'occult' intraabdominal metastases in patients with
pancreatic or periampullary cancer. Furthermore, the significant advantage of
laparoscopy in this role was demonstrated conclusively by prospective blind
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comparison with USS, CT and SVA. In common with Study 2, most other reports of
staging laparoscopy in the staging of pancreatic cancer were comprised of patients
selected retrospectively by USS and / or CT on the basis that they were free of
R^ R^ ?*>! 90S ?QR 7qqmetastatic disease ' ' ' ' . In the present study, prospective
standardisation of the methods of scanning and reporting had little impact on the
failure of USS and CT to detect metastases in approximately two-thirds of cases
examined. This demonstrates beyond doubt the limitations of these conventional
imaging modalities in the detection of "occult" intraabdominal metastases.
The advent of more refined CT scanning techniques, in particular helical CT
scanning (see Section 1.2.4), raises the question of whether this technology would
have been more succesful in identifying metastatic disease than the conventional
intravenous contrast enhanced CT utilised herein. A further study comparing helical
CT with laparoscopy with or without LapUS would be required to determine this
issue. Neverthless, of the two patients examined using helical CT scanning in the
present study, a laparoscopically detected liver metastasis of the left hepatic lobe was
missed in one patient. To date there has been only one published study of helical CT
in the staging of pancreatic cancer303. Liver metastases were proven in 13 out of the
35 patients studied (37%), in five of whom (38%) helical CT failed to detect such
lesions "...owing to their small size (between 1-3 mm) and only proved
intraoperatively or laparoscopically . Based upon this limited available evidence
it seems unlikely that helical CT will diminish the role of staging laparoscopy in
detecting such small lesions in patients with pancreatic cancer.
The investigative algorithm employed in the present study necessitated the
avoidance of SVA in most patients with detected metastases, and was thus a source
of bias against its ability to fulfill this role. Neverthless, SVA failed to identify
metastases in all four such patients examined. This is not at variance with the
findings of other studies in which SVA was also shown to have been ineffective in
detecting hepatic metastases, with reported sensitivities of 33-47%174'175'180.
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However, the tendency of SVA, in a previous report from this department , to
over-diagnose hepatic metastases was not observed in the present study, in which
there were no such false positives.
The principle that LapUS may identify intrahepatic metastases which are
imperceptible to USS, CT and laparoscopy was illustrated in seven out of the 16
patients with Mi stage disease on a 'lesion-by-lesion' basis. However, in agreement
with the results of Study 2, the impact of LapUS as the only means of diagnosing
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metastatic disease on a 'patient by patient' basis was once again marginal. As
discussed in Section 4.4, these findings differ from those of Bemelman and
colleagues for whom LapUS was the sole means of detecting intrahepatic metastases
OQO
in approximately a third of such cases . While the overall incidence of liver
metastases in the present series was similar to that reported by Bemelman et al, the
relatively higher sensitivity of laparoscopy observed in our experience, as opposed to
that of laparoscopy and LapUS in the Dutch study, could have been the result of our
rigorous laparoscopic technique. This included the use of a 30° telescope to
scrutinise the subphrenic spaces and inferior aspects of the left and right hepatic
lobes (as described in Section 2.3). Unfortunately, details of the laparoscopic
OQQ
technique employed in their study were not provided , although the authors did
allude to difficulty in the laparoscopic diagnosis of metastases "on top of the dome
or upper border of the liver". An alternative possibility is that LapUS failed to
identify "occult" metastases in additional patients in our study. As discussed in
Section 4.4, the ultimate arbiter of false negativity would require detailed long-term
follow-up and study of patterns of tumour recurrence. Such measures were not
available in any of these studies, although our routine use of high-resolution IOUS to
298examine the liver for metastases during laparotomy (c.f Bemelman et al ) makes
this a less likely explanation.
5.4.3 Evaluation of T stage
Having observed stringent criteria for defining T stage resectability, LapUS was
found to be at least as predictive as USS, CT and SVA in determining resectability
by T stage. However, the identification of six false negative results out of 19 cases
(32%) of T2-T3 tumour unresectability (due to peripancreatic soft tissue invasion or
portal vein involvement) has indicated the fallibility LapUS in this role. As regards
the diagnosis of portal vein invasion, large (i.e. > 5 cm diameter) hypoechoic
tumours and diffusely infiltrative, isoechoic tumours have been identified as pitfalls.
It is pertinent to note the former scenario has also been identified as limiting EUS in
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the staging of vascular invasion * . While such tumours are unlikely to be
resectable for cure, their recognition and interpretation may improve with
experience. Extrapancreatic soft tissue invasion also prove to be difficult to define
reliably by LapUS. While loss of the hyperechoic serosal-tumour interface was
apparent in retrospect following IOUS in the patient with a pancreatic body
carcinoma infiltrating the posterior wall of the stomach, no sonographic features for
the identification of diffuse retropancreatic infiltration were apparent. This is
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probably because the sonographic interface between the pancreatic parenchyma and
the retroperitoneal tissues is less well defined compared with those delineating
vascular and ductal structures. This aspect of the LapUS examination remains,
therefore, a potential weakness, although it was of clinical significance in a minority
of patients.
Apart from obvious errors in the execution and interpretation of this operator
dependent technique, other factors should also be considered regarding the failure of
LapUS to define accurately local tumour invasion. Firstly, high-resolution contact
ultrasonography does not always abolish the ill-defined global degradation of image
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quality discussed in the context of USS in Section 1.2.8 . This concept is
largely subjective and difficult to quantify, and is usually indicated by the
ultrasonographer experiencing a "difficult examination" in a patient who "does not
scan well". This factor may be compounded by technical difficulties during LapUS
such as those associated with the adhesions of previous surgery or the presence of a
large fatty omentum overlying the pancreas. Several of the LapUS examinations
which yielded false negative results fell into this category, although precise
documentation of these effects had not been undertaken routinely during the study.
Secondly, the decision of an experienced pancreatic surgeon during exploratory
laparotomy and trial pancreatic dissection was adopted as the arbiter of local tumour
resectability, although this also must be regarded ultimately as an essentially
subjective measure. Notwithstanding that this surgical decision is the endpoint
which matters most to the patients' immediate fate in clinical practice, this concept
has not been validated in more objective terms. Although other workers have been
prepared to perform portal vein resections when confronted with apparent locally
invasive tumour, and report having refuted venous invasion on histopathological
2QQ
examination , such instances are rare and the departmental policy remams one of
avoidance of this aggressive approach for the reasons discussed in Sections 1.1.1 and
1.1.2. It is therefore highly unlikely that surgical overdiagnosis of vascular invasion
was a factor in the work presented in this thesis. Alternatively, several surgeons
have identified the fallibility of early trial pancreatic dissection in identifying tumour
invasion of the lateral aspect of the spleno-porto-mesenteric venous junction, and
cite the occasional need to perform portal vein resection when this is discovered
unexpectedly following transection of the pancreatic neck (i.e. "the point of no
OC 304
return")^ ' ' J . However, there were no such instances where this scenario
occured unexpectedly because of prior understaging, nor were positive resection
margins documented in this site.
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Reassuringly, LapUS did not overstage local tumour status in this study, as reflected
by a specificity and PPV of 100%. Features of portal-superior mesenteric vein
invasion such as occlusion, stenosis, loss of the hyperechoic vein-parenchymal
interface, luminal invasion and vessel encasement prove to be reliable in this respect.
This high specificity for LapUS was supported by the findings of Bemelman and
colleagues who correctly identify locally unresectable tumours in 13 out of 14 cases,
their one false positive result occuring in a patient with retroperitoneal radiation
fibrosis298.
In addition to these encouraging results, the rationale for LapUS in the local staging
of pancreatic and periampullary cancer appears to have been strengthened by the
parallel experience of those working with EUS, inasmuch as the two techniques
share the fundamental principle of high-resolution contact sonography. The
observations of the present study concur with the findings of Snady and colleagues
who simultaneously investigated EUS criteria for vascular invasion in 38 patients
with pancreatic tumours . They defined three such criteria (vessel obliteration
with venous collaterals, luminal tumour invasion and abnormal vessel contour with
loss of vessel-parenchyma sonographic interface), and reported having observed at
least one of them in the 21 patients subsequently shown to have vascular invasion.
Conversely, none of these defined criteria were said to have been present in the 17
patients with resectable tumours .
Other studies of EUS in the evaluation of portal vein invasion134'136'138'140 also
indicate few false negatives (sensitivity 88-100%, NPV 89-100%; see Table 1.8),
although false positives were sometimes a problem with this technique (specificity
65-97%, PPV 83-100%; see Table 1.8). In Palazzo's series of 49 patients with
pancreatic cancer, five false positive EUS examinations were attributed to large
pancreatic tumours and duodenal infiltration, resulting in failure of duodenal
intubation and a reliance on oblique sonograms, with consequent failure to image the
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tumour periphery . Notwithstanding the occasional problem with upper
abdominal adhesions, LapUS should in theory be less prone to such limitations since
the transducer is not limited to the duodenal lumen and has a far greater range of
manoeuvre. Thus, in the hands of experienced operators, high resolution contact
sonography appears an appropriate method for defining local tumour stage whether
applied during laparoscopy or endoscopy.
No evidence was provided in this study to support a definitive role for USS in the
locoregional staging of patients with pancreatic or periampullary cancer. Although
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Campbell and Wilsons' retrospective study concluded that USS was an effective
staging tool in their institution, having correctly identified vascular invasion in 12
10 1
out of 16 patients (75%) with no false positives , the results of the present study
did not reproduce these findings. Both under- and overestimation of T stage was
observed, giving respective positive and negative predictive values of 66% and 58%,
and a specificity which was significantly inferior to that of LapUS (Table 5.2).
Operator dependency and technical considerations were not an issue. All USS
examinations were performed by a defined consultant radiologist, who is a
recognised by his peers as an expert sonographer, using "state of the art" equipment
including Doppler and colour Doppler techniques to evaluate the peripancreatic
vasculature. This experience reflects more closely the experience with USS reported
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in a Norwegian multi-centre review , and in several prospective comparative
studies investigating USS alongside EUS in the staging of pancreatic and
periampullary cancer136'138'140 (see Table 1.2). Nevertheless, this experience does
not detract from the utility of USS as a first-line method for confirming the diagnosis
and defining the level of extrahepatic biliary obstruction, and for screening the liver
for overt metastases. Convincing evidence supporting this primary role for USS
already exists as discussed in Section 1.2.3, and was not evaluated further in this
thesis.
While the performance of CT in predicting tumour resectability was shown to have
been similar to that of LapUS, and in this respect was not at variance with the results
reported by Freeny and colleagues150'154 the present study also identified a
tendency for CT to overstage local tumour status, particularly with regard to
peripancreatic fat invasion of (six patients) and portal vein invasion (three patients).
This was manifested by a specificity (47%) and PPV (61%) which were significantly
worse compared with the performance of LapUS (100%). Although other workers
have expressed similar concerns regading the specificity of CT in the staging of
pancreatic cancer135'152'155, these studies were retrospective, and confounded by
suboptimal scanning techniques such as the use of non-enhanced CT. Nevertheless,
these flaws were avoided in the present study, which observed a similar technique to
that described by Freeny et al150'154, while other workers utilising updated CT
protocols have also documented false positive CT examinations in the locoregional
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staging of pancreatic and periampullary cancer ' ' ' (see Table 1.4).
These facts should be viewed with some concern as CT is widely regarded as the
staging investigation of choice, particularly in the United States. A national survey
of patterns of care for pancreatic cancer comprising 16 942 patients in 978 American
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institutions reported that abdominal CT was performed in 79% of patients during
1983-1985, increasing to 88% of patients during 1990294. As discussed in Section
1.2.4, the main proponents of CT as a reliable means of staging of pancreatic cancer
have claimed a high specificity for the technique150'154. Although no false positives
were reported amongst the 53 patients who did undergo surgical evaluation, final
validation of tumour unresectability by exploratory laparotomy was performed in
less than a third of Freeny's patients despite the incidence of local tumour invasion
having been deemed to be 68%150. The results of the present study highlight the
importance of prospective validation, by surgical exploration if necessary, of tumour
unresectability when evaluating staging modalities. A relatively low resectability
rate of 28% reflects this policy.
As discussed above, more advanced CT techniques have now superseded the
methods used in this study, which nevertheless remain the mainstay of cross
sectional imaging in many hospitals. Thin-section CT of the pancreas using 1.5 mm
slice thickness at 5 mm intervals was recently reported by Fuhrman et al to have
correctly identified patients with resectable pancreatic carcinomas in 88% of cases.
However, their contention that thin-section CT "represents the only accurate
method" for the preoperative evaluation of vascular invasion can be criticised for
several reasons. Their study should be regarded in the context of an aggressive
surgical policy where portal vein resection was not necessarily considered a
contraindication to curative resection, and mere patency of the superior mesenteric-
portal vein was accepted as being indicative of resectability. Furthermore, having
deemed it "inappropriate to surgically confirm unresectability", exploratory
laparotomy was performed in only 42 out of 145 patients . Their consequent
resectability rate of 88% reflected this failure to validate positive CT findings '
. Certainly, the results of the present study refute Fuhrman's contention that "the
accuracy of CT to predict unresectability is well established and does not need
w
further confirmation" . Gmeinwieser and colleagues recently reported their
experience with "state of the art" helical CT in the evaluation of vascular invasion in
38 patients with pancreatic cancer303. Although the technique performed well in its
assessment of portal vein involvement (sensitivity 91%, specificity 94%), complete
avoidance of both false negative and false positive examinations proved elusive .
The present study has provided further evidence against the routine use of SVA in
the preoperative assessment of patients with pancreatic and periampullary
malignancy. False negative examinations were largely due to the inability of SVA to
identify peripancreatic soft tissue invasion, whereas the diagnosis of vascular
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encasement from the appearance of subtle narrowing in the vicinity of the superior
mesenteric-portal venous junction yielded four false positives. This scenario has
been documented previously35'159' 180 while Dooley and colleagues described
"notching" in the vicinity of the portal-superior mesenteric venous junction as a
"normal variant" of SVA which could be misconstrued as tumour encasement160.
Therefore, while SVA contributed little additional useful information regarding T
stage compared with less invasive investigations, serious concern has again been
raised regarding its propensity to overestimate local tumour stage and so risk
denying "curative" resections to patients with potentially resectable disease.
The utility of SVA in providing a "roadmap" of the peripancreadc vascular anatomy
was discussed in Section 1.2.6 (see Table 1.6). In this regard, the contribution of
SVA, and that of LapUS, in this role was investigated in Study 1, and discussed
further in Section 3.4.2. Angiography provided clinically useful information in one
other patient, in whom coeliac and superior mesenteric arterial occlusion was
demonstrated. However, this diagnosis was also apparent during intraoperative
inspection and palpation of the splanchnic vasculature, and its clinical benefit was
therefore marginal.
5.4.4 Evaluation of lymph node status
The difficulty of accurately staging regional lymph node metastases in patients with
pancreatic and periampullary cancer has again been demonstrated. Also, the
relatively small number of patients defined as having positive regional nodes inhibits
the formulation of definite conclusions regarding the diagnostic accuracies of the
various investigations. The occurence of both false positive and false negative
results for each of USS, CT and LapUS concurs with the experience of those
evaluating EUS in confirming that malignant lymph node enlargement cannot be
reliably identified on the basis of lymph node size alone136'138'262'265. Nodal
enlargement is frequently the result of reactive hyperplasia, and conversely, nodes of
smaller size may harbour micrometastases. Consequently, patients with pancreatic
or periampullary cancer should not be denied surgical assessment of resectability on
the basis of regional lymphadenopathy alone in the absence of biopsy confirmation
of nodal malignancy, and it is pertinent to note that this was not the case with any of
the patients in this study.
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5.4.5 Overall tumour staging
Critical evaluation of LapUS in comparison with USS, CT and SVA has broadly
OQO
reproduced the results of Study 2, and those of Bemelman and colleagues in the
overall staging of patients with pancreatic and periampullary cancer. The sensitivity
of laparoscopy and LapUS in identifying overall tumour unresectability was 83%,
compared with 88% in the earlier study, probably reflecting the more stringent
methods of validation in the present study. Nevertheless, high specificity was
retained, the only significant errors in tumour overstaging occuring in the assessment
of node status. Indeed, the specificity and PPV calculated for laparoscopy and
LapUS (93% and 97%) were a statistically significant improvement over CT (54%
and 79%) (Table 5.8).
The advantage of laparoscopy with LapUS over USS, CT and SVA in the overall
staging of patients with pancreatic and periampullary carcinoma lies predominantly
with the significantly superior sensitivity of laparoscopy in identifying
intraabdominal metastases and facilitating their biopsy. The unique role of
laparoscopy in this respect has been proven, and justifies its mandatory use prior to
laparotomy in patients with potentially resectable lesions, irrespective of the results
of USS and CT. While the sensitivity and NPV of LapUS in predicting tumour
resectability are roughly comparable to those of USS and CT, its superior specificity
and PPV in defining stigmata of unresectability support its adoption in the staging
algorithm for such patients.
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Chapter 6 Study 4
Laparoscopic peritoneal cytology in the evaluation of
patients with carcinoma of the pancreas and
periampullary region
6.1 INTRODUCTION
As discussed in Section 1.2.9, it has been suggested that peritoneal cytology may
have an important role in the preoperative assessment of patients with pancreatic
cancer, both as an index of tumour resectability, and as a determinant of
prognosis ' . Furthermore, an association between positive peritoneal cytology
and preceding operative tumour manipulation or needle biopsy has been
hypothesised, implicating these manoeuvres in the dissemination of malignant cells.
However, in previous studies of peritoneal cytology in patients with pancreatic
cancer, peritoneal washings were either obtained during laparotomy , or during
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laparoscopy in only a subset of patients . If cytological analysis of peritoneal
washings is to be useful in the preoperative staging of patients with pancreatic and
periampullary cancer, the reproducibility of the aforementioned results must be
demonstrated in the context of staging laparoscopy.
A prospective study was performed in parallel with Study 3 to evaluate the
contribution of peritoneal cytology performed exclusively during staging
laparoscopy. The aims of the study were to evaluate the incidence of positive
peritoneal cytology in this group of patients, to investigate patterns of tumour spread
associated with positive peritoneal cytology and to assess the impact of positive
peritoneal cytology on short term survival. Also, the reproducibility of the results of
the routine hospital cytopathology service was assessed.
6.2 PATIENTS AND METHODS
6.2.1 Patient details
Forty six patients of the 50 patients with carcinoma of the pancreas or periampullary
region in Study 3 who underwent staging laparoscopy with LapUS between March
1993 and April 1995 were evaluated. There were 29 men; median age 61 years;
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range 42-78 years. Eight patients were classified as having periampullary tumours
where endoscopic, operative and pathological findings indicated the carcinoma to be
arising predominantly within the papillary region.
A histological diagnosis of pancreatic or periampullary carcinoma was obtained in
38 patients by percutaneous (four patients) or operative (n=10) needle biopsy of the
pancreas, laparoscopic (n=13) or operative (one patient) biopsy of metastatic lesions
in the liver, serosal surfaces or regional lymph nodes, histopathological examination
of the pancreatic resection specimen (n=13) and / or endoluminal biopsy of
periampullary lesions (n=10). As discussed in Section 5.2.1, no histological
diagnosis was obtained in the other six patients, although a pancreatic mass lesion
was documented by imaging investigations, and death from carcinomatosis was
observed in each case (crude mean survival 34 weeks (range 12-67 weeks)). The
primary tumour was situated in the pancreatic head (32 patients), pancreatic body
(five patients), pancreatic head and body (one patient) and periampullary region
(eight patients). A biliary stent had been inserted in thirty patients by the endoscopic
(22 patients) or percutaneous route (eight patients), and a cholecystjejunostomy had
previously been performed in one patient at the referring hospital.
6.2.2 Laparoscopic peritoneal cytology
Laparoscopic peritoneal cytology was not performed in four of the 50 consecutive
patients studied in Study 3 due to breaches of protocol.
Laparoscopy with LapUS was performed as described in Section 2.3. Peritoneal
washings, or samples of ascitic fluid, were retrieved during laparoscopy for
cytological anlysis as described in Section 2.4 (see Figure 33B). Ascites was
defined as being present when > 100 ml of free intraperitoneal fluid was discovered
during laparoscopy. The samples were prepared, and interpretation of the slides was
performed, as described in Section 2.4.
All cytological examinations were performed initially as part of the routine hospital
service by a number of cytopathologists, and were later reviewed independently by a
defined cytologist (EMcG) who was both experienced in the technique and blinded
to patient details.
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6.2.3 Validation of tumour resectability
As in Study 3, the end-point of overall tumour resectability was determined
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according to the adopted staging convention defined in Table 2.1 / Section 2.1.1 .
Validation of tumour resectability was by laparoscopic biopsy of intraabdominal
metastases to distant sites (n=13) or regional lymph nodes (n=2), by surgical
assessment of resectability (27 patients), by histopathological examination of the
resection specimen with regard to involvement of the planes of transection and
lymph nodes with tumour (13 patients), and by the corroborating findings of USS /
CT / LapUS and SVA (five patients).
Summary measures of diagnostic accuracy were calculated and compared as
described in Section 2.1.2 (Table 2.2). Actuarial survival was calculated for patients




The decision regarding tumour resectability, and the treatment received by the 46
patients in whom laparoscopic peritoneal cytology was performed, is summarised in
Table 6.1. For the purposes of this study, 13 patients (28%) were deemed to have
resectable disease as confirmed at laparotomy and histopathological examination of
resection specimens. As discussed in Section 5.3.1 of Study 3, three patients were
considered during exploratory laparotomy to have potentially resectable tumours,
although pancreatoduodenectomy was considered inappropriate for reasons not
related to tumour extent. Also, three patients who underwent pancreatic resection
were subsequently reclassified as having unresectable disease due to
histopathological evidence for retroperitoneal tumour invasion (one patient), and
overt regional lymph node metastases (n=2).
Thirty three patients were considered unresectable (72%). Laparoscopic biopsy
demonstrated distant metastases to the liver and / or peritoneum in 13 patients, and
malignant regional lymphadenopathy in two patients. Sixteen patients were shown
to have locally unresectable tumour, of whom nine underwent palliative biliary and /
or duodenal bypass surgery. One patient with previously unsuspected malignant
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Table 6.1
Outcome for 46 patients with pancreatic or periampullary carcinoma in whom




Transduodenal local resection 3
Biliary bypass ± gastroenterostomy 3




Biliary bypass and gastroenterostomy 1
"Unresectable" - T2-3 16
No operation 5
Distal Pancreatectomy 1
Laparotomy and biopsy 1
Biliary bypass and gastroenterostomy 5
Gastroenterostomy alone 2
Biliary bypass alone 2
infiltration of the posterior stomach wall from carcinoma of the pancreatic body
underwent laparotomy and biopsy.
6.3.2 Peritoneal Cytology
The results of independent review of the cytology specimens concurred with those
reported by the routine hospital service in all cases. Laparoscopic peritoneal
cytology was positive for the presence of malignant cells in seven patients (15%)
(Figure 44). Review of the laparoscopic peritoneal cytology preparations revealed
the following additional observations: a bloodstained sample was reported in 36
cases (78%), the preparations contained scanty mesothelial cells making satisfactory
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interpretation difficult in six cases (13%), and degenerative mesothelial cells were
present in 11 cases (24%). Large amounts of an amorphous material which was
presumed to represent a fibrinous or mucoid exudate was present in 23 patients
(50%) (Figure 45). In 27 patients (59%), inflammatory or reactive mesothelial cells
were observed in large numbers (Figure 45), the interpretation of which required
particular care to avoid confusion with malignant cells. However, there was no
instance where a false positive result was identified under these circumstances.
All seven patients with positive peritoneal cytology had laparoscopic evidence of
tumour unresectability due to extrapancreatic dissemination ofmalignancy (lymph
node metastases in one patient; peritoneal metastases in four and / or liver metastases
in four. i.e. stage III-IV disease). Negative peritoneal cytology results were
obtained in 39 patients, 13 of whom were deemed to have resectable tumours (i.e.
predictive value 33%). These results are expressed in terms of summary measures of
diagnostic accuracy in Table 6.2.
Table 6.2
Diagnostic accuracy of laparoscopic peritoneal cytology in the staging of 46






Sensitivity = 7/33 = 21% Specificity = 13/13 = 100%
PPV = 7/7 = 100% NPV = 13/39 = 33%
Positive peritoneal cytology was observed more frequently in patients with
carcinoma involving the pancreatic body (three out of six padents (50%)) compared
with those with tumour in the pancreatic head (four out of 28 patients (14%)), or
periampullary region (none) (see Table 6.3). Malignant peritoneal cytology was also
observed in three of the four patients (75%) in whom previous percutaneous




biopsy (11%)) (see Table 6.3). Twelve patients were found to have clinically
undetectable free ascitic fluid during laparoscopy. Positive peritoneal cytology was
Table 6.3
Results of laparoscopic peritoneal cytology in 46 patients with pancreatic or
periampullary carcinoma in relation to the tumour site and stage, and the
presence of ascitic fluid and preceding percutaneous needle biopsy
Result
Positive Negative
Number of patients 7 39
Tumour site
Periampullary - 8
Pancreatic head 4 28
Pancreatic head & body - 1















sje . . , •
six patients had intraabdominal metastases in more than one site
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recorded in six (50%) of these patients, compared with one out of 34 patients
without ascites (3%) (see Table 6.3). One patient with a periampullary carcinoma
underwent pancreaticoduodenectomy with curative intent and with histologically
negative resection margins following the discovery of cytology negative ascites at
laparoscopy. This patient was alive and well one year later with no clinical or
radiological evidence of tumour recurrence. Of the 13 patients with proven distant
metastases to the liver (11 patients) and / or serosal surfaces (eight patients),
peritoneal cytology was negative in seven (54%) and positive in six (46%) (see
Table 6.3). Negative peritoneal cytology was obtained in all 16 patients in whom
local tumour invasion (i.e. stage T2-3 unresectable) was the sole contraindication to
tumour resection.
The cumulative survival of patients found to have positive laparoscopic peritoneal
cytology was less than that of patients with negative peritoneal cytology (Figure 46).
The median cumulative survival at three and six months was 17% and 8% for
patients with positive cytology, compared with 87% and 71% respectively for those
with negative cytology. All patients with positive peritoneal cytology had died by
nine months, whereas 45% of those with negative cytology were still alive.
As described in Section 5.3.1, malignant port site seeding at the umbilicus was
diagnosed in one patient six weeks after laparoscopy. This patient had carcinoma of
the pancreatic body, and had undergone CT-guided percutaneous needle biopsy of
the pancreas two weeks prior to laparoscopy with a negative yield. Peritoneal
carcinomatosis, multifocal superficial liver metastases and positive peritoneal
cytology had been revealed at laparoscopy. Otherwise, there were no instances of




Malignant peritoneal cytology specimen (magnified x250: Papanicalou
stain). A clump of large epithelial cells of bizarre appearance showing
hyperchromatic staining, nuclei with visible nucleoli of varying sizes and
with visible mitotic bodies indicating an underlying adenocarcinoma.
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Figure 45
"Negative" peritoneal cytology specimen (magnified xlOOO: Papanicalou
stain). A sheet of normal mesothelial cells with uniform staining and
cellular morphology is situated along the left side of the photograph.
Scattered erythrocytes indicate a degree of contamination with blood. There
is a cluster of abnormally large cells (bottom right) exhibiting
polychromasia and enlarged nuclei, although with no cellular atypia or
features of malignancy. These features indicate benign reactive mesothelial
cells. A strand of homogenous material and interpreted as mucoid or
fibrinous exudate is also shown (top right).
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Figure 46
Cumulative survival of 46 patients with pancreatic or periampullary carcinoma















The incidence of positive peritoneal cytology in the present study (15%) was less
9Sf^ 9S7
than that recorded previously (25-30%) by Martin and Goellner and Warshaw .
This difference could be due to the inclusion in the present study of eight patients
with periampullary cancer, none of which were associated with malignant peritoneal
cytology. However, the apparent rarity of positive peritoneal cytology in patients
with pancreatic malignancy has been supported by the findings of similar work
published more recently from other centres (see Table 6.4). Studies performed in
Toledo, Ohio310, the University of Milan, Italy311 and MD Anderson Cancer
Center, Houston, Texas312 have reported positive peritoneal cytology in 8%, 13%
and 7% of cases, although their resectability rates of 33-70% may reflect a high
degree of patient selection. Furthermore, Warshaw's group's recent update of their
experience indicated that the incidence of positive peritoneal cytology had fallen to
one 9S7
17% , compared with 30% in their earlier report , while their overall
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resectability rate of 32% was not disimilar to that reported herein (28%). It is also
pertinent to note that both these studies differ from others in that fluid samples for
peritoneal cytology were obtained exclusively at laparoscopy (see Table 6.4), thus
facilitating an evaluation of its specific contribution to the preoperative staging
process. However, there is no obvious reason why the incidence of positive
peritoneal cytology should be influenced by the method of retrieval of peritoneal
washings providing that the sample is removed before the tumour is mobilised or
traumatised in any way.
As with any staging investigation, the avoidance of 'false positive' results is of
paramount importance and accurate interpretation of the cytological samples is
critical given that the majority of lavage samples contained many mesothelial cells
showing inflammatory changes. Furthermore, as cytological interpretation is a
highly observer-dependent techniqe and prone to inter-observer variation. It was
reassuring that independent retrospective review of the specimens by a specialist
cytologist appears to have validated the accuracy of the routine hospital cytology
service. Despite having deferred laparoscopic biopsies until after retrieval of
peritoneal washings, significant bloodstaining was present microscopically in 78%
of samples. This may reflect minor bleeding associated with trocar and port
insertion, minor trauma associated with the LapUS procedure and / or a direct effect
of the underying malignancy. However, bloodstaining did not prevent cytological
diagnosis in any case. Degenerative mesothelial cells were observed in 24% of
samples, perhaps reflecting an imperfect choice of collecting fluid. Furthermore, the
adequacy of the laparoscopic peritoneal cytology technique could be questioned in
the six cases (13%) where scanty mesothelial cells were present in the sample. This
highlights the importance of utilising the maximum 'dwell time' that is practicable,
and supports the practice of altering the position of the operating table to ensure
'agitation' of the intraperitoneal fluid, manoeuvres which were not routinely
performed in the present study. Neverthless, the failure of Leach and colleagues to
retrieve peritoneal washings laparoscopically in 18% of patients due to the presence
of adhesions was not experienced in the present study. The observation of large
quantities of an amorphous substance in a half of the samples was a new finding
which does not appear to have been reported before. Its exact significance is
unclear.
Although laparoscopic peritoneal cytology was found to have been insensitive (23%)
in identifying patients with unresectable tumours, the predictive value of a positive
result was 100% and was associated with tumour unresectability due to metastatic
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Table 6.4
Summary of studies of peritoneal cytology in assessment of patients with
















5 / 20 = 25%
(all laparotomy)





















3 / 36 = 8%
(all laparotomy)








2/ 15 = 13%
(all laparotomy)













4 / 60 = 7%
(laparoscopy 29)
(laparotomy 31)








Present study 7/46 = 15%
(all laparoscopy)








PPC = number of patients with prior percutaneous needle biopsy / aspiration
cytology who had positive peritoneal cytology
§ resectability in 35 patients with cancer of the pancreatic head only. Palliative
resection in one patient with positive peritoneal cytology.
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disease in all seven cases. However, laparoscopic peritoneal cytology contributed no
additional staging information, all seven patients with positive results having been
shown to have metastases within the peritoneal cavity by laparoscopy, LapUS and
biopsy. These observations concur with those of Martin and Goellner and Lei
310and co-workers who also reported positive peritoneal cytology exclusively in the
context of intraabdominal metastases, while Leach and colleagues documented
distant metastatic disease at a median of 4.8 months after diagnosis in the four
31 9
patients with positive cytology in their study . These findings are at variance with
1S1those initially reported by Warshaw during 1985-1990 , who observed that of 12
out of 40 patients with positive peritoneal cytology, only one was associated with a
visible surface tumour implant. All 12 patients with positive cytology in the latter
study were found to have locally advanced tumour, while all six patients with liver
9^7
metastases had yielded negative peritoneal cytology . These disparate results were
not reproduced in subsequent work from the same group which showed a significant
association between positive peritoneal cytology and visible intra-abdominal tumour
9QC
spread (45%, versus 8% in patients without metastases) . However, 31% of
patients with positive peritoneal cytology were said to have been unresectable
because of vascular invasion.
It is pertinent to note that none of the 49 patients found to have malignant peritoneal
cytology in seven studies256'257'295'310-312 (including the seven patients in the
present study) have undergone potentially curative pancreatoduodenectomy,
although a palliative resection with grossly positive resection margins was
9S7
performed in one patient in Warshaw's series .
If transcoelomic spread of exfoliated cancer cells is accepted as the likely
mechanism whereby peritoneal tumour seedlings become established, then the
failure to detect malignant cells in four out of eight patients with serosal
dissemination was surprising and may indicate the need for better methods of
313
retrieval, or more sensitive analytical methods such as immunocytology .
Nevertheless, peritoneal cytology must be readily undertaken utilising existing
hospital resources if it is to become useful as a routine staging investigation, and it is
within this context that these results should be interpreted. Alternatively, and based
on an assumption that there were no false negative results in this, or other studies,
the observation that peritoneal carcinomatosis is not always associated with
cytologically demonstrable malignant cells within the peritoneal cavity supports an
alternative hypothesis that peritoneal dissemination of malignancy is established by
the haematogenous or lymphatic route.
183
957As described in Section 1.2.9, it has been suggested that needle biopsy or surgical
07 o 1 r\
mobilisation of the pancreas ' may be significant in the dissemination of cancer
cells into the peritoneal cavity, and that such tumour disturbance might be implicated
in establishing tumour unresectability as reflected by positive peritoneal cytology .
Such observations have stimulated recommendations that injudicious percutaneous
757
or transduodenal biopsy of potentially resectable pancreatic tumours be avoided '
Preoperative percutaneous needle biopsy of the pancreas was performed too
infrequently in the present study to allow definite conclusions regarding its
association with malignant peritoneal cytology or tumour dissemination.
Nevertheless, three out of four such patients were found to be unresectable with
cytologically malignant ascites, although all had presented with advanced tumours,
three of which were situated in the pancreatic body. The possibility that such
advanced and unresectable tumours were the source of positive peritoneal cytology,
irrespective of subsequent biopsy, is a confounding factor which cannot be excluded.
257A similar criticism can be made of Warshaw's original report , and it is
noteworthy that further work in the same institution subsequently revealed no
significant difference between patients with positive laparoscopic peritoneal
705
cytology who had undergone biopsy (27%) and those who had not (15%) .
Furthermore, the association between positive peritoneal cytology, unresectability
and prior percutaneous FNA biopsy has since been refuted by Leach and
017
colleagues who reported a series of 60 patients with pancreatic cancer, of whom
49 (82%) had previously undergone biopsy. When these were compared with 11
patients in whom no biopsy had been attempted, they found no significant
differences in the incidence of positive peritoneal cytology (6% versus 9%),
"eventual peritoneal failure" (10% versus 18%) or disease-free survival .
oiq 9S7
Malignant peritoneal cytology has previously been detected in 9% and 50% of
patients with pancreatic cancer associated ascites, while Garrison and colleagues
reported positive cytology in 52 out of 92 patients (57%) with clinically evident
90Q
malignant ascites associated with a variety of intraabdominal tumours . The
results of the present study suggest that patients who are found to have small
quantities of ascitic fluid on laparoscopy should not necessarily be considered as
257 oin
having a poor prognosis, which concurs with the views of others ' . Indeed,
five out of nine such patients proved to be peritoneal cytology negative, one of
whom with a localised periampullary carcinoma was found to be suitable for tumour
resection with curative intent.
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The case of malignant port site seeding in the present study gives cause for concern.
There have been two other case reports of malignant seeding to the parietes
oni on9
following laparoscopy in patients with pancreatic cancer ' , and one instance of
O 1 c
needle track seeding of pancreatic cancer following percutaneous FNA biopsy .
The patient reported herein had presented with malignant ascites and peritoneal
carcinomatosis following a recent, albeit negative, percutaneous needle biopsy of a
carcinoma of the pancreatic body, and was clearly at increased risk of such an
occurrence. Although there has been increasing concern regarding the risks of port
site seeding following laparoscopy in patients with a variety of intraabdominal
malignancies, the majority of reported cases have been in the context of therapeutic
01/
laparoscopy in patients with gallbladder or colorectal cancers . Although, as
discussed in Studies 2 and 3, the benefits of staging laparoscopy in the evaluation of
selected patients with pancreatic cancerappear to outweigh such potential risks, it
would also seem prudent to recommend that laparoscopic biopsy or manipulation of
potentially resectable tumours be avoided. The incidence and mechanisms of
malignant seeding in the context of laparoscopy clearly require further attention.
The grave prognosis associated with positive laparoscopic peritoneal cytology in the
ocz: 9^7 910 919
present study concurs with the findings of other studies ' ' ' that positive
peritoneal washings are an indicator of advanced disease, characterised by
unresectability, early metastasis and short survival. Nevertheless, the results of the
present study do not support the adoption of routine peritoneal cytology as a useful
adjunct to staging laparoscopy in the detection of patients with unresectable tumours.
However, the available information suggests that those patients with positive
peritoneal cytology have an appalling prognosis irrespective of tumour stage. The
identification of this subgroup of patients with a short life expectancy may therefore
aid clinical decision making such as the appropriateness of adjuvant therapy or
palliative surgical intervention.
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Chapter 7 Summary and Conclusions
The results of the studies comprising this thesis have verified the feasibility and
safety of laparoscopy with LapUS as an imaging investigation in a tertiary referral
population of patients with suspected pancreatic and periampullary cancer.
Staging laparoscopy was shown to be highly sensitive (83-94%) in the detection and
biopsy of distant intraabdominal metastases, and was significantly superior to USS,
CT and / or SVA in this role. Its clinical impact was to prevent unnecessary
laparotomy in 30-35% of patients studied, although laparoscopy was of limited
utility as a diagnostic and staging modality in the absence of disseminated
malignancy. Nevertheless, these findings support routine staging laparoscopy as a
prelude to laparotomy in any patient considered to have potentially resectable
pancreatic or periampullary cancer.
Having devised a systematic method for LapUS examination of the hepatobiliary
and pancreatic region, the ability of LapUS to identify defined anatomical points of
reference was demonstrated in the majority of patients. The technique is inherently
operator dependent and a "learning curve" effect seemed likely. Most difficulty was
experienced in identifying the superior mesenteric artery and coeliac axis (20-22%),
and the distal reaches of the common bile duct and papilla (15-25% after the first 40
examinations).
Laparoscopic ultrasonography was highly sensitive (82-96%) in demonstrating the
presence of a primary pancreatic or periampullary malignant lesion. The presence of
pancreatic carcinomas with a diffusely infiltrative and isoechoic appearance was
identified as a potential pitfall. Independent comparison with USS, CT and SVA
showed these diagnostic modalities to be less sensitive (66-93%).
Laparoscopy with LapUS was shown to be superior to laparoscopy alone in the
overall staging of patients with pancreatic or periampullary cancer, primarily
because of its ability to identify tumour invasion of the portal-superior mesenteric
vein. In this regard, there was minimal tendency to overstage the tumour (0-4%) as
verified by surgical validation of positive findings. Understaging of local tumour
invasion by LapUS was encountered more frequently, and LapUS was shown to be
fallible in demonstrating peripancreatic soft tissue invasion. Although LapUS was
as least as predictive of tumour resectability (73%) as USS, CT and SVA (58-64%),
there were no significant differences in this respect. However, the tendency for the
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latter "conventional" investigations to overstage local tumour stage in our study was
a cause for concern. No patient should therefore be denied exploratory laparotomy
with a view to 'curative' pancreatic resection on the sole basis of an USS, CT or
SVA result.
All the techniques studied were ultimately unreliable in determining lymph node
status on the conventional basis of node size alone. Better criteria must be devised
for differentiating malignant from reactive lymph nodes, and no patient should be
denied surgical intervention on this basis without biopsy confirmation of nodal
metastases. This highlights a deficiency of the LapUS technique with regard to the
accurate retrieval of tissue specimens, and further development of LapUS-targeted
needle biopsy (or aspiration cytology) is required.
Laparoscopic peritoneal cytology was simple to perform and yielded results which
were not affected by inter-observer variation. Positive results were relatively rare
(15%), and always reflected overt intraabdominal metastatic disease which had been
obvious during laparoscopy. However, the appalling survival of the sub-group of
patients with positive laparoscopic peritoneal cytology suggested that this technique
might be useful in identifying patients with a particularly poor prognosis.
Concealed port-site bleeding and malignant seeding to the parietes were identified as
potential complications. The former was of little clinical consequence and should be
minimised by careful technique. Port-site tumour implantation remains a cause for
concern although seems to be rare and occured in a patient with short life expectancy
without influencing survival.
The work in this thesis permits the proposal of a rationalised staging algorithm for
the investigation of patients with suspected pancreatic or periampullary cancer
(Figure 47). Transabdominal USS remains the first-line treatment for establishing
the diagnosis of extrahepatic biliary obstruction, and for excluding (or confirming by
guided-biopsy) the presence of obvious liver metastases. Confirmation of biliary
obstruction by ERCP (and treatment by biliary stent insertion where appropriate)
also remains standard practice. The next stage of the algorithm might be addressed
appropriately by laparoscopy with LapUS. The rationale for omitting Doppler USS
and CT as staging investigations at this juncture rests with the relative insensitivity
of these modalities in detecting "occult" intraabdominal metastases, a role where
laparoscopy has been shown to be uniquely performant. Furthermore, compared
with USS and CT, local tumour staging by LapUS is as least as sensitive and
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predictive in determining tumour resectability, and much less likely to overestimate
tumour stage. The abandonement of SVA in the routine investigation of patients
with pancreatic or periampullary cancer is supported, both from the point of view of
local tumour staging, and that of demonstrating the peripancreatic arterial anatomy.
Figure 47
Proposed staging algorithm for patients with potentially resectable pancreatic
or periampullary carcinoma
However, these proposals should be considered in the context of the the prevailing
expertise in radiological imaging and the philosophy of the clinicians practising in
the Department of Surgery where this work was undertaken. These conclusions will
not necessarily be applicable to all hospitals, and the reproducibility of these LapUS
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findings in other institutions is required before it can be adopted as a routine staging
modality by the wider surgical community. Clearly the pattern of patient referrals to
a particular hospital would influence the feasibility of such an approach.
Laparoscopy with LapUS is inherently operator dependent and a learning curve
phenomenon was identified during the course of the work presented herein. While
the general surgeon may acquire sufficient skill with LapUS to demonstrate the
important hepatobiliary and peripancreatic anatomical structures during operations
such as laparoscopic cholecystectomy, it does not necessarily follow that this will
ensure accurate staging of patients with pancreatic and periampullary malignancy. It
would seem appropriate thereforethat the inexperienced laparoscopic
ultrasonographer validate his initial findings against a recognised "benchmark" (e.g
surgical exploration).
Investigative algorithms may need to be revised as newer imaging techniques
become available, while further evaluation and validation of future biotechnologies
will be required prior to integration into clinical use. Already, comparison of
laparoscopy and LapUS with alternatives such as EUS and spiral CT scanning is
desirable to evaluate the relative merits of each in the staging of patients with
pancreatic or periampullary cancer.
Finally, the advent of laparoscopic techniques for the minimal access palliation of
patients with established or impending malignant biliary and / or duodenal
obstruction will introduce a further treatment option into an already complex
situation. Neverthless, the establishment of such an alternative management stategy
for patients with unresectable tumours would clearly benefit from accurate methods
of laparoscopic staging such as that provided by LapUS. Such issues should be
addressed by further clinical studies, and ideally these would incorporate measures
of endpoints such as quality of life and health economic factors.
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Ex vivo examinations were performed using an Aloka UST-5521-7.5 laparoscopic
ultrasound probe connected to an Aloka SSD 500 portable scanner. A tissue
mimicking test was used to objectively assess a number of single image
017
parameters . The test object ('Cardiff test object', Diagnostic Sonar Ltd,
Livingstone, Scotland, UK) contained a gelatin base loaded with graphite particles
and an array of 0.15mm stainless steel wires as specified in British Standards
017
BS5724 . The gelatin / graphite mixture gives the speckled appearance of tissue
parenchyma and has an attenuation of 0.86 dB cm"1 MHz"1 and a speed of sound of
1539 ms"1. The probe was coupled to the test object using a shallow water bath.
With the time gain compensation controls set to give a uniform speckle pattern to as
great a depth as possible, the speckle pattern could be imaged to a depth of 27 mm
using low contrast penetration, and to greater than 50 mm in depth using high
contrast penetration. The transducer "dead zone" was estimated to be < 1 mm.
Optimum lateral resolution of 2.0 - 3.0 mm was obtained between 3 and 27 mm from
the transducer face. Over the same depth range the axial resolution was estimated to
be 0.8 ±0.1 mm.
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Appendix B
Pancreatic and AmpuIIary Cancer Staging Study: Laparoscopy
Name: Date: Surgeon:
Tumour seen? Yes/No Ascites: Yes/No
Secondary signs of biliary obstruction:
Unresectahilitv Details








Peritoneal Cytology: +ve /-ve / equivocal /not done
Biopsy: Yes /No Site:
Laparoscopic Ultrasonography
Result: +ve /-ve










Distant mets: Liver Yes /No
Guided Biopsy: Yes/No +ve /-ve






[ ] Tx Cannot be assessed
[ ] To No evidence of primary tumour
[ ] Tj Tumour limited to the pancreas (or ampulla)
[ ] T2 Tumour extends directly to duodenum, bile duct or peripancreatic tissues
[ ] T3 Tumour extends directly to major vessels, stomach, spleen or colon
Lymph Nodes (N) Distant Metastases (M)
[ ] Nx Cannot be assessed [ ] Mx Cannot be assessed
[ ] No No lymph node metastases [ ] Mo No distant metastases
[ ] N1 Regional lymph node metastases [ ] Mi Distant metastases
Lap US Findings: Intrahepatic duct dilatation Yes /No
CBD Yes/No Size: mm
PD Yes/No Size: mm





Decision: Resectable / Unresectable
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Appendix C
Pancreatic and Ampullary Cancer Staging Study: USS Examination
Name: Date:
Tumour seen: Yes/No /Possibly Biliary endoprosthesis: Yes/No





Regional lymphadenopathy (>5mm): Yes/No
Vascular involvement: Yes /No
Distant metastases: Liver Yes/No
Peritoneal Yes/No
Primary tumour (T)
[ ] Tx Cannot be assessed
[ ] To No evidence of primary tumour
[ ] Ti Tumour limited to the pancreas (ampulla)
[ ] T2 Tumour extends directly to duodenum, bile duct or peripancreatic tissues
[ ] T3 Tumour extends directly to major vessels, stomach, spleen or colon
Lymph Nodes (N)
[ ] Nx Cannot be assessed
[ ] Nq No lymph node metastases
Distant Metastases (M)
[ ] Mx Cannot be assessed
[ ] Mo No distant metastases
[ ] N1 Regional lymph node metastases [ ] Mi Distant metastases
Decision: Resectable / Unresectable
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Appendix D
Pancreatic and Ampullary Cancer Staging Study: CT Examination
Name:
Tumour seen? Yes /No/Possibly



















[ ] Tx Cannot be assessed
[ ] To No evidence of primary tumour
[ ] T] Tumour limited to the pancreas (ampulla)
[ ] T2 Tumour extends directly to duodenum, bile duct or peripancreatic tissues
[ ] T3 Tumour extends directly to major vessels, stomach, spleen or colon
Lymph Nodes (N)
[ ] Nx Cannot be assessed
[ ] Nq No lymph node metastases
Distant Metastases (M)
[ ] Mx Cannot be assessed
[ ] Mq No distant metastases
[ ] N1 Regional lymph node metastases [ ] M1 Distant metastases
Decision: Resectable / Unresectable
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Appendix E
Pancreatic and Ampullary Cancer Staging Study: Angiography
Name: Date:











































Decision: Resectable / Unresectable
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Appendix F
Pancreatic and Ampullary Cancer Staging Study - Patient Details
Name: DOB: Male /Female Age: yrs
Presenting symptoms:
Mode of diagnosis prior to referral:
ERCP: Yes/No Date: Findings:
Biliary endoprosthesis: Yes/No
Preoperative biopsy: Yes/No +ve /-ve /equivocal Method:
Surgical Staging / Final Outcome
Operation: Yes /No Date:
Resectable: Yes/No Procedure:
Primary tumour (T)
[ ] Tx Cannot be assessed
[ ] To No evidence of primary tumour
[ ] Ti Tumour limited to the pancreas (ampulla)
[ ] T2 Tumour extends directly to duodenum, bile duct or peripancreatic tissues
[ ] T3 Tumour extends directly to major vessels, stomach, spleen or colon
Lymph Nodes (N) Distant Metastases (M)
[ ] Nx Cannot be assessed [ ] Mx Cannot be assessed
[ ] No No lymph node metastases [ ] Mo No distant metastases
[ ] N1 Regional lymph node metastases [ ] Ml Distant metastases
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Objective
The authors performed a prospective evaluation of staging laparoscopy with laparoscopic
ultrasonography in predicting surgical resectability in patients with carcinomas of the pancreatic
head and periampullary region.
Summary Background Data
Pancreatic resection with curative intent is possible in a select minority of patients who have
carcinomas of the pancreatic head and periampullary region. Patient selection is important to plan
appropriate therapy and avoid unnecessary laparotomy in patients with unresectable disease.
Laparoscopic ultrasonography is a novel technique that combines the proven benefits of staging
laparoscopy with high resolution intraoperative ultrasound of the liver and pancreas, but which has
yet to be evaluated critically in the staging of pancreatic malignancy.
A cohort of 40 consecutive patients referred to a tertiary referral center and with a diagnosis of
potentially resectable pancreatic or periampullary cancer underwent staging laparoscopy with
laparoscopic ultrasonography. The diagnostic accuracy of staging laparoscopy alone and in
conjunction with laparoscopic ultrasonography was evaluated in predicting tumor resectability
(absence of peritoneal or liver metastases; absence of malignant regional lymphadenopathy;
tumor confined to pancreatic head or periampullary region).
Results
"Occult" metastatic lesions were demonstrated by staging laparoscopy in 14 patients (35%).
Laparoscopic ultrasonography demonstrated factors confirming unresectable tumor in 23
patients (59%), provided staging information in addition to that of laparoscopy alone in 20 patients
(53%), and changed the decision regarding tumor resectability in 10 patients (25%). Staging
laparoscopy with laparoscopic ultrasonography was more specific and accurate in predicting
tumor resectability than laparoscopy alone (88% and 89% versus 50% and 65%, respectively).
Conclusions
Staging laparoscopy is indispensable in the detection of "occult" intra-abdominal metastases.
Laparoscopic ultrasonography improves the accuracy of laparoscopic staging in patients with
potentially resectable pancreatic and periampullary carcinomas.
Methods
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Accurate tumor staging is important for selecting pa¬
tients with carcinoma of the head of the pancreas in
whom it may be appropriate to attempt pancreatic resec¬
tion with curative intent. Unfortunately, the natural his¬
tory of ductal adenocarcinoma of the pancreas is such
that only a minority of patients prove to be candidates
for curative resection. Signs of advanced disease fre¬
quently are present at operation, leaving surgical pallia¬
tion of established or impending duodenal or biliary ob¬
struction the only surgical option. The availability of en¬
doscopic1 and percutaneous2 biliary intubation and,
more recently, the development of laparoscopic duode¬
nal and biliary bypass,3,4 has reinforced the need to iden¬
tify patients with unresectable disease who might avoid
unnecessary laparotomy. Ideally, the preoperative as¬
sessment of patients with malignant biliary obstruction
should include investigations that are sensitive in detect¬
ing localized and potentially curable lesions, and at the
same time, specific enough to identify factors that render
the tumor unresectable.
The pancreas is a difficult organ to evaluate radiologi-
cally because of its anatomic location within the retro-
peritoneum and its intimate relationship with the adja¬
cent viscera and major vascular structures. Although the
continued development of modern radiologic tech¬
niques has been accompanied by an apparent decline in
the incidence of "nontherapeutic" laparotomy for pan¬
creatic carcinoma,5 it also has been recognized increas¬
ingly that imaging modalities, such as ultrasonography,
computed tomography (CT), magnetic resonance im¬
aging, and selective visceral angiography, may not al¬
ways be sufficiently accurate in staging pancreatic can¬
cer, even when used in combination.6 Several authors
have stressed the inability of these techniques to detect
"occult" metastatic deposits within the peritoneal cavity
and liver. Discovery of such lesions at the time of lapa¬
rotomy will curtail the intended operative procedure,
whereas their failure to detect them before resection sur¬
gery results in early tumor recurrence. These limitations
of imaging techniques have supported recommendations
for routine laparoscopy as a highly sensitive means of
detecting lesions that cannot be resected.7"10 Laparo¬
scopic ultrasonography is a new technique that provides
the surgeon with a sensitive means ofdetecting small me¬
tastases within the peritoneal cavity by direct inspection
and allows assessment of local tumor invasion, regional
nodal involvement, and distant metastatic spread to the
liver using high resolution, real-time. B-mode ultra-
Address reprint requests to Mr. T. G. John. F.R.C.S.. Lecturer in Sur¬
gery, Department of Surgery. University of Edinburgh, The Royal
Infirmary, Lauriston Place. Edinburgh EH3 9YW. Scotland. U.K.
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sound. We already have reported encouraging prelimi¬
nary results with laparoscopy and laparoscopic ultraso¬
nography in the assessment of patients with pancreatic
tumors" and liver malignancy.12,13 In this prospective
study, we report the use of laparoscopy with laparoscopic
ultrasonography in the evaluation of resectability in pa¬
tients with carcinoma of the head of the pancreas and
periampullary region.
PATIENTS/METHODS
From January 1991 to September 1993, 40 patients di¬
agnosed as having pancreatic or periampullary carcinoma
were considered, at the time of referral to our department,
as candidates for tumor resection with curative intent ei¬
ther by pancreatoduodenectomy or by transduodenal local
resection. Patients considered unsuitable for surgical inter¬
vention for reasons of advanced age, infirmity, or pre¬
viously recognized distant metastases were not evaluated
laparoscopically or by angiography and have not been in¬
cluded in this study. Failure to achieve laparoscopic access
to the peritoneal cavity occurred in one patient with adhe¬
sions from a previous laparotomy, and this patient has
been excluded from further analysis. The diagnosis usually
was made on endoscopic retrograde cholangiopancreatog¬
raphy (ERCP), transabdominal ultrasonography, or dy¬
namic CT scanning, and histopathologic confirmation was
obtained in each case. All patients were managed according
to an algorithm in which staging laparoscopy with laparo¬
scopic ultrasonography was followed by angiography be¬
fore assessment of tumor resectability at exploratory lapa¬
rotomy. Preoperative radiologic assessment typically com¬
prised transabdominal ultrasonography and intravenous
enhanced (dynamic) CT scanning. A variety of scanning
techniques and equipment were employed by the various
referring hospitals, and such investigations were repeated
only if our unit radiologist considered them to be inade¬
quate.
After laparoscopy with ultrasonography was performed,
selective visceral angiography was undertaken in patients
1) with no evidence ofmetastatic tumor spread and disease
that still was considered operable or 2) a tumor that was
considered inoperable because of locoregional extension,
but in whom further evaluation of these findings was con¬
sidered appropriate before surgical exploration. The tech¬
nique of selective visceral angiography employed in this
study has been described previously.14 Histopathologic
confirmation always was obtained, either after examina¬
tion of the surgically resected specimen, by needle biopsy
of the primary tumor, by luminal biopsy of periampullary
tumors during ERCP. or after biopsy ofmetastatic deposits
during laparoscopy or laparotomy.
Laparoscopic ultrasonography was performed under
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general anesthesia by a standardized technique that has
been described previously.13'15 Briefly, two disposable
10/n-mm laparoscopic cannulae (Endopath, Ethicon
Ltd., Edinburgh. United Kingdom) were inserted at the
umbilicus and right flank, and a thorough inspection of
the abdominal cavity was performed using a 30-degree
telescope. Particular attention was paid to evidence of
metastatic disease involving the liver, mesenteric and hi¬
lar lymph nodes, and all visible serosal surfaces. No at¬
tempt was made to enter the lesser sac to visualize the
pancreas directly.
Laparoscopic ultrasonography was performed using a
9-mm diameter linear-array contact ultrasound probe
(Aloka UST-5521-7.5, Keymed Ltd., Southend-on-Sea,
United Kingdom), connected to an Aloka SSD-500 B-
mode portable ultrasound machine. Both the ultrasound
and laparoscopic images were viewed simultaneously us¬
ing "picture-in-picture" visual mixing. The liver was ex¬
amined for evidence of metastatic disease, and the hilar,
peripancreatic, and para-aortic regions were examined
for lymphadenopathy. Identification of regional lymph
nodes larger than 10 mm in diameter was interpreted as
evidence of tumor unresectability, and where possible,
this was confirmed by biopsy during laparoscopy or sub¬
sequent laparotomy. The criteria used to define primary
tumor advancement and locoregional irresectability
were as follows: 1) tumor size of 5 cm or greater; 2) ex-
trapancreatic invasion of adjacent tissues (i.e., duode¬
num, stomach, common bile duct, retroperitoneum);
and 3) occlusion or stenosis of the portal or superior mes¬
enteric veins, or major branches of the celiac trunk or
superior mesenteric artery (with the exception of the gas-
troduodenal artery). Laparoscopic ultrasonography was
performed and interpreted by members of the surgical
team (OJG/TGJ) and was undertaken as a separate pro¬
cedure from laparotomy. The entire laparoscopic exam¬
ination always was completed within 30 minutes.
Locoregional resectability of tumor ultimately was de¬
termined by an experienced pancreatic surgeon (DCC or
OJG) at the time of exploratory laparotomy. Palpation,
mobilization, and trial dissection of the head and neck of
the pancreas were performed to assess the extent of the
tumor and its relationship with the adjacent vascular and
visceral structures as described elsewhere.16'17 Intraoper¬
ative ultrasound scanning of the liver was performed to
detect nonvisible liver metastases and guide needle biop¬
sies (5-MHz linear-array contact ultrasound probe,
Aloka UST-587T-5, Keymed Ltd.). In patients whose
earlier laparoscopic findings had contraindicated further
assessment of resectability at open operation, tumor un¬
resectability always was confirmed by biopsy of intra-ab¬
dominal metastases or by selective visceral angiography
when vascular invasion was suspected. Data were tabu¬
lated using a standard 2X2 matrix analysis,18 whereb\
the actual tumor resectability (negative) or "irresectabil¬
ity" (positive) was correlated with that predicted by the
operator (true or false) after laparoscopy/laparoscopic
ultrasonography. The sensitivity, specificity, and overall
accuracy of the prediction regarding resectability was ex¬
pressed for laparoscopy alone, and in combination with
laparoscopic ultrasonography. These staging parameters
were not assigned to laparoscopic ultrasonography inde¬
pendent of the findings on prior laparoscopic examina¬
tion.
RESULTS
Forty consecutive patients underwent staging laparos¬
copy (22 women, 18 men; median age 59 years [range
36-78 years]). 38 ofwhom also underwent laparoscopic
ultrasonography. Endoscopic insertion of a biliary stent
had been performed previously in 21 patients (53%).
Procedure-related complications were encountered in
one patient in whom an asymptomatic port-site hemor¬
rhage had occurred with the discovery of intraperitoneal
blood at laparotomy 6 days later (2.5% complication
rate).
Laparoscopy (n = 40)
It was not possible to directly inspect the primary tu¬
mor in any patient during the laparoscopic examination,
although it was occasionally possible to palpate a retro-
gastric mass with the tip of the ultrasound probe. Tumor
resectability was inferred correctly from the absence of
signs of dissemination within the abdominal cavity in all
12 patients considered resectable (i.e., 100% sensitivity).
Previously unsuspected metastatic tumor spread to the
liver (ten patients), peritoneal surfaces (eight patients)
(Fig. 1), and hilar lymph nodes (two patients) were iden¬
tified during laparoscopy in a total of 14 patients (35%).
Biopsy material was obtained and metastatic carcinoma
was confirmed in each case. Exploratory laparotomy
was, therefore, withheld from these patients, who in
terms ofpredicting resectability, were regarded as having
undergone "true positive" laparoscopic staging exami¬
nations (Table 1).
Laparoscopy failed to detect malignant dissemination
to distant sites within the abdominal cavity in three pa¬
tients (i.e., "false-negative" procedures). In one patient,
a cluster of tiny peritoneal tumor deposits were con¬
cealed by adhesions in the right subhepatic space and
were not recognized by the laparoscopist. Liver metasta¬
ses were not demonstrated laparoscopically in three pa¬
tients. In one case, laparoscopic biopsy of a suspicious
subcapsular lesion indicated biliary ectasia, although bi-
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Figure 1. Preoperative staging laparoscopy performed in a patient
thought to have a resectable periampullary carcinoma revealed a small
white nodule situated at the junction of the falciform ligament and capsule
of the left hepatic lobe. Laparoscopic biopsy confirmed metastatic adeno¬
carcinoma. There was no other evidence for extrapancreatic spread of
tumor.
opsv at open operation confirmed metastatic carcinoma.
A 10-mm metastasis within the caudate lobe, a region
not always readily accessible to laparoscopic inspection,
was demonstrated by laparoscopic ultrasonography in
another patient. A small tumor deposit on the free edge
of the right lobe of the liver was discovered during lapa¬
rotomy after an unremarkable laparoscopy in a third pa¬
tient. A delay of 2 months had ensued between laparos¬
copy and laparotomy in this deeply jaundiced patient.
Ultimately, unsuspected small liver and peritoneal tu¬
mor deposits were demonstrated after laparoscopy, lap¬
aroscopic ultrasonography, or laparotomy in 17 of the
40 patients (43%).
Laparoscopy alone failed to identify the 12 patients
(30%) with locoregional tumor unresectability, which
subsequently was demonstrated by laparoscopic ultraso¬
nography, angiography, or operative assessment. Over¬
all. there were 14 false-negative laparoscopic examina¬
tions, including those where distant metastases were
overlooked, resulting in a specificity of only 50% in pre¬
dicting resectability and an overall accuracy of 65% for
staging laparoscopy (Table 1).
Laparoscopic Ultrasonography (n = 38)
Satisfactory images of the primary pancreatic/periam-
pullarv lesion were obtained using laparoscopic ultraso¬
nography in 31 patients (82%) (Figs. 2 and 3). The pan¬
creatic duct was identified proximal to the obstructing
mass lesion in 31 cases, in 23 (74%) ofwhom duct dila¬
tation >3 mm was observed. In each case, the sono¬
graphic appearance of the primary tumor was of a pre¬
dominantly heterogeneous hypoechoic mass (Fig. 3).
Factors indicating tumor unresectability were identified
correctly by laparoscopic ultrasonography in 23 cases
(61%), namely the following: liver metastases (10 pa¬
tients); locally invasive tumor measuring >5 cm (12 pa¬
tients); and vascular involvement with tumor (12 pa¬
tients) (Fig. 3). In addition, regional lymph node enlarge¬
ment > 10 mm was identified in 14 patients (Fig. 4), and
biopsies were obtained to confirm malignant infiltration
in three cases. In those patients without biopsy proof of
malignant lymphadenopathy, tumor unresectability al¬
ways was confirmed by the other criteria outlined above.
In 20 patients (53%), information relevant to the assess¬
ment of tumor stage—and not apparent after laparos¬
copy—was derived from the laparoscopic ultrasound ex¬
amination. This new staging information altered the
decision concerning tumor resectability based on lapa¬
roscopy alone in 10 patients (25%). Six of these ten pa¬
tients had locally advanced tumors >5 cm in diameter,
eight had invasions of the adjacent superior mesenteric
and portal venous trunk (Fig. 3), and. as detailed above,
one patient had metastatic liver disease, which had re¬
mained undetected during laparoscopy. Enlarged re¬
gional lymph nodes also were demonstrated in six of
these patients, although biopsies were not obtained. Hav¬
ing correctly predicted tumor unresectability in 23 of 26
patients, these factors were responsible for increasing the
specificity and accuracy to 88% and 89%, respectively
(Table 2).
Failure of the surgeon performing laparoscopic ultra¬
sonography to recognize tumor invasion of the superior
mesenteric and main portal vein in one patient and tu¬
mor infiltration of the common bile duct and pylorus
in another yielded false-negative results for laparoscopic
ultrasound. In another patient, laparoscopic ultrasonog-
Table 1. PREDICTION OF RESECTABILITY
BY STAGING LAPAROSCOPY IN 40







Sensitivity = 12/12 = 100%; specificity = 14/28 = 50%; accuracy = 26/40 = 65%.
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Figure 2. Laparoscopic ultrasonog¬
raphy was performed in a patient sus¬
pected of having a periampullary tu¬
mor, causing obstructive jaundice, al¬
though no mass lesion was identified
by other investigations. The linear-ar¬
ray probe has been placed on the
duodenum (insert), and the rectilinear
sonogram obtained defined a 10-mm
periampullary carcinoma. This tumor
was deemed to be resectable and







raphy suggested local infiltration of the duodenum with
tumor, but this finding was not confirmed at laparotomy,
and the patient underwent a Whipple operation. This
represents the only false-positive laparoscopic ultra¬
sound examination, accounting for the sensitivity of92%
observed for laparoscopic ultrasonography in recogniz¬
ing resectable disease (Table 2).
Outcome
Twenty-two patients (55%) progressed to laparotomy
and operative assessment of resectability; 12 were con¬
sidered to have resectable tumors (30% overall resectabil¬
ity). Pancreatoduodenectomies were performed in ten
patients, and one patient underwent transduodenal re¬
section ofa periampullary adenocarcinoma. Another pa¬
tient, in whom resectability of a periampullary carci¬
noma was confirmed at laparotomy, became profoundly
hypotensive, and it was considered appropriate to per¬
form a biliary bypass rather than attempt pancreatic re¬
section on this occasion. This patient is alive and well at
8 months, with no evidence of disease progression. The
patient has refused further surgery and for the purposes
of this study, has been classified as having resectable dis¬
ease. Palliative biliary and duodenal bypass procedures
were performed in ten patients in whom tumor unresect-
ability was confirmed at laparotomy.
DISCUSSION
For the majority of patients with ductal adenocarci¬
noma of the exocrine pancreas, the outlook is bleak.19 It
Figure 3. A laparoscopic sono¬
gram in the region of the neck of the
pancreas (parasagittal cut) has de¬
fined a 20-mm diameter hypoechoic
carcinoma within the head of the
pancreas, causing a stenosis of the
adjacent superior mesenteric—por¬
tal vein. The constant appearance
of a venous stenosis during real¬
time scanning in several planes was
interpreted as "irresectable" vascu¬
lar involvement. Selective visceral
angiography with portography
(right) corroborated the appear¬
ances of tumor invasion at the con¬
fluence of the portal, superior mes¬
enteric and splenic veins (arrow).
PV = portal vein; SMA = superior
mesenteric artery
Tumour
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Figure 4. With the laparoscopic ul¬
trasound probe placed on the stom¬
ach (inset), a sagitally orientated
sonogram defining the origin of the
celiac axis from the aorta has been
obtained. A cluster of enlarged para¬
aortic lymph nodes were identified;
their malignant infiltration was con¬
firmed after laparotomy and biopsy.
The node depicted measures 15 mm
and has a hypoechoic and well-cir¬








is one of the causes of death from cancer encountered
most commonly in surgical practice, its incidence ap¬
pears to be rising,20 and most patients exhibit local inva¬
sion of tumors and distant metastatic spread by the time
symptoms occur. Nevertheless, recent reports indicate
that in experienced hands, potentially curative pancreat¬
icoduodenectomy (Whipple operation) can be under¬
taken with negligible perioperative morbidity and mor¬
tality16'21"23 and a prospect of prolonged survival if it is
discovered an early stage.24
Of those investigations traditionally employed in the
selection of patients with pancreatic and periampullary
carcinoma for resection surgery, ultrasonography is non¬
invasive, repeatable, and relatively inexpensive, al¬
though it is highly operator dependent. Its usefulness as
a hrst-line test in confirming extrahepatic biliary obstruc-
Table 2. PREDICTION OF RESECTABILITY
BY COMBINED STAGING LAPAROSCOPY/
LAPAROSCOPIC ULTRASONOGRAPHY IN








Sensitivity =11/12 = 92%; specificity = 23/26 = 88%; Accuracy = 34/38 = 89%.
tion and for screening the liver for metastatic disease is
widely recognized, and it can be at least as accurate as CT
scanning in determining local resectabilitv of pancreatic
cancer.25'26 However, these results have not been repro¬
duced widely, and in practice, suboptimal imaging of the
retroperitoneal structures caused by overlying bowel gas
and body-wall tissues may limit the usefulness of this
modality.27 High-resolution dynamic CT scanning is re¬
garded widely as the diagnostic and staging investigation
of choice in the assessment of pancreatic cancer28'29 and
has been shown to be more accurate than transabdomi¬
nal ultrasonography.30 However, most studies of CT in
the diagnosis and staging of pancreatic cancer have been
subject to some degree of bias. In a blind analysis of dy¬
namic CT scanning in a random population of patients
with cancer of the pancreas or periampullary region.
Brvde Anderson and colleagues showed that CT was too
inaccurate to recommend its use alone as a staging inves¬
tigation.31 Similarly, Ross and co-workers concluded
that predictions of tumor unresectabilitv based solely on
the CT diagnosis of locally advanced disease were unre¬
liable.32 although not all scans were enhanced with intra¬
venous contrast. There is no evidence that magnetic res¬
onance imaging currently confers any advantage over
dynamic CT scanning in this context10'28
Although some surgeons have successfully resected
segments of the superior mesenteric and portal vein to
achieve extirpation of tumors in the head of the pan¬
creas.16'33"35 most would regard tumor invasion of these
vascular structures as a contraindication to pancreatic
resection with curative intent, and this philosophy was
observed in selecting patients for resection in this study.
Selective visceral angiography has been reported as an
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accurate means of defining locally advanced tumor as
demonstrated by encasement, stenosis, or occlusion of
the extrapancreatic arteries and veins (Fig. 3).36'37 Con¬
versely, angiography can be potentially misleading in
predicting tumor unresectability,16'38 and has been
shown to confer little additional benefit to dynamic CT
scanning.14 29 Nevertheless, it may be of value in con¬
firming tumor unresectability in selected cases in which
doubt persists.16 In the current study, we used angiogra¬
phy primarily as a means of validating the findings of
laparoscopic ultrasonography regarding vascular inva¬
sion. Selective visceral angiography also provides a vas¬
cular road map of the abdomen, but although recogniz¬
ing that peripancreatic vascular anomalies may occur in
30% to 35% of patients with pancreatic and periampul¬
lary carcinoma,14 39'40 not all surgeons would accept that
this justifies routine preoperative arteriography.
Use of laparoscopic ultrasonography to assess pancre¬
atic malignancy seems logical. The detailed view of the
peritoneal cavity at laparoscopy is superior to that pro¬
vided by any other contemporary investigation in detect¬
ing tiny peritoneal tumor deposits and liver metastases
(especially subcapsular lesions measuring less than 10
mm in diameter) (Fig. I)."'31 Although abdominal ultra¬
sound and CT scanning revealed no metastatic disease
in those patients in the current study, this characteristic
pattern of intra-abdominal tumor dissemination ulti¬
mately was demonstrated in 42% of patients. In 83% of
these cases, laparoscopy had been confirmatory, a find¬
ing that supports previous observations.7"10 Neverthe¬
less, the laparoscopist is limited in his/her ability to as¬
sess the primary tumor directly. Although direct laparo¬
scopic inspection of pancreatic tumors from within the
lesser sac has been described well by both infragastric41'42
and supragastric routes,43-45 and although recognizing
that this may be useful in the diagnosis and biopsy of
tumors of the body and tail of the pancreas, it is not,
in practice, a suitable means of assessing resectability of
small inaccessible tumors within the head of the gland.
However, we found that direct apposition of a high-reso¬
lution. linear-array ultrasound transducer at laparoscopy
consistently provided highly detailed images of the pan¬
creas and neighboring retroperitoneal structures (Figs. 2
and 3). Accordingly, it was possible to demonstrate the
signs of local tumor invasion, peripancreatic lymphade-
nopathy (Fig. 4), and vascular invasion (Fig. 3) so that
the combination of laparoscopy and laparoscopic ultra¬
sonography gave a more reliable prediction of tumor un¬
resectability than laparoscopy alone (specificity 88% vs.
50%). A tissue diagnosis was not always obtained in those
cases in which the inability of tumor resection due to ma¬
lignant lymphadenopathy was diagnosed, although this
finding of its own always was supported by other features
precluding resection with curative intent. Nevertheless,
further evaluation is required to determine the reliability
of a laparoscopic ultrasound diagnosis of lymph node
metastases, and biopsy or fine-needle aspiration of en¬
larged nodes is recommended in cases of doubt.
Since Japanese workers described the combination of
A-mode ultrasound scanning with laparoscopy 30 years
ago,46 laparoscopic ultrasonography has evolved to the
extent that ultracompact linear-array B-mode ultra¬
sound probes currently can be used laparoscopically to
obtain high resolution images comparable to those ob¬
tained by intraoperative ultrasonography at laparotomy.
Although intraoperative ultrasound has gained accep¬
tance as the most sensitive method of detecting occult
liver metastases at the time of resection ofprimary colo¬
rectal tumors47 48 and as an indispensable tool in liver
resection,49"52 the technique has had limited application
to the operative assessment of pancreatic carcinoma. It
has been proven useful in the localization of neuroendo¬
crine tumors within the pancreas,53"6' and others have
reported its use in the operative assessment of pancreatic
cancer.58'69 Machi and colleagues recently reported60 that
intraoperative ultrasound was significantly more specific
(86.4% vs. 54.5%) and accurate (89.7% vs. 64.1%) than a
combination of preoperative transabdominal ultrasound,
dynamic CT scanning, and angiography in assessing por¬
tal vein invasion by pancreatic cancer, findings that reflect
our current experience in this context. Several authors
have reported the use of laparoscopic ultrasonography to
confirm the presence of primary pancreatic tumors and
accurately define hepatobiliary and pancreatic anat¬
omy,61"63 and our experience demonstrates its potential
for accurate staging assessment ofpatients with pancreatic
and periampullary cancer, both in relation to distant met¬
astatic spread and locoregional invasion.
Endoscopic ultrasonography offers another impressive
alternative to conventional imaging in evaluation of the
pancreas. Rosch and colleagues assessed tumor size,
lymph node status, and vascular invasion in defining lo¬
cal tumor stage in patients with pancreatic and periam¬
pullary carcinomas,30 whereas Tio and colleagues report
overall accuracies of 92% and 88%, respectively, in the
assessment of local tumor infiltration from pancreatic
and periampullary cancers.64 However, endosonography
cannot be expected to detect peritoneal and liver metas¬
tases, and this is reflected in its overall accuracy of 66%
in TNM staging of pancreatic cancer.64
In this study, we examined the role of staging laparos¬
copy with laparoscopic ultrasonography in a cohort of
patients who would otherwise have been regarded as suit¬
able for operative assessment of tumor resectability. Al¬
though preceding patient selection increased the propor¬
tion of patients with resectable disease and introduced
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an element of bias, we believe that this is representative
of clinical practice if laparoscopic staging were to be in¬
troduced at this point in an investigative algorithm. Our
results suggest that staging laparoscopy is a valuable rou¬
tine undertaking before laparotomy and operative as¬
sessment of resectability in patients with pancreatic and
periampullary cancer. Comparative studies between
conventional investigations and this new technology are
indicated to fully evaluate of the precise role of laparo¬
scopic ultrasound.
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